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ABSTRACT
Ca2+, a “signal for death and life”, is closely involved in the regulation of
numerous important cellular events. Ca2+ carries out its function through its
binding to Ca2+-receptors or Ca2+-binding proteins. The EF-hand protein, with a
helix-loop-helix Ca2+-binding motif, constitutes one of the largest protein families.
To facilitate our understanding of the role of Ca2+ in biological systems (denoted
as “calciomics”) using genomic information, an improved pattern search method
(http://www.chemistry.gsu.edu/faculty/Yang/Calciomics.htm) for the identification
of EF-hand and EF-like Ca2+-binding proteins was developed. This fast and
robust method allows us to analyze putative EF-hand proteins at the genomewide level and further visualize the evolutionary scenario of the EF-hand protein
family.
This prediction method further enables us to locate a putative viral EFhand Ca2+-binding motif within the rubella virus nonstructural protease that
cleaves the nonstructural protein precursor into two active replicase components.
A novel grafting approach has been used to probe the metal-binding properties of

this motif by engineering the predicted 12-residue Ca2+-coordinating loop into a
non-Ca2+-binding scaffold protein, CD2 domain 1. Structural and conformational
studies were further performed on a purified, bacterially-expressed NS protease
minimal metal-binding domain spanning the EF-hand Ca2+-binding motif. It was
revealed that Ca2+ binding induced local conformational changes and increased
thermal stability. Furthermore, functional studies were carried out using RUB
infectious cDNA clone and replicon constructs. Our studies have shown that the
Ca2+ binding loop played a structural role in the NS protease and was specifically
required for optimal stability under physiological conditions.
In addition, we have predicted and characterized a calmodulin-binding
domain in the gap junction proteins connexin43 and connexin44. Peptides
encompassing the CaM binding motifs were synthesized and their ability to bind
CaM was determined using various

biophysical approaches.

Transient

expression in HeLa cells of two mutant Cx43-EYFP constructs without the
putative CaM-binding site eliminated the Ca2+-dependent inhibition of gap
junction permeability. These results provide the first direct evidence that CaM
binds to a specific region of the ubiquitous gap junction protein Cx43 and Cx44 in
a Ca2+-dependent manner, providing a molecular basis for the well-characterized
Ca2+-dependent inhibition of Cx43-containing gap junctions.
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1. Introduction

1.1. The roles of Ca2+ in biological systems and calciomics
Ca2+, a “signal for life and death”, acts as a universal and versatile
messenger in cellular signal transduction, and functions as a pivotal regulator of
the cell life cycle including cell division, differentiation and apoptosis (3). In recent
years, accumulating evidence indicates that Ca2+ even play its unique roles in the
lower form of lives, such as bacteria and viruses (4-6). A new term, calciomics,
has been coined to describe the sophisticated roles of Ca2+ in biological systems
in the post-genomic era.
The versatile speed, amplitude and spatial-temporal patterning of Ca2+ in
eukaryotic cells controls vital biological processes by precisely modulating the
activity of a repertoire of signaling components including cellular receptors, ion
channels, pumps, exchangers, Ca2+ buffers, Ca2+ effectors, Ca2+-sensitive
enzymes and transcription factors in different cellular compartments (Fig. 1.1).
The extracellular space and the internal Ca2+ stores serve as two sources of
cytosolic Ca2+ signals. The temporal Ca2+ signaling pattern is mainly observed as
Ca2+ oscillation in the cytosol, whereas the spatial pattern of Ca2+ is reflected by
Ca2+ spikes and Ca2+ waves due to the dynamic changes of Ca2+ concentration
in different compartments following signal stimulation. In general, the cellular
ionized Ca2+ gradient follows the order of extracellular space ([Ca2+]o: ~10-3 mM)
> sarcoplasmic reticulum (SR)/endoplasmic reticulum (ER) ([Ca2+]ER: ~10-3 mM) >

2
Ca 2+ channels
(ROC/SOC/VOC/TRP)

([Ca2+]e 10–3 M)
PMCA

GPCR
RTK

NCX
Ca 2+

effectors (e.g. CaM, S100)
Ca 2+ buffers (e.g. calreticulin, calbindin D9K)
Ca 2+-sensitive enzymes (e.g., CaMKI-IV, calpain)
Uniporter

([Ca2+]i 10-7- 10–6 M)

IP3R

Golgi
Complex

SERCA
SPCA

IP3R

RyR

NCX/HCX

Mitochondria

RyR

ER/SR
Genes transcription
(NFAT, CREB, DREAM)

([Ca2+]ER10-4- 10–3 M)

Nucleus

Figure 1.1. The choreography of Ca2+ signaling in eukaryotic cells. Upon
extracellular stimulation, the free cytosolic Ca2+ ([Ca2+]c) rapidly increases due
to the entry of extracellular Ca2+ across the plasma membrane via Ca2+
channels, such as voltage-operated channels (VOC), receptor-operated
channels (ROC), transient receptor potential ion-channel (TRP) and storeoperated channels (SOC), or by the release of Ca2+ from internal stores (e.g.,
endoplasmic reticulum (ER), Golgi complex, and lysosomes) through inositol1,4,5-triphosphate receptors (IP3R) and ryanodine receptors (RyR) due to
activation of membrane receptors (G protein coupled receptor (GPCR) and
receptor tyrosine kinase (RTK)) and the subsequent synthesis of IP3. At the
resting state, [Ca2+]c is maintained at submicromolar range by extruding Ca 2+
outside of the plasma membrane via plasma membrane Ca2+-ATPase
(PMCA) and Na+/Ca2+ exchanger (NCX), or by pumping Ca2+ back into
internal stores through sarcoplasmic/endoplasmic reticulum Ca2+-ATPase
(SERCA) or secretory pathway Ca2+-ATPase (SPCA). The Ca2+ signals are
delivered by affecting the activity of Ca2+ buffers, Ca2+ effectors and Ca2+regulated enzymes. The signals can also have “long-term” effects by
modulating the activity of transcriptional factors including nuclear factor of
activated T cells (NFAT), cyclic AMP response element-binding proteins
(CREB) and downstream regulatory element modulator (DREAM).

3
cytosol ([Ca2+]c: ~10-7 M to ~10-5 µM) > other internal calcium stores such as the
mitochondrion ([Ca2+]o: ~10-7 M)

and nucleus ([Ca2+]n: ~10-7 M). Extracellular

Ca2+, sensed by the extracellular Ca2+-sensing receptor, is believed to maintain
the long-term Ca2+ homeostasis by replenishing the internal calcium stores. In
contrast, the internal calcium stores are directly responsible for the changes in
cytosolic Ca2+ concentration through the activity of two principal Ca2+ release
channels, e.g., the ryanodine (RyR) receptor and the inositol 1,4,5-triphosphate
(IP3) receptor (Fig. 1.1).
Following signal stimulation or alteration in the membrane potential, the
cytosolic Ca2+ concentrations can be elevated by 100 fold from 10-7 M to 10-5 M
(7). Ca2+ carries out its functions by binding to specific Ca2+ receptors or Ca2+binding proteins (CaBPs) with varying affinities (Fig. 1.2A). According to the role
Ca2+ ions or the proteins play in a biological context, most Ca2+ binding proteins
may fall into one of three categories: trigger or sensor proteins (e.g., calmodulin)
(8), buffer proteins (e.g., calbindin D9K and parvalbumin) (9), or Ca2+-stabilized
proteins (e.g., thermolysin) (10) (Figs. 1.2B-D). The Ca2+-binding sites may be
divided into continuous or discontinuous ones. In the continuous Ca2+-binding
sites, the Ca2+-coordinating ligand residues are from a short continuous stretch of
amino acids. A discontinuous Ca2+-binding pocket, however, is formed by ligands
from a number of residues that are separated in the primary sequence but are in
close spatial proximity in spatial arrangement. Among the continuous Ca2+binding sites, the helix-loop-helix EF-hand Ca2+-binding proteins can be found in

4

Figure 1.2. Tunable Ca2+-binding affinities and 3D representation of typical
Ca2+-binding proteins. (A), The Ca2+-binding affinities of Ca2+-binding proteins
may vary by 105, depending on their diversified function and location in the
cellular compartments. (B), 3D cartoon of prototypical EF-hand protein
calmodulin (PDB code: 3cln). (C), 3D representation of calbindin D9K or
S100G (PDB code:1b1g). (D) 3D structure of thermolysin (PDB code: 1tlx).
(E), 3D structure of prokaryotic CaM-like protein calerythrin (PDB code:1nya).
(F-G), 3D cartoon of EF-hand-like Ca2+-binding proteins: alginate binding
protein (F; pdb:1kw) and dockerin (G; PDB code: 1daq).Ca2+ ion is shown as
black sphere.

5
each category and constitute more than 50% of all well-characterized Ca2+binding proteins (6,11).

1.2. Properties of EF-hand Ca2+-binding proteins
The helix-loop-helix EF-hand moiety is one of the most common motifs in
proteins of bacteria, archaea, and eukaryotes (6,11). Since the delineation of the
EF-hand motif in 1973, the family of EF-hand proteins has expanded to include at
least 66 subfamilies thus far (11-13). By binding to Ca2+, this motif may undergo
conformational changes enabling Ca2+-modulated functions, as seen in the
trigger or sensor proteins calmodulin and troponin C (8,14), or may buffer the
concentration of Ca2+ to maintain local Ca2+ homeostasis as reported in buffering
proteins such as parvalbumin (12) and calbindin D9k (9). The coordination of Ca2+
in EF-hand motifs is fulfilled by adopting a pentagonal bipyramidal geometry with
seven oxygen atoms from the side-chain carboxyl or hydroxyl groups, the main
chain carbonyls, and a bridged water. Though EF-hands have been found
abundantly in eukaryotes and bacteria (4-6,15-17), this Ca2+-binding motif has
seldom been reported in viruses.
EF-hand motifs are divided into two major types: the canonical EF-hands
as seen in calmodulin (CaM) and the prokaryotic CaM-like protein calerythrin (Fig.
1.2E), and the pseudo EF-hands exclusively found in the N-termini of S100 and
S100-like proteins (Fig. 1.2B). The major difference between these two groups
lies in the Ca2+-binding loop: the 12-residue canonical EF-hand loop binds Ca2+
mainly

via

side-chain

carboxylates

or

carbonyls

(loop

sequence

6

A

B

1 x
Ca
*
3 Y
bi
*
5 ZG
*
* n -X* -Z12
-Y
H0
92
7

1 x
*
*
4 YG

C

7

1

Ca
bi

* -Z
* * n -X
-Y * H20 14
9
11

5
3

9

12

Figure 1.3. Ligand residues and coordination geometry of typical helix-loophelix EF-hand Ca2+ binding motifs. (A), Cartoon illustration of the canonical
EF-hand Ca2+-binding motif. (B), Cartoon illustration of the pseudo EF-hand
Ca2+-binding motif. (C), the pentagonal bipyramidal geometry adopted by the
Ca2+ binding site of the canonical EF-hand motif.

7
positions 1, 3, 5, 12) (Fig. 1.3A), whereas the 14-residue pseudo EF-hand loop
chelates Ca2+ primarily via mainchain carbonyls (positions 1, 4, 6, 9) (Fig. 1.3B).
The residue at the –X axis coordinates the Ca2+ ion through a bridged water
molecule. The EF-hand loop has a bidentate ligand (Glu or Asp) at axis –Z.
Among all the structures reported to date, the majority of EF-hand motifs are
paired either between two canonical or one pseudo and one canonical motifs.
For proteins with odd numbers of EF-hands, such as the penta-EF-hand calpain,
EF-hand motifs were coupled through homo- or hetero-dimerization (18-22).

1.3. Prokaryotic EF-hand-like Ca2+-binding proteins
Recently, EF-hand-like proteins with diversified flanking structural
elements around the Ca2+-binding loop have been reported in bacteria (Figs.
1.2F-G) (5,23,24). Several lines of evidence indicate that these prokaryotic EFhand-like proteins are widely-implicated in Ca2+ signaling and homeostasis in
bacteria (4,5,17,25). They contain flexible lengths of Ca2+-binding loops that differ
from the EF-hand motifs. However, their coordination properties resemble
classical EF-hand motifs. For example, the semi-continuous Ca2+-binding site in
D-galactose-binding protein (GBP) contains a nine-residue loop (aa 134-142).
The Ca2+ ion is coordinated by seven protein oxygen atoms, five of which are
from the loop mimicking the canonical EF-loop whereas the other two are from
the carboxylate group of a distant Glu (aa 205). Another example is a novel
domain named Excalibur (extracellular Ca2+-binding region) isolated from Bacillus
subtilis. This domain has a conserved 10-residue Ca2+-binding loop strikingly
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similar to the canonical 12-residue EF-hand loop (23). The diversity of the
structure of the flanking region is illustrated by the discovery of EF-hand-like
domains in bacterial proteins. For example, a helix-loop-strand instead of the
helix-loop-helix structure is observed in periplasmic galactose-binding protein
(Salmonella typhimurium, 1gcg) (24) or alginate-binding protein (Sphingomonas
sp., 1kwh) (Fig. 1.2F) (26); the entering helix is missing in protective antigen
(Bacillus anthracis, 1acc) (27) or dockerin (Clostridium thermocellum, 1daq) (Fig.
1.2G) (28). Previous studies in our laboratory have also shown that the single
Ca2+-binding loops from CaM are capable of binding Ca2+ either alone or with the
flanking helices when they are inserted into a non-Ca2+-binding host protein CD2
domain 1 with β-strand structure (1,2). The four EF-loops of CaM in the host
protein have dissociation constants (Kd) ranging from 34 μM to 814 μM (1). NMR
studies revealed that the grafted EF-loop is directly involved in chelating Ca2+
(29).

1. 4. Viral Ca2+-binding proteins
Being extremely adept at hijacking the host cellular machinery, viruses
have been extensively reported to interfere with the Ca2+ signaling pathways or
Ca2+-dependent processes, and thereby, achieve their optimal infectivity to
produce progenies (30). The interplays between virus and Ca2+, in general, fall
into three major categories: 1) viral particles or viral proteins directly or indirectly
disturb the Ca2+ homeostasis by altering membrane permeability and/or
manipulating key components of the Ca2+-signaling repertoire; 2) a number of
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important structural or nonstructural viral proteins directly bind to Ca 2+ for
structural integrity or optimal functions; 3) virus-host interactions that require
cellular Ca2+-sensitive proteins or processes.
Ca2+-binding motifs are present in virus proteins and are involved in virion
assembly and stability (31-43), virion-associated activities such as cell fusion
(44,45), and neuraminidase activity (46,47). To date, almost all of the reported
viral CaBPs are structural proteins.

1.5. Calmodulin as a ubiquitous Ca2+ sensor protein in eukaryotic cells
CaM is a small (148 amino acids; MW: 16.7 kDa) and acidic (pI: ~4.0) EFhand Ca2+-binding protein. It was first discovered in the brain and heart as cyclic
nucleotide phosphodiesterase activator protein (PAF) (48). It consists of two
globular and autonomous domains, each of which contains two helix-loop-helix
EF-hand motifs. Through its reversible or irreversible binding to Ca 2+, the
resultant conformational changes and the interaction with target proteins, CaM is
capable of transducing the intracellular Ca2+ signal changes into a myriad of
divergent cellular events, such as cell proliferation, cell differentiation and
apoptosis (3).
Upon signal stimulation or alteration in the membrane potential, the
cytosolic Ca2+ concentrations might be elevated by 100 fold from 10-7 M to 10-5 M.
The elevation of [Ca2+]c can be effectively sensed by CaM since the Ca2+ binding
affinity of CaM ranges from 0.2 µM to 2 µM. Ca2+ signaling is a fast process and
takes place in milliseconds (3). To convert this transient Ca2+ signals into more
sustained

physiological

processes,

CaM

undergoes

conformational

10

Figure 1.4. The sophisticated and fine-tuned CaM-target network. Through
Ca2+-dependent interaction with targets, CaM relays the Ca2+ signaling to a
multitude of target enzymes or proteins, which are distributed in different
subcellular compartments, to carry out diversified cellular functions.
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Table 1.1. List of characterized CaM target proteins.
Category

Target Protein

Receptors, ion channels, exchangers, and pumps
SK channels
EGFR
Na+/K+ Ca2+ exchanger
connexin
Ca2+ ATPase
IP3 receptor
L-type Ca2+ channel
Ca2+-pump PMCA
RyR receptor
Signaling proteins
Adenylate cyclase I
G-protein coupled receptor
NOS I, III
cAMP phosphodiesterase
Kinases and phosphatases
CaMK I-IV
CaMKKs
calcineurin
phosphorylase kinase
phosphofructokinase
NAD kinase
glycogen synthase kinase
Cytoskeleton and motility
MLCK
caldesmon
spectrin
myosin
MARCKS
dystrophin
synthrophin
actinin
IQGAP1
P190
tau
synapsin
Gene expression and regulation
p68 RNA helicase
hnRNP
p62
Others
cyclin E
neuromodulin
neurogranin
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changes and interacts with a variety of protein kinases and phosphatases, both
of which are capable of covalently modifying downstream effectors by adding or
removing a phosphate group (49-53). The time scale of these processes usually
lasts for seconds or even minutes. In addition, to more efficiently modulate the
signaling cascades, Ca2+-CaM (sometimes apo-CaM) targets to enzymes or
proteins (e.g., adenylate cyclases, phosphodiesterase, nitric oxide synthase, Gprotein coupled receptor) involved in the conversion of other secondary
messengers, such as cAMP and cGMP (49-53). These enzymes or proteins
themselves do not respond to changes in Ca2+ concentration. Thus, CaM relays
the Ca2+ signaling to more than 100 target enzymes or proteins to carry out
corresponding cellular functions (Fig. 1.4; Table 1.1) (54). More importantly, the
Ca2+ signal itself can be modulated by CaM through its interaction with
membrane receptors, ion channels and pumps (55,56). CaM resides primarily in
the cytosol and targets to a wide range of proteins (54). The sophisticated and
fine-tuned CaM-target network leads to the occurrence of divergent cellular
responses to transient Ca2+ signals in different types of cells. Our findings, as
shown in Chapter 6, suggest that gap junction proteins can be added to the
expanding list of CaM targets.

1.6. A grafting approach to probe metal binding properties of continuous
Ca2+- binding sites
A grafting approach has been developed in our laboratory to validate the
Ca2+-binding capability of any predicted EF-hand motifs, and to further analyze
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the factors governing the metal binding properties in an isolated EF-hand motif
(1,57). In this approach, any single Ca2+-binding site can be engineered into a
scaffold protein, obviating the expression and purification of the intact proteins
and the complexity of cooperativity. Thus, it is possible to dissect key local factors
that contribute to the intrinsic Ca2+-binding affinity and conformational properties.
Through previous study in our laboratory, we find that the domain 1 of the
rat cell adhesion protein CD2 is an excellent scaffold protein (1,57). It can be
used to make an accurate measurement of metal-binding affinity using aromatic
residue-sensitized Tb3+ fluorescence resonance energy transfer (Tb3+-FRET) and
a competition assay utilizing Trp residues in CD2 (Fig. 1.5). CD2 retains its native
structure with the inserted Ca2+-binding sites, which allows for the measurement
of the intrinsic Ca2+-binding affinity with a minimized contribution of protein
conformational change and metal-metal interaction (1,2,29,57). The metalbinding affinity of the grafted EF-loop is independent of the host protein
environment. Using this grafting approach, we have reported the first estimation
of the intrinsic Ca2+ affinities of the four EF-hand loops of CaM and their
associated cooperativity (1). Further, this grafting approach can be applied to
identify and verify continuous Ca2+-binding sites in naturally-occurring proteins.

1.7. The objectives of this dissertation
The objectives of this research are to predict and investigate EF-hand
Ca2+-binding proteins using computational tools and protein engineering. The
main focus of this research is to develop robust tools or methods to predict and
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Figure 1.5. Schematic representation of the grafting approach.
Any
2+
continuous Ca -binding sequence can be inserted into a scaffold protein
CD2 domain 1 (CD2.D1) between S52 and G53. The host protein CD2.D1
remains stable at pH 4-11 and is highly tolerant to mutations and insertions.
Triple-glycine (-GGG-) linkers are added on each side to render increased
flexibility. The aromatic residue Trp32, which is buried between two layers of
β-sheets, is within 20 Ǻ of the potential metal binding pocket. This unique
design makes it possible to directly monitor Tb3+ binding utilizing
fluorescence resonance energy transfer (Tb3+-FRET).
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analyze the EF-hand Ca2+-binding motif as well as its interaction with target
proteins. To reflect the implication of Ca2+ in all biological systems,
representatives were

particularly selected from

prokaryotes (prokaryotic

genomes), virus (Rubella virus nonstructural protease) and eukaryotes (CaM).
Specifically, this research focuses on three key objectives, as follows:
A. Developing a robust and reliable prediction method for EF-hand
Ca2+-binding proteins and analyzing prokaryotic EF-hand proteins
To facilitate the understanding of the role of Ca2+ in biological systems
using genomic information, we will establish a web searching platform for the
prediction of EF-hand and EF-hand-like Ca2+-binding proteins. Improvements will
be introduced to currently existing patterns to increase prediction accuracy.
Systemic analysis of prokaryotic and viral EF-hand proteins will be made to grasp
the evolutionary scenario of EF-hand motifs.
B. Investigating the biological role of a putative viral EF-hand motif
The biological role of a predicted viral EF-hand Ca2+-binding domain within
the rubella virus (RUB) nonstructural (NS) protease will be investigated by three
approaches. 1) A grafting approach will be applied to investigate the metal
binding properties of the isolated EF-hand motif and its mutant. 2) A minidomain
approach will be used to analyze the metal induced conformational changes. 3)
The physiological relevance of the EF-hand Ca2+-binding motif to virus replication
and posttranslational processing will be assessed using rubella virus infectious
clone and its replicon systems.
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C. Elucidating the molecular basis underlying the calmodulinconnexin interaction in eukaryotic cells
We propose a model in which the regulation of gap junctions is mediated
by calmodulin (CaM) in a Ca2+-dependent manner. The molecular basis for the
interaction of CaM with putative CaM-binding sequences in the connexins will be
revealed using various biophysical methods, including high resolution NMR.

1.8. The significance of this dissertation
The significance and high impact of this research is multifaceted. First,
our development of easily accessible computational tools for the prediction of EFhand or EF-hand-like Ca2+-binding protein will benefit the whole metalloprotein
field.

To

our

knowledge,

our

server

(http://www.chemistry.gsu.edu/faculty/Yang/Calciomics.htm) will be the first of its
kind to provide such service for scientists. Second, the comprehensive prediction
and detailed analysis on putative prokaryotic and viral EF-hand and EF-hand like
Ca2+-binding proteins will contribute to our understanding of the versatile roles
Ca2+ ions play in various biological systems; Third, our study on the viral EFhand Ca2+-binding protein provides a novel approach to probe individual Ca 2+binding site at simplified and more readily achievable levels, and concurrently
overcomes the barriers encountered in the expression of intact proteins; Fourth,
the biological relevance of the EF-hand Ca2+-binding motif within the rubella virus
(RUB) nonstructural (NS) protease will be elucidated; Fifth, the confirmation of
Ca2+-dependent CaM-Cx interaction model will facilitate understanding of
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mechanisms underlying gap junction regulation, and thus provide a molecular
basis of potential therapeutic intervention of diseases related to malfunction of
gap junctions, such as cataracts and heart diseases.

Chapter 2 in this dissertation summarizes all the methods used in this
study, including molecular cloning, protein engineering, protein expression and
purification, spectroscopic techniques (UV, circular dichroism, fluorescence,
NMR), biocomputational analyses of genomes, homology structure modeling,
and biochemical assays. All mathematical equations used in this study are also
listed in Chapter 2.

Chapter 3 explains the development of robust and complete patterns (or
motif signatures) for the prediction of EF-hand Ca2+-binding proteins. It also
includes our systemic genome-wide analysis of putative prokaryotic EF-hand
proteins and discussion of possible evolutionary scenarios of the EF-hand protein
family.

Chapter 4 summarizes most of the known mechanisms underlying virusmediated alterations in Ca2+ homeostasis and Ca2+-dependent virus-host
interactions. The altered Ca2+-signaling is closely associated with virus entry, viral
gene expression, virion maturation and release. In addition, a total of 93 EF-hand
motifs in viral proteins that are worthy of further studies are predicted.
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Chapter 5 is devoted to the identification and confirmation of a viral EFhand Ca2+-binding, and Zn2+-binding domain in the rubella virus nonstructural
protease. The unique and important biological relevance of this motif with the
virus infectivity is characterized.

Chapter 6 in this dissertation is focused on the elucidation of the
molecular basis underlying the interaction between gap junction protein
connexins and calmodulin, a prototypical EF-hand Ca2+-binding protein.
Predicted CaM-target sequences in the connexins are synthesized and their
ability to bind CaM is determined using a range of biophysical approaches.

Chapter 7 is a succinct summary of major discoveries of this dissertation.

Appendices list preliminary results obtained from related side projects
that remain incomplete. It includes: 1) analyzing key factors governing the metal
binding events by inserting well-characterized Ca2+-binding sequences from
cellular proteins into CD2.D1 with the grafting approach; 2) predicting putative
CaM binding site(s) in rubella virus nonstructural protease.
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2. Materials and methods

2.1. Molecular cloning and plasmid construction
The sequence encoding the putative Ca2+-binding domain (RUBCa, aa
1143-1252 of the NS-ORF) with 5’ BamH I and 3’ EcoR I sites was amplified from
the RUB infectious cDNA clone Robo502 (58,59) by using standard PCR
methods. The PCR product was subsequently inserted into the BamH I-EcoR Idigested pGEX-2T vector (GE Healthcare) to produce the plasmid pGEX-2TRUBCa.

2.2. Protein engineering
The predicted 12-residue Ca2+-binding loop was directly inserted between
S52 and G53 (denoted as pGEX2T-CD2.RUBCa) by PCR using an established
protocol (60). The mutant (denoted as pGEX2T-CD2.RUBCa-AA) with double
mutations D5A and D12A (numbered according to the loop position of inserted
Ca2+-binding motif) was produced using standard PCR methods. All sequences
were verified by automated sequencing on an ABI PRISM-377 DNA sequencer
(Applied Biosystems) in the Advanced Biotechnology Core Facilities of Georgia
State University.
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2.3. Expression and purification of proteins
CD2.RUBCa and its mutant. The engineered proteins CD2.RUBCa and
its mutant CD2.RUBCa.AA were expressed as GST fusion proteins in
Escherichia coli BL21 (DE3) transformed with the plasmid pGEX2T-CD2.RUBCa
or pGEX2T-CD2.RUBCa-AA in LB medium with 100 mg/L of ampicillin and
grown at 37 °C. 100 µM of isopropyl-β-D-thiogalactopyranoside (IPTG) was
added when the O.D.600 reached 0.6 to induce protein expression for another 3 to
4 hours at 37 °C. The cultures were centrifuged at 7,000 rpm at 4 °C with a
Sorvall centrifuge equipped with a SG-3 rotor. The harvested cell pellets were
resuspended in lysis buffer consisting of 0.2% sarcosine, 1mM DTT, 1 mM
AEBSF in PBS, pH 7.4. The resuspended solution was sonicated 6 times with
each time 20 seconds with 80% duty. After centrifugation at 17,000 rpm with a
Sorvall centrifuge equipped with a SS-34 rotor at 4 °C, the clarified supernatant
was passed through a flow-through affinity column loaded with 4-5 mL slurry
GS4B beads (GE Healthcare). After a minimum of 10 bead-volume of washing
with PBS, on-column cleavage was performed to remove the GST tag by adding
20 units of thrombin to each column. The elutant containing the target protein
was filtered through 0.45 µM filter and injected into Superdex 75 gel filtration
column. The eluted proteins were pooled together and further purified by Hitrap
SP cation exchange chromatography. The molecular weight of CD2.RUBCa and
its mutant were also confirmed by MALDI-TOF-MS. The concentration was
determined by using the absorption at 280 nm with an extinction coefficient of
11,700 M-1 cm-1 (61).
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RUBCa (Fig. 2.1). The RUBCa was expressed as a GST fusion protein in
Escherichia coli BL21 (DE3) transformed with the plasmid pGEX-2T-RUBCa in
LB medium with 100 mg/L of ampicillin and grown at 37 °C. 100 µM of isopropylβ-D-thiogalactopyranoside (IPTG) and 50 µM of ZnCl2 were added when the
O.D.600 reached 0.7 to induce protein expression for another 3 to 4 hours. The
proteins were purified following the protocols for GST-fusion protein purification
(60) using glutathione sepharose 4B beads (GE Healthcare). The protein was
cleaved from its GST tag on beads by taking advantage of the thrombin cleavage
site and eluted. The elutants containing RUBCa were further purified using
Superdex 75 and Hitrap SP columns (GE Healthcare). The molecular weight of
RUBCa was confirmed by MALDI-TOF-MS in the Advanced Biotechnology Core
Facilities of Georgia State University. The concentration of RUBCa was
measured by its absorption at 280 nm with an extinction coefficient of 19,630 M-1
cm-1, which was calculated according to previously described methods (62).
CaM. Recombinant rat CaM was expressed in Escherichia coli strain
BL21(DE3)pLysS transformed with the plasmid pET7-CaM that harbors the
synthetic CaM gene (63). pET7-CaM transformed cells were grown in LB
medium to obtain unlabeled CaM. 15N-labeled CaM was expressed in SV minimal
medium using 0.5 g/L
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NH4Cl (Cambridge Isotope Laboratories, MA, USA) as

the sole nitrogen source. Bacterially-expressed CaM was purified by phenylSepharose (Sigma, MO, USA) chromatography as previously described. The
purity of CaM was examined by mass spectrometry or SDS-PAGE (Fig. 2.2). The
concentration of CaM was determined by using the ε276 of 3,030 M-1cm-1 (64).
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Figure 2.1. The cloning, expression and purification scheme of GST fusion
proteins. (A), Target genes are inserted into EcoR I and BamH I digestion sites
of pGEX-2T vector which harbors a GST tag that could be removed by
thrombin. (B), A typical purification scheme of GST fusion proteins. (C), SDSPAGE, elution profiles and MS spectrum of the purified protein RUBCa. The
SDS-PAGE (left) shows the cleavage of GST fused RUBCa with thrombin for
1 h (lane 1) and 3 h (lane 2), as well as the elutants containing target proteins
(Lane 3). The elutants are further purified to homogeneity by gel filtration
(Superdex) and cation exchange (SP) chromatography (middle). The
molecular weight is finally confirmed by MALDI-TOF-MS (right).
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Dansyl CaM was prepared according to the method of Johnson et al with slight
modifications (65). Briefly, rat CaM was dansylated in the dark by mixing 1 ml
protein (1 mM) with a 5-fold molar excess of dansyl chloride (dissolved in 1:1
acetone/ethanol) in 10 mM Mops, 100 mM KCl, 1 mM CaCl2, pH 7.0 for 16 h at
4 °C. The reaction mixture was then extensively dialyzed against 10 mM Tris,
100 mM KCl at pH 7.4 to remove the residual free dansyl chloride. The
modification of CaM by dansyl chloride was confirmed by ESI-MS with an
increase of +233 in the molecular mass. The bound dye concentration was
determined by using the ε 335 of 3980 M-1 cm-1 (65). An average of ~0.8 mol of the
dansyl chromophore was incorporated into per mol of CaM.
Peptides. The peptides Cx43136-158 (Ac-KYGIEEHGKVKMRGGLLRTYIISNH2) and Cx44129-149 (Ac-VRDDRGKVRIAGALLRTYVFN-NH2) were synthesized
by Sigma-Genosys (Sigma, USA) and purified by preparative reversed-phase
HPLC

with

purity

over

95%.

A

randomized

control

peptide

(Ac-

LGGEYLVTMESKIHIKGKRIGYR-NH2), with the same composition of amino
acids as Cx43136-158 but arranged in a different order, was similarly synthesized.
The molecular weight of the synthetic peptide was determined by matrix-assisted
laser desorption/ionization time-of-flight mass spectrometry. To mimic its protein
environment and eliminate extra charges, the designed peptide was blocked at
its N-terminus with an acetyl group and at its C-terminus with an amide group.
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Figure 2.2. SDS-PAGE (A) and MS
binding to Ca2+, the CaM undergoes
from a globular shape at its apo-form
therefore, moves faster in the electric
(16706.98 Da) matches well with the
(16707 Da).

(B) spectrum of purified CaM. Upon
conformational changes by switching
to an elongated dumbbell shape, and
field. The measured molecular weight
calculated theoretical molecular mass
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2.4. Mass spectroscopy
Electrospray ionization mass spectrometry (ESI-MS). The detection of
metal-protein complex by ESI-MS was performed by using a Waters Micromass
Q-Tof micro instrument. The data were acquired in positive ion mode by syringe
pump infusion of the protein solutions at a flow rate of 7 µL/min. The protein
sample stock (~1 mM) in 10 mM Tris, pH 7.4 was diluted 100 folds into water.
Metal ions were added in 5 molar excess to the protein concentration to observe
specific binding.
Inductively coupled plasma mass spectrometry (ICP-MS). All the
glassware, plastiware and Teflon containers used in the preparation of samples
were pretreated with 2% HNO3 (optima grade, Fisher Scientific). All buffers were
pretreated with chelex-100 (Bio-Rad) to remove the background Ca2+ ions. 20 to
30 µM of the refolded proteins were acidified with 2% HNO3 and analyzed by
ICP-MS (Finnigan Element 2). The dialyzed buffer was used as a blank, and the
residual Ca2+ background of 2-5 µM was subtracted from the measurement of
protein samples.

2.5. Circular dichroism spectroscopy
CD2.RUBCa and RUBCa. The CD spectra of proteins were recorded in a
Jasco-810 spectropolarimeter at ambient temperature using a quartz cell of 10
mm path length with protein concentrations ranging from 2 to 5 µM. All spectra
were obtained as the average of at least eight scans with a scan rate of 100
nm/min. The calculation of secondary structure elements was performed by using
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DICHROWEB, an online server for protein secondary structure analyses (66).
The thermal denaturation was studied using a 1 mm quartz cell with protein
concentration of 15-30 µM in 10 mM Tris-HCl (pH 7.4), 10 mM KCl with 1 mM
EGTA or 1 mM CaCl2. The ellipticity was measured from 190 to 260 nm and
converted to mean residue molar ellipticity (deg cm 2 dmol-1 res-1). To obtain the
thermal transition point, the signal changes at 222 nm were fitted using the
equation described previously (67).
CaM and CaM-Cx complex. Circular dichroism spectra were acquired in
the far UV (190-260 nm) or near UV region (250-340 nm) on a Jasco-810
spectropolarimeter at room temperature using a 1 cm path length quartz cuvette.
All spectra were an average of 10-20 scans. The background signals from the
corresponding buffers were subtracted from the sample signals. The far UV CD
spectra of the peptide in different percentages of trifluoroethanol (TFE) were
obtained using 10 mM of the peptide in 10 mM Tris-HCl, 10 or 100 mM KCl, pH
7.4. In the peptide titration of CaM experiment, 2-5 µL aliquots of the peptide
stock solution (150 µM in 10 mM Tris-HCl, 10 or 100 mM KCl, pH 7.4) was
gradually added into a 2-mL solution containing 1-2 µM CaM in the same buffer
with 5 mM CaCl2 or 5 mM EGTA. The signals from the peptide itself were
subtracted. All the measurements were carried out in at least triplicate. The
binding constants of the synthetic peptide to CaM were obtained with a 1:1
binding model by fitting the following equation (Eq. 1):

f 

([ CaM ]T  [ P]T  Kd )  ([ CaM ]T  [ P]T  Kd )2  4[CaM ]T [ P]T
2[CaM ]T

(1)
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where f is the fractional change of CD signals at 222 nm, Kd is the dissociation
constant for the peptide, and [P]T and [CaM]T are the total concentrations of the
synthetic peptide and CaM, respectively. The secondary structure contents of the
peptides or proteins were calculated with the online secondary structure
prediction server DICHROWEB that integrates analysis algorithms such as
SELCON, CONTINLL, CDSSTR and K2D (66). Near UV CD spectra were
recorded with protein/peptide concentration of 80-100 µM in 10 mM Tris-HCl, 100
mM KCl, pH 7.4 with 5 mM Ca2+ or 5 mM EGTA.

2.6. Stopped-flow measurements
Stopped-flow

experiments

were

performed

in

a

Jasco-810

spectropolarimeter equipped with a BioLogic stopped-flow apparatus at 25 °C.
The instrument dead-time is ~2.5 ms at a drive force of about 0.4 MPa. The
optical cuvette pathlength is 0.5 cm. All the experiments were performed in 50
mM Tris-HCl, 100 mM KCl, pH 7.4 with at least 15 traces recorded. The changes
of CD signal at 222 nm were monitored with 1 ms sampling interval in the time
range of 0-2 s. EGTA-induced Ca2+ dissociation was studied by mixing 100 μL of
2 μM CaM-peptide mixture (with 0.1 mM Ca2+) in Syringe 1 with an equal volume
of 10 mM EGTA in Syringe 2 within 15 ms. The acquired data were fitted by a
single exponential model.
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2.7. Fluorescence spectroscopy
CD2.RUBCa and RUBCa. Fluorescence emission spectra were measured
with a 1-cm pathlength cell on a PTI lifetime fluorometer at ambient temperature.
For intrinsic tryptophan fluorescence, spectral measurements were carried out at
protein concentrations of 2-4 µM in 20 mM PIPES-10 mM KCl at pH 6.8 with slit
widths of 4 and 8 nm for excitation and emission, respectively. The emission
spectra were collected from 300 to 400 nm with an excitation wavelength of 282
nm. 8-Anilino-1-naphthalene sulfonic acid (ANS) fluorescence emission spectra
were recorded from 400 to 600 nm with an excitation wavelength of 390 nm.
Protein samples (5 µM) with 1 mM CaCl2 or 1 mM EGTA were added into the
solution containing 40 µM ANS, 20 mM PIPES-10 mM KCl at pH 6.8.
Tyr/Trp-sensitized

Tb3+

fluorescence

energy

transfer

(Tb3+-FRET)

experiments were conducted as described previously (68,69). For the metal
competition studies, the solution containing 40 µM of Tb 3+ and 1.5 µM of protein
was set as the starting point. The stock solution of metal ions with the same
concentration of Tb3+ and protein was gradually added into the initial mixture.
The fluorescence intensity was normalized by subtracting the contribution of the
baseline slope using logarithmic fitting. The Tb3+-binding affinity of protein was
obtained by fitting normalized fluorescence intensity data using (Eq. 2):

f 

([ P]T  [M ]T  K d )  ([ P]T  [M ]T  K d ) 2  4[ P]T [M ]T
2[ P]T

(2)

where f is the fractional change, Kd is the dissociation constant for Tb3+, and [P]T
and [M]T are the total concentrations of protein and Tb3+, respectively.
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The Ca2+ competition data were first analyzed using the apparent
dissociation constant obtained by equation 1. By assuming that the sample is
almost saturated with Tb3+ at the starting point of the competition, the Ca2+binding affinity is further obtained by using the equation (Eq. 3)

K d ,Ca  K app 

K d ,Tb
K d ,Tb  [M Tb ]

(3)

where Kd,Ca and Kd,Tb are the dissociation constants of Ca2+ and Tb3+,
respectively. Kapp is the apparent dissociation constant. All the measurements
were conducted in triplicate.
CaM. Steady-state fluorescence spectra were recorded using a QM1
fluorescence spectrophotometer (PTI) with a xenon short arc lamp at ambient
temperature. Tyrosine fluorescence was monitored using excitation at 277 nm
and emission at 307 nm with 2-4 nm bandpasses. The Ca2+ binding constants
were determined by titrating the CaM (8 mM) or 1:1 CaM-peptide mixture (8 µM)
in 1 mM EGTA, 100 mM KCl, 50 mM Tris-HCl, pH 7.4 with 1-5 µL aliquots of 10
mM Ca2+ stock solution in the same buffer containing equal concentrations of
CaM and peptide. The pH change (0.03 to 0.04) was minimal during the titration
process. To obtain the accurate Ca2+ concentrations during titration, Ca2+
concentration at each point was determined with the Ca 2+ dye Oregon Green 488
BAPTA-5N (0.2 µM; Kd = 20 µM; Invitrogen) with an excitation wavelength of 492
nm and an emission wavelength of 520 nm. The ionized Ca2+ concentration was
subsequently calculated according to the equation (Eq. 4):
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Ca  K
2

d

F  Fmi n
Fmax  F

(4)

where F is the fluorescence intensity of the dye at each titration point, Fmin and
Fmax are the intensities of the Ca2+-free and the Ca2+-saturated dyes, respectively.
The Ca2+ titration of CaM data was fit to the nonlinear Hill equation (Eq. 5):

[M ]n
f  n
K  [M ]n

(5)

Where, f is the relative signal change observed during the experiment; [M] is the
concentration of free Ca2+; K refers to dissociation constants of Ca2+; and n is the
Hill coefficient.
For dansyl-CaM fluorescence measurement, 1 mL solution containing 1-2
µM dansyl-CaM in 10 mM Tris-HCl, 100 mM KCl, pH 7.4 with 5 mM Ca2+ or 5 mM
EGTA was titrated with 5-10 µL aliquots of the peptide stock solution (10 µM) in
the same buffer. The fluorescence spectra were recorded using an excitation of
335 nm and an emission between 400 and 600 nm with the slit width set at 4-8
nm.
Tb3+ luminescence lifetime measurement was performed on a QM1
fluorescence spectrophotometer with a xenon flash lamp (PTI) at 25 °C. The
buffer consists of 50 mM Tris, 100 mM KCl, pH 7.4. The lifetime value was
obtained by fitting the acquired data to a single-component exponential decay
function.
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2.8. Isothermal titration calorimetry
ITC experiments were performed on a Microcal VP-ITC microcalorimeter.
Samples were prepared and dialyzed in a buffer consisting of 20 mM PIPES, 100
mM KCl, 2 mM CaCl2, pH 6.8. All the solutions were degassed for at least 15 min
prior to experiments. 4-6 µL aliquots of peptides (400-600 µM) were injected from
the syringe into the reaction cell containing 25 µM CaM in the same buffer at 5
min intervals at 25 °C. The heat of dilution and mixing was measured by injecting
the same amount of peptides into the reaction cell that contained the reaction
buffer and subtracted. All the data were analyzed by using the Microcal Origin
software. The data fit well to a single-site binding mode which provided the
stoichiometric information, Ka and thermodynamic parameters including enthalpy
(ΔH) and entropy (ΔS) of binding.

2.9. Surface plasmon resonance measurements
Real time binding was performed using surface plasmon resonance (SPR)
at the Center for Disease Control and Prevention (Atlanta, GA, USA) on a
Biacore 3000 system (Biacore AB, Uppsala, Sweden). CaM (500 nM in 10 mM
sodium formate, pH 3.5) was directly immobilized onto the sensor chip CM5
using an amine coupling kit as described by the manufacturer. Synthetic peptides
with varying concentrations were subsequently injected over the sensor surface
at a flow rate of 50 mL/min in binding buffers (5 mM Ca, 100 mM KCl, 50 mM
Tris-HCl, pH 7.4). Two minutes later, peptide-free binding buffer was injected to
monitor the dissociation process. All measurements were carried out in parallel
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using two cells, one with immobilized CaM and the other as blank control with the
carboxylated dextran matrix deactivated. Binding of peptide to CaM-immobilized
flow cells was corrected for binding to control flow cells. The sensor chip was
regenerated using 10 mM glycine, pH 2.2.

2.10. Nuclear magnetic resonance spectroscopy
One-dimensional 1H NMR spectra were recorded on a Varian 500 MHz
NMR spectrometer with a spectral width of 6600 Hz. Samples of 200 to 250 µM
were prepared in 20 mM PIPES-10 mM KCl, 10% D2O at pH 6.8. La3+ stock
solution was gradually added into the NMR sample tube. The program FELIX98
(MSI) was used to process NMR data with an exponential line broadening of 2
Hz window function and the suppression of water signal with a Gaussian
deconvolution function with a width of 20.
All NMR experiments were performed using either Varian Inova 500 or 600
MHz spectrometers. NMR spectra were acquired with a spectral width of about
13 ppm in the 1H dimension and 36 ppm in the
(1H,

15

N)-HSQC experiment, 0.5 mM

15

N dimension at 35 °C. For the

15

N uniformly-labeled CaM was titrated with

10-20 µL aliquots of the peptide stock solution (2.1 mM) in a buffer consisting of
10% D2O, 100 mM KCl, 50 mM Tris-HCl with 10 mM EGTA or 10 mM Ca2+. The
pH values of both sample solutions were carefully adjusted to 7.4 with trace
amounts of 2M KOH. NMR data were processed using the FELIX98 program
(Accelrys).
For gradient diffusion experiments, spectra were collected using a
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modified diffusion LED pulse sequence in 20 mM PIPES- 10 mM KCl at 25 ⁰C as
previously described (70). The diffusion constants (D) were obtained by fitting the
integrated areas of arrayed spectrum with equation 6:
I=I0 exp[-(γδG)2(Δ-δ/3)D]

( 6)

where γ is the gyromagnetic ratio of proton. The time between PFG pulse (Δ) and
the PFG duration time (δ) were 100.5 and 5 ms, respectively. The gradient
strength (G) was arrayed from 0.2 Gauss/cm to about 28.9 Gauss/cm using 50
steps. I0 is the integrated area of selected resonances at 0 Gauss/cm and I is the
integrated area of the desired resonances at each array spectrum after baseline
corrections. PIPES and dioxane were used as internal references. The diffusion
process of a spherical particle is governed by Stokes-Einstein’s equation:
D=kT/6πηrs

(7)

where k is the Boltzman constant, η is the solvent viscosity, rs is the
hydrodynamic radius.

2.11. Cells, infectious clone and site-directed mutagenesis
The infectious genomic cDNA clone Robo502 was previously described
(58,59). To generate the mutated construct Robo502AA (D1210A, D1217A), a tworound asymmetric PCR strategy was employed to create the mutations in an
amplified fragment between unique BsmI and RsrII sites at nts 3243 and 3897 of
the RUB genome.

The doubly digested fragment was used to replace the

corresponding fragment in Robo502. The mutations were also transferred to the
replicons, RUBrep-FLAG/GFP and RUBrep-HA/GFP (71), which express a P150
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tagged with the FLAG or the HA epitope and the reporter protein, green
fluorescent protein (GFP), in place of the SP-ORF.

2.12. In Vitro transcription, transfection, Northern blotting and Western
blotting
Vero cells were obtained from the American Type Culture Collection and
maintained at 35 °C under 5% CO2 in Dulbecco’s modified Eagle’s medium
(DEME, Gibco) supplemented with 5% fetal bovine serum and 10 μg/mL
gentamicin. CsCl density gradient purified plasmids were linearized with EcoRI
(New England Biolabs), followed by phenol-chloroform extraction and ethanol
precipitation. RNA transcripts were synthesized at 37 °C in a 25-μl reaction
mixture containing 40 mM Tris-HCl (pH 7.5), 1 μg DNA, 6 mM MgCl2, 2 mM
spermidine, 10 mM dithiothreitol, 1 mM of each NTP, 1 unit of RNasin (Roche
Applied Science), 2 mM cap analog m7G(5’)ppp(5’)G (New England Biolabs), and
25 units of SP6 DNA-dependent RNA polymerase (Epicenter Technologies). The
transcription reaction mixtures were directly used for cell transfection without
DNase treatment. The transcripts were analyzed by electrophoresis of 2 μL
aliquots of the reaction mixture in 0.8% agarose gel. The precise yield was
determined using a UV/vis spectrometer (Shimadzu). Transfection of the RNA
transcripts was done when using Vero cells at ~80% confluence in 60 mm 2
plates. Vero cells were washed twice with 3 mL of phosphate-buffered saline and
once with 3 ml of Opti-MEMI (Gibco). 10 μL of the transcripts were subsequently
mixed with 500 μL Opti-MEMI and 7 μL lipofectamine-200 (1 mg/ml). The mixture
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and 1.5 mL of Opti-MEMI were added onto the plates to cover the monolayer of
Vero cell. After 4 h of incubation, the transfection mixture was removed, and 4 ml
of DMEM supplemented with 2% fetal bovine serum was added (transfection is
designated as passage 0 or P0). Following development of significant cytopathic
effect (CPE), the medium was harvested and passed twice in Vero cells (P1 and
P2). Virus titers were determined by plaque assay as previously described
(72,73). To determine if the D1210A and D1217A mutations were maintained
following transfection and passage, plaques were picked from terminal dilution
plaque assay plates of P1 culture fluid and amplified once in Vero cells.
Following amplification, total infected cell RNA was extracted and the NS
protease region of the genome was amplified by RT-PCR and the RT-PCR
product was sequenced (74).
The expression of reporter gene GFP in living, transfected cells was
monitored by a Zeiss Axioplan upright microscope with epifluorescence capability
and photographed with a Zeiss Axiocam. Northern blotting was used to detect
replicon-specific RNA species by following previously established protocols (71).
To detect in vivo NS protease activity, Vero cells transfected with RUBrepHA/GFP, RUBrepAA-HA/GFP, or RUBrepNS*-HA/GFP (containing a C1152A
mutation of the catalytic site) were incubated at 35 ⁰C or 39 ⁰C. 6 hrs posttransfection, the cells were lysed and resolved by 8% SDS-PAGE, electroblotted
onto nitrocellulose membranes, and probed with anti-HA monoclonal antibodies
(Sigma) according to a previously established procedure (71).
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2.13. Dye transfer assay
Confluent monolayers of HeLa cells grown on glass coverslips were
loaded with the Ca2+ indicator Fura-2 AM (5 μM) in 2 ml HBSS++ buffer
(containing 1.8 mM Ca2+, with added 10 mM HEPES, 5 mM NaHCO3, pH 7.2),
then transferred to a microincubation chamber (model MSC-TD, Harvard
Apparatus, Holliston, MA) as described previously (68). Imaging of intracellular
Ca2+ was performed with a Nikon TE300 (Nikon Inc., Melville, NY) inverted
microscope equipped with Nikon filter blocks for Fura-2 emission and AF594
optics (Chroma Technology Corp, Rockingham, VT), a Metaltek filter wheel
(Metaltek Instruments, Raleigh, NC) housing excitation filters for Fura-2, a 75
watt xenon short arc lamp, a Hamamatsu CCD digital camera (Hamamatsu
Corporation, Bridgewater, NJ), and supported on a vibration isolation table
(Technical Manufacturing, Peabody, MA). [Ca2+]i was measured ratiometrically
(λ340 / λ380) with Fura-2 throughout each experiment in the injected cell and the
cells adjacent to the injected cell, and Ca2+ concentrations determined as
described previously (75). MetaFluor software (Universal Imaging Corp.,
Downington, PA) was used for data collection. Micropipettes (borosilicate glass
capillaries: 1 mm O.D., 0.75 mm I.D, 100 μm internal microfilament; Dagan
Corporation, Minneapolis, MN) were pulled on a Flaming/Brown-type pipette
puller (P-87; Sutter Instruments, Novato, CA). Micropipettes had tip diameters of
<1 µm and resistances of ~100-300 MΩ when filled with AlexaFluor 594 (1 mM)
dissolved in deionized water. The micropipette was positioned with a low-drift
hydraulic micromanipulator (MW-3; Narishige, Greenvale, NY), and AlexaFluor
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594 was microinjected iontophoretically using a train of 5-ms current pulses
applied every 100 ms for 60 s (3 s total injection time) at ambient temperature. If
the micropipette became plugged, it was replaced with a new micropipette, and
the data from such a partial injection were excluded from the analysis. Current
was generated with a Duo 773 (World Precision Instruments, Sarasota, FL).
Current duration, magnitude, and polarity were controlled with an A310
Accupulser pulse generator (World Precision Instruments, Sarasota, FL).
Digitized images of AlexaFluor594 cell-to-cell transfer were recorded 2 min
following the iontophoretic injection of fluorescent dye. A sustained elevation in
[Ca2+]i was effected by adding 1 μM ionomycin to the medium, then 2 min later
increasing the extracellular [Ca2+] from 1.8 mM to 21.8 mM. All these works were
carried out by Dr. Monica Lurtz.

2.14. Bioinformatic tools and homology structure modeling
Multiple sequence alignments and phylogenetic analysis. 1904 proteins
with potential canonical EF-hands and 84 proteins with pseudo-EF-hands from
SwissProt encompassing 66 distinct subfamilies of EF-hand proteins were
included in our EF-hand databases. Typical members of each subfamily were
collected to generate a sub-database for multiple sequence alignments and
phylogenetic analysis. Multiple sequence alignment (MSA) was performed using
the ClustalW program with a gap open penalty of 10 and gap extension penalty
set at 0.5.(76) The same program was applied to generate N-J tree for further
display by the TreeView program.(77)
Generation of profile HMM and patterns. Profile HMM (Hidden Markov
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Models) was generated from multiple sequence alignment results using HMMER
by choosing both hmmbuild and hmmcalibrate algorithms. The statistical profile is
subsequently visualized as HMM logo using LogoMat-M.(78,79) The EF-hand
patterns were generated by taking into account highly conserved residues within
both the pseudo and canonical EF-hand motifs.
Evaluation of canonic and pseudo EF-hand pattern. The precision,
sensitivity and positive predictive values (PPV) of canonical EF-hand patterns
loop, eloop, loopf, and eloopf were compared to that of the pattern PS00018. A
total of 170 hits, including true positive, false negative, and false positive, were
randomly selected from the results of PS00018 and set as the sub-database for
comparison. The newly generated pseudo EF-hand patterns, as well as the wellestablished S100 pattern PS00303, were used to search for possible pseudo-EFhand Ca2+ binding domains against major protein sequence databases such as
SwissProt, iProClass and NCBI reference sequences (RefSeq). The Ca 2+-binding
properties of the proteins in the selected dataset have been experimentally
verified and the prediction is compared with the verified information to determine
the true positive, true negative, false negative, and false positive. The methods
are then applied to predict proteins with unknown Ca2+-binding properties in
bacterial genomes. For statistical analysis, the precision, sensitivity, and PPV
were determined as follows:

precision 

TP  TN
TP  TN  FP  FN

sensitivity 

TP
TP FN

(8)

(9)
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PPV 

TP
TP  FP

(10)

(TP: true positive; TN: true negative; FN: false negative; FP: false positive)

The

Ca2+-binding

motif

signatures

developed

(http://www.chemistry.gsu.edu/faculty/Yang/Calciomics.htm)
pattern

PS00018

from

PROSITE

in
as

our
well

laboratory
as

the

(http://us.expasy.org/cgi-

bin/nicedoc.pl?PDOC00018) were used to scan through the genome of rubella
virus for any potential EF hand Ca2+-binding site (6). Sequence alignments were
conducted by using the program ClustalW. The secondary structure was
predicted based on the consensus prediction results using programs PSIPRED,
JPRED, and PHD (80-82). The homology modeling of the engineered protein and
the protease was constructed using the comparative structure modeling SWISSMODEL (83). CD2 (PDB code: 1hng) and the leader protease of foot-and-mouth
disease virus (PDB code: 1qmy) were used as the templates for structure
modeling based on their available high resolution structure (61,84). Prediction of
Ca2+-binding sites in the modeled structure was conducted by using the program
GG, a computational algorithm developed in our laboratory on the basis of the
geometric description, graph theory and key structural and chemical features
associated with calcium binding in proteins (85).
Bioinformatic analyses and prediction of CaM-binding site in connexins.
The topology and orientation of transmembrane regions of the rodent connexin
43 and sheep Cx44 were predicted on the basis of the consensus results using
four different programs including SOSUI (86), TMHMM (87), MEMSAT (88), and
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HMMTOP (89). The potential CaM binding sites were predicted using the CaM
target database based on several criteria, including the distribution of
hydrophobic and basic residues, propensity to form helix, and hydrophobicity of
the sequence, that are common to more than 100 CaM target sequences (90).

2.15. Determination of zinc amount by colorimetric PAR assay
PAR colorimetric assay with slight modification was used as described
(91). Protein samples were pretreated by Chelex 100 to remove background
metal ions and then digested in a total volume of 100 μL with 100 μg protease K
(Sigma) per mL in HSD buffer (50 mM HEPES-KOH, 200 mM NaCl, 5 mM
dithiothreitol [DTT]), pH 7.0 at 56 ⁰C for 30 min. Subsequently, an identical
volume of HSD containing 5 mM iodoacetamide (IAM; Sigma) and 200 μM 4-(2pyridylazo)resorcinol (PAR, Sigma) was added. The absorption ranging from 300
nm to 600 nm was measured by RF-1501 UV spectrometer (Shimadzu). HSD
containing 0-15μM standard ZnCl2 solution was used to create a standard curve.
The amount of protein in the samples to be analyzed for metal content was
adjusted so that the amount of metal released was in the linear range of the
standard curve. Carbonic anhydrase that contained one zinc binding site is used
as positive control.
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3. Prediction of prokayotic EF-hand and EF-hand like Ca2+binding proteins

Since the delineation of the EF-hand motif in 1973, the family of EF-hand
proteins has thus far expanded to include at least 66 subfamilies. As noted in
section 1.2, there are two types of EF-hand motifs: the canonical and pseudo EFhands. The major difference between these motifs lies in the Ca2+-binding loop:
the 12-residue canonical EF-hand loop binds Ca2+ mainly via sidechain
carboxylates or carbonyls (loop sequence positions 1, 3, 5, 12), whereas the 14residue pseudo EF-hand loop chelates Ca2+ primarily via backbone carbonyls
(positions 1, 4, 6, 9) (Fig. 3. 1). The residue at the –X axis coordinates the Ca2+
ion through a bridged water molecule. The EF-hand loop has a bidentate ligand
(Glu or Asp) at axis –Z.
With the continuing expansion of genomic information, many efforts have
been made to predict the continuous EF-hand Ca2+-binding proteins and to
understand the role of Ca2+ in biological systems. Pattern (motif signature)
search is one of the most straightforward ways to predict continuous EF-hand
Ca2+-binding sites in proteins. Based on the sequence alignment results of
canonical EF-hand motifs, especially the conserved side chains directly involved
in

Ca2+

binding,

a

pattern

PS00018

(http://us.expasy.org/cgi-

bin/nicesite.pl?PS00018) has been generated to predict canonical EF-hand sites.
Alternative patterns have also been proposed with the addition of other
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conserved residues in the motif (92,93). For the pseudo EF-hand loop, however,
each type of amino acid may serve as potential Ca2+ binding ligands because of
the use of main chain, which makes prediction solely from the sequences
relatively difficult. To circumvent this problem, the prediction of pseudo EF-hand
sites was achieved by detecting the canonical EF-hands based on the
assumption that all the pseudo EF-hands are paired by a C-terminal canonical
EF-hand. The currently available pattern PS00303 from EXPASY website
(http://us.expasy.org/cgi-bin/nicedoc.pl?PDOC00275) predicts the S100 type
Ca2+ binding proteins by spanning the C-terminal canonical EF-hand motifs. It is
worth pointing out that the prediction results obtained using this strategy do not
directly provide the sequence of the pseudo EF-hand Ca2+ binding loop.
Toward our goal of predicting and understanding the role of Ca 2+ in
biological systems (denoted as calciomics), we report herein our progress in
identifying EF-hand and EF-like motifs from the primary sequences. A series of
patterns were generated by taking advantage of the metal binding properties of
currently available EF-hand proteins and considering the helical structural
context around the Ca2+-binding loop. We modified the pattern PS00018 by
allowing more choices (Glu, Gln, and Ser) at position 1 (axis X) and adding
constraints at the flanking helical regions. By easing the constraints at the Cterminal canonical EF-hand, and simultaneously incorporating reserved residues
in the N-terminal pseudo EF-hand, we also generated a modified pattern for the
prediction of pseudo EF-hand sites. Compared with the pattern PS00303, the
new pattern, reflecting conserved genomic information in both the N- and C-
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terminal EF-hands, significantly improved the predictive accuracy and sensitivity.
Finally we report our analysis of EF-hand proteins in bacterial genomes using the
prediction method we developed. Our prediction results indicate that no pseudo
EF-hand protein is found in bacteria, which provides an additional piece of
evidence suggesting that pseudo EF-hand motif likely evolved later than
canonical EF-hand motifs.

3.1. Pattern development
Based on the sequence alignment results and the statistical profile
corresponding to each type of EF-hand Ca2+-binding site (Fig. 3.1), several
patterns reflecting the most conserved information at particular positions have
been developed and summarized in Table 3.1. Among them, patterns 1-4, in
addition to the commonly used pattern PS00018, can be used for the prediction
of canonical EF-hand Ca2+-binding sites with varying degrees of constraints on
the sequences. Patterns PS00303 and PC (abbreviation of pseudo and canonical
EF-hands pattern) can be used for the prediction of Ca 2+-binding motifs within
S100 and S100-like proteins. The patterns for EF-hand-like proteins are applied
to the prediction of EF-hand-like Ca2+-binding motifs with the loop length ranging
from 10 to 15 residues.

3.2. Canonical EF-hand motif
The widely applied pattern PS00018 has a stringent restraint at loop
sequence position 1 (axis X) that only allows Asp, although Asn or Ser also
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Table 3.1. Summary of patterns to predict EF-hand proteins.
Pattern
number

Pattern name

Conservation
positions

Motif signature

To predict Canonical EF-hand
eloopf
1

Canonical EF-loop
and both flanking
helices

x-{DNQ}-x(2)-{GP}-{ENPQS}-x(2)-{DPQR}-[DNS]-x[DNS]-{FLIVWY}-[DNESTG]-[DNQGHRK]-{GP}[LIVMC]-[DENQSTAGC]-x(2)-[ED]-[FLYMVIW]-x(2){NPS}-{DENQ}-x(3)

Canonical EF-loop
and the entering helix

x-{DNQ}-x(2)-{GP}-{ENPQS}-x(2)-{DPQR}-[DNS]-x[DNS]-{FLIVWY}-[DNESTG]-[DNQGHRK]-{GP}[LIVMC]-[DENQSTAGC]-x(2)-[ED]

Canonical EF-loop
and the exiting helix

[DNS]-x-[DNS]-{FLIVWY}-[DNESTG]-[DNQGHRK]{GP}-[LIVMC]-[DENQSTAGC]-x(2)-[ED][FLYMVIW]-x(2)-{NPS}-{DENQ}-x(3)

Canonical EF-loop

[DNS]-x-[DNS]-{FLIVWY}-[DNESTG]-[DNQGHRK]{GP}-[LIVMC]-[DENQSTAGC]-x(2)-[ED]

Canonical EF-loop

D - x - [DNS] - {ILVFYW} - [DENSTG] - [DNQGHRK] {GP} - [LIVMC] - [DENQSTAGC] - x(2) - [DE] [LIVMFYW]

Both helices of the
pseudo EF-motif,
both helices and the
loop of the paired
canonical EF-motif

[LMVITNF]-[FY]-x(2)-[YHIVF]-[SAITV]-x(5,9)[LIVM]-x(3)-[EDS]-[LFM]-[KRQLE]-x(20,28)-[LQKF][DNG]-x-[DNSC]-x-[DNK]-x(4)-[FY]-x-[EKS]

Both helices of the
pseudo EF-motif

[LMVITNF]-[FY]-x(2)-[YHIVF]-[SAITV]-x(5,9)[LIVM]-x(3)-[EDS]-[LFM]-[KRQLE]

Both helices and the
loop of the paired
canonical EF-motif

[LIVMFYW](2) - x(2) - [LK] - D - x(3) - [DN] - x(3) [DNSG] - [FY] - x - [ES] - [FYVC] - x(2) - [LIVMFS] [LIVMF]

The 10-residue loop

D-x-D-x-D-G-x(2)-C-E

The loop

D - x - [DNS] - {ILVFYW} - [DEN] - G - {GP}-x(5, 6)[DE]

eloop
2

loopf
3
loop
4
PS00018

a

5

To predict Pseudo EF-hand
PC
6

Pseudo
7
PS00303

b

8

To predict EF-hand-like
Excalibur
9
EF-hand-like
10
a
b

http://us.expasy.org/cgi-bin/nicesite.pl?PS00018
http://au.expasy.org/cgi-bin/nicesite.pl?PS00303
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Figure 3.1. Consensus sequence of canonical EF-hand (A) and pseudo EFhand domains (B) drawn based on profiles HMM using LogoMat-M
(http://logos.molgen.mpg.de/cgi-bin/logomat-m.cgi). n: the hydrophobic
residues within the flanking helices. #: the potential Ca2+ binding ligands
involving the mainchain carbonyl groups.
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occupy the position in a few EF-hands (Ca2+ and integrin binding protein 2
(Q9Z309), CaBPE63-1 (P48593), rat CaM (pdb code: 3cln)). The pattern
PS00018 focuses solely on the loop region and does not reflect conserved
information within the flanking regions. To improve the pattern PS00018, we
incorporated the diverse features of the flanking structural contexts and
developed patterns catering to different constraints on EF-hands. Based on
multiple sequence alignment results on over 1,000 canonical EF-hands from the
SwissProt protein sequence database, constraints on both flanking helices and
the 12-residue loop were well defined in separate patterns. As shown in Table 3.1,
three patterns were derived: a) x-{DNQ}-x(2)-{GP}-{ENPQS}-x(2)-{DPQR} for the
entering

helix;

b)

[DNS]-x-[DNS]-{ILVFYW}-[DNESTG]-[DNQGHRK]-{GP}-

[LIVMC]-[DENQSTAGC]-x(2)-[ED] for the Ca2+-binding loop; and c) [FLYMVIW]x(2)-{NPS}-{DENQ}-X(3) for the exiting helix. As revealed by the sequence
alignment, hydrophobic residues are favored at positions -1, -4, -5 and -8 in the
entering helix and at positions 13, 16, and 17 in the exiting helix (Fig. 3.1A).
Hence, hydrophilic residues or residues tending to interrupt helical structure were
excluded at these positions. The prediction of loop only (b), E-loop (a+b), loop-F
(b+c) and E-loop-F (a+b+c) can then be achieved using the patterns in
combination. This strategy provides an alternative way to perform prediction of
EF-hands as well as EF-hand-like sites with deviations at the flanking regions.
Fig. 3.2A shows the statistical results of the prediction of canonical EFhand motifs using the pattern eloopf. According to the Prosite documentation
PDOC00018, the pattern PS00018 results in more than 2,000 hits in the
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SwissProt database. To compare our patterns with PS00018, a total of 170
protein sequences were randomly selected from the SwissProt database. Of
these, 119 are true canonical EF-hand proteins with experimental validation,
while 51 are not. With these sequences as the testing database, prediction
results show that patterns 1-5 have similar sensitivity while the precision and
PPV of patterns 1-3 increased by 10% to 20% compared to the pattern PS00018.
Fewer false positive hits were detected when using the patterns 1-3. Hence,
additional constraints on the flanking regions enhance the overall accuracy of
prediction and the true positive predictions.

3.3. Pseudo EF-hand motif
As listed in Table 3.2, pseudo EF-hands are mostly found in the S100
protein family and among members of the “fused gene” family, such as
trichohyalin, horenin and repetin (94-99). The small, acidic S100 protein,
calbindinD9K, carries two distinct EF-hands: a canonical EF-hand at the C
terminus and a pseudo EF-hand motif at the N-terminus. The canonical EFhands are highly-conserved among all the S100 proteins (Fig. 3.3). However,
there is significant sequence variation in the Ca2+-binding loop of the pseudo EFhand (Fig. 3.1B). The pseudo EF-hand within the S100A10 even loses the
capacity to bind Ca2+ ion due to the lack of chelating ligands (100). Therefore,
one important concept that must be kept in mind is that the prediction of pseudo
EF-hand does not presume the capability of binding Ca2+ ion.
Using the multiple sequence alignment, we analyzed the Ca 2+-binding
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Figure 3.2. Statistical analysis on prediction performance of patterns. (A)
Prediction results using patterns eloopf (gray bar) and PS00018 (open bar).
The patterns were applied to search for canonical EF-hand proteins in a test
database containing 170 proteins. (B) Prediction results using the pseudo EFhand pattern PC (gray bar) and PS00303 (open bar). Both patterns were used
to search for potential pseudo EF-hand proteins against major protein
sequence databases SwissProt, NCBI RefSeq, and iProClass.
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ligands of all pseudo EF-hands with known structures in Protein Data Bank
(Table 3.2). Based on the statistical results, a profile HMM and the resultant HMM
logo were built (Fig. 3.1B). Of the Ca2+-binding ligands, Ser and Ala are preferred
at loop position 1 (X); Glu dominates at both positions 4 (Y) and 14 (-Z); Gly and
Leu are preferred at the positions 5 and 10, respectively; Asp is most frequently
found at position 6 (Z); and Thr and Lys reside equally at position 9 (-Y). By
integrating highly conserved residues located at the flanking helices (positions –1,
-4, -5, 15, and 16), we generated a pattern (Table 3.1, pattern pseudo) for the
prediction of pseudo EF-hand Ca2+-binding site. The pattern PC was further
developed by incorporating the conserved signature in the downstream canonical
EF-hand (positions -1, 1, 3, 5, 10, and 12).
To assess the performance of the developed patterns, we applied the
patterns against major protein sequence databases such as SwissProt,
iProClass (including PIR, trEMBL) and NCBI reference sequences (RefSeq). Fig.
3.2B shows the comparison of the pattern PC and the pattern PS00303. A
notable limitation of the pattern PS00303 is its failure to predict pseudo EF-hands
within S100A13, S100A14, S100A16, S100A17 and S100P from some species
due to stringent restraints at the C-terminal EF-hand motif. Moreover, since the
prediction is based on the C-terminal canonical EF-hand, the prediction of
PS00303 includes more false positive hits from the Ca2+-binding proteins
possessing only canonical EF-hands, such as calneuron 1 and Ca2+-binding
protein 7. In comparison with PS00303, 12.5% more true positive hits, in
average, resulted with the pattern PC in the three databases. Meanwhile, the
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Table 3.2. List of pseudo EF-hand proteins.
Protein

Synonyms

PDB codes

Accession Number (species*)

S100A1

S-100 protein alpha chain

1k2h

P02639 (b), P23297 (h), P56565 (m),
P35467 (r), Q7LZT1 (weatherloach)

S100A2
S100A3

S-100L, CAN19
S-100E

1kso

S100A4

Metastasin, Calvasculin, Mts1 protein, 18A2, PEL98,
Placental calcium-binding protein homolog, P9K,
Nerve growth factor induced protein 42A

S100A5

S-100D

S100A6

Calcyclin, Prolactin receptor associated protein, 5B10

S100A7

Psoriasin, Dermal allergen BDA11, Allergen Bos d 3
Calgranulin A, Neutrophil cytosolic 7 kDa protein P7,
Migrion inhibitory factor-related protein 8,
Chemotactic cytokine CP-10, MRP-8

S100A8

1m31

P63084 (m), P63083 (r), P33763(h)
P14069 (m), P05964 (r), P06703 (h),
P30801 (rb), Q98953 (c), O77691
(hs)

1psr, 2psr, 3psr

P31151 (h), Q28050 (b)

1mr8

P28782 (b), P05109 (h), P27005 (m),
P50115 (r)
P28783 (b), P06702 (h), P50117 (rb),
P31725 (m), P50116 (r)

Calgranulin B, Neutrophil cytosolic 23 kDa protein,
Migrion inhibitory factor-related protein 14 (MRP-14),
P23, BEE22, P14, Leukocyte L1 complex heavy
chain, Calprotectin L1H subunit

1irj

S100A10

Calpactin I light chain, p10 protein, p11, Cellular
ligand of annexin II, Nerve growth factor induced
protein 42C

1a4p, 1bt6

S100A11

Endothelial monocyte-activating polypeptide,
Calgizzarin, S100C, MLN 70, EMAP

1nsh, 1qls

S100A12

Putative S100 calcium-binding protein A11
pseudogene
Calgranulin C, CAGC, Calcium-binding protein in
amniotic fluid 1, CAAF1, RAGE binding protein,
Neutrophil S100 protein, p6

P35466 (b), P26447 (h), Q9TV56 (d),
P07091 (m), P05942 (r)

1a03, 1cnp, 1jwd,
1k8u, 1k96, 1k9k,
1k9p, 2ncp

S100A9

S100A11P

P10462 (b), P29034 (h)
P62818 (m), P62819 (r), P33764 (h)

P60902 (b), P60903 (h), P04163 (p),
P620504 (rhesus macaque),
P08207 (m), P05943 (r), P27003 (c),
P27004 (African clawed frog)
P31949 (h), P24480 (rb), P50543
(m), Q6B345 (r), P31950 (p), P24479
(c)
O60417 (h)

1e8a, 1gqm, 1odb

P79105 (b), P80310 (p),
P80511 (h), O77791 (rb)

S100A13
S100A14

8 kDa amlexanox-binding protein
S114

P79342 (b), Q99584 (h), P97352 (m)
Q9HCY8 (h), Q9D2Q8 (m)

S100A15
S100A16

S100F

Q86SG5 (h)
Q96FQ6 (h)

S100A17

clone:5430400H23 product:hypothetical EF-hand/S100/ICaBP type calcium binding protein

S100B

S-100 protein beta chain

S100G

Vitamin D-dependent calcium-binding protein
intestinal, Calbindin D9K, Cholecalcin

S100H

Putative S100 calcium-binding protein
H_NH0456N16.1

S100P
S100Z

Q9D3P1 (m)
1b4c, 1cfp, 1mho,
1dt7, 1mwn,
1psb, 1qlk, 1sym,
1uwo
1b1g, 1boc, 1bod,
1cb1, 1cdn, 1clb,
1d1o, 1ht9, 1ig5,
1igv, 1kcy, 1kqv,
1ksm,1n65, 2bca,
2bcb, 3icb, 4icb

P50114 (m), P04631 (r), P04271 (h),
P02638 (b)

P29377 (h), P02632 (p), P02633 (b),
P51964 (c), P02634 (r), P97816 (m)

Q9UDP3 (h)
1ozo, 1j55

P25815 (h)
Q8WXG8 (h)

Hornerin
Ictacalcin

Q86YZ3 (h), Q8VHD8 (m)
Q91061 (channel catfish)

MRP-126
Reptin

P28318 (c)
P97347 (m)

Trichohyalin

Q07283 (h), P37709 (rb), P22793 (s)

* The abbreviation for species: b, bovine; c, chicken; d, dog; h, human; hs, horse; m, mouse; r, rat; rb, rabbit; s, sheep
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Figure 3.3. Multiple sequence alignment of the pseudo EF hand proteins. 25
entries representing 84 proteins with pseudo EF-hand motif from SwissProt
were used for alignment. The N-terminal pseudo EF-hand and C-terminal
canonical EF-hand motifs with typical helix-loop-helix structure are shown at
the top (box: helical structure; line: loop region). The oxygen atoms chelating
the Ca2+ ion adopts a pentagonal bipyramid geometry. (n: the hydrophobic
residues within the flanking helices. #: the potential Ca 2+ binding ligands
involving the mainchain carbonyl groups. bi: the bidentate chelating ligands.)
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false positive hits were reduced by 10.5% on average. The average sensitivity
and PPV of the pattern PC were 96 and 99%, respectively, which were 10 and
13% higher than those of the pattern PS00303 (Fig. 3.2B). The pattern PC was
able to identify the pseudo EF-hand motifs in at least 3 more subgroups of S100
proteins including S100A13, S100A14, and S100A16 than the pattern PS00303
was. The first half of the pattern PC (or pattern pseudo) could be of great
advantage in predicting S100-like proteins with deviations in the downstream
canonical Ca2+-binding loop or in predicting partially-characterized, incomplete
hypothetical proteins. For instance, the pseudo EF-hand motifs in the novel Ca2+binding protein p26olf (named as the protein from frog olfactory epithelium)
(101,102) could not be predicted by either PS00303 or PC since the C-terminal
EF-hand contains an atypical EF-hand motif with a 4-residue insertion. However,
without constraints on the C-terminus, the pattern pseudo (Table 3.1) can easily
detect them.

3.4. Properties of EF-hand like motif
With the overall structural geometry of the Ca2+ coordination remaining
conserved, “EF-hand-like” motif refers to the one containing the following
deviations from the canonical EF-hand: (1) the length of the Ca2+-binding loop is
shorter or longer than 12 residues and/or (2) the secondary structure elements of
the flanking regions are not two helices. The first deviation can be represented in
the motif signature by varying the length of the loop region (Patterns 9-10 in
Table 3.1). However, the structural deviation in the flanking regions can hardly be
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Table 3.3. EF-hand-like Ca2+-binding proteins with known structure.

a. 1. Shorter loop. 2. Longer loop. 3. Entering helix missing.
helix missing.
5. Distal located ligands
b. Ligand residues are underlined

4. Exiting
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predicted merely from the sequences. Therefore, we conducted a retrospective
search of EF-hand-like proteins in the PDB database (Table 3.3). Four classes of
EF-hand-like motifs are currently observed. The first class has a shorter loop (as
seen in Excalibur) that contains a conserved 10-residue DxDxDGxxCE motif. The
cysteine in the sequence may facilitate the orientation of the loop toward Ca 2+
binding by forming disulfide bonds(23). The second class has a longer loop as
seen in Slt35 (PDB code: 1qut), a soluble fragment of lytic transglycosylase B
from Escherichia coli that has a 15-residue Ca2+-binding loop flanked by two
helices (103,104). The third class lacks the entering helix as seen in protective
antigen (PDB code: 1acc) from Bacillus anthracis (27) and dockerin from
Clostridium thermocellum (PDB code: 1daq) (28). The fourth class lacks the
exiting helix as seen in alginate-binding protein (PDB code: 1kwh) from
Sphingomonas sp (26). Some EF-hand-like proteins even infringe the EF-hand
paradigm by possessing two or more types of deviations (Table 3.3).

3.5. EF-hand proteins in the bacterial genomes
To understand the roles of Ca2+ in bacteria, we predicted putative EF-hand
proteins in the bacteria genomes from the Non-Redundant REFerence protein
database (NREF) (105). No pseudo-EF-hand motif was predicted using the
pattern PC. A total of 467 EF-hand motifs in 397 entries of proteins were
predicted using the pattern eloopf (Table 3.1) for the canonical EF-hand motifs
(Table 3.4). There are 39 proteins that contain multiple EF-hand motifs ranging
from 2 to 6. The other 358 proteins were predicted to contain mononuclear EF-
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hands. The roles of Ca2+ in most of these proteins are yet to be characterized.
The 39 proteins with multiple EF-hand motifs, among which 16 proteins
have been summarized before(4), are implicated in a variety of cellular activities,
including Ca2+ homeostasis (106-108), chemotaxis (24,109,110), scaffold protein
binding (111), resistance to acid stress (112,113) and so on. According to the
sequence homology and assuming these proteins evolved from a common
ancestor, they could be further classified into three major phylogenetic groups
(Fig. 3.4). The first group includes calerythrin (Saccharopolyspora erythrea,
P06495), calsymin (Rhizobium etli, AAG21376), putative glycosyl hydrolase
(Bacteroides fragilis, NF02360737), α-xylosidase (Bacteroides thetaiotaomicron,
NF01244792), and putative Ca2+ binding proteins from the Gram-positive
bacterial

genus

streptomyces

(Streptomyces

ambofaciens,

BAB19055;

Streptomyces coelicolor, CAB76018, NP_628579, CAC16980). Calerythrin is the
first characterized prokaryotic CaM-like protein possessing three canonical and
an atypical EF-hand motif (114,115). Two of the three high-affinity sites
cooperatively chelate the metal ions and the apo protein adopts a molten globule
state conformation. It may function as Ca2+ buffer or transporter (116). Being
highly homologous to calerythrin, several members in this group (BAB19055,
CAB76018, NP_628579, CAC16980, and NF02549883) are expected to adopt
similar Ca2+-dependent structural and biological behavior (117). Another protein
calsymin was implicated in symbiotic nitrogen fixation (118). It contains three
repeated homologous domains, each of which possesses two EF-hand motifs.
Extracellular polysaccharide-degrading enzymes, putative glycosyl hydrolase and

56
α-xylosidase are involved in the metabolism of the bacterial wall. The Ca2+
binding in the mesophilic xylanase and other members (NF02715683 and
NF02518859) may protect the proteins from enzyme attack and thermal
denaturation (119).
The protein functions and the role of Ca2+ in the second group are not well
understood except for the acid shock protein (AAB69346) from the Gramnegative bacterial genus Brucella. This protein is actively synthesized in
response to the low pH to facilitate adaptation to acidic environments (112). In
addition, the putative EF-hand protein NF01724660 may link to the Ca2+-induced
aggregation of the sulfate-reducing bacteria Desulfovibrio (120).
The third group encompasses dockerin (Clostridium acetobutylicum,
NF00465242, NF00464378), bacterial transaldolase (Synechocystis sp. P72797),
adhesin (Vibrio vulnificus, NF01147763), and others with unknown functions.
Dockerin is involved in the degradation of the plant cell wall by incorporating
glycosyl hydrolase into the extracellular cellulose complex “cellulosome” via
interaction with the cohesion domain (111). Ca2+ induces the folding of dockerin
(121). Bacterial transaldolase, like its eukaryotic homologues, is involved in the
metabolism of glucose (122). No explanation has thus far been offered for the
unique presence of EF-hand motifs in this bacterial enzyme. Autotransporter
adhesin, a prototype of the adhesin family, mediates the specific attachment of
bacteria to target cells (123). The binding of Ca2+ would probably provoke the
efficient interaction and facilitate the attachment.
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Protein/domain name
(Accession ID)

Group 1

Group 2

Group 3

No.
of EF-hands

Organism

Bll5679 protein (NF01145262)
Ca 2+-binding EF-hand precursor (NF01530872)
CaBP (NF02715386)
Ca 2+-binding EF-hand precursor (NF02518859)
CaBP (NF00981304)
Calsymin (AAG21376)
SCO5464 (CAB76018)
Ca 2+-binding EF-hand (NF02549883)
EF hand domain protein (NF02637914)
Putative CaBP (CAC16980)
Putative CaBP (NP_628579)
Putative glycosyl hydrolase (NF02360737)
Alpha-xylosidase (NF01244792)
Calerythrin (P06495)
CaBP A (BAB19055)
Calcium-binding EF-hand (NF02492865)
Putative calcium binding signal (NF00850536)
EF hand domain protein (NP_421029)
Hypothetical protein CC2193 (NP_420996)
Putative CaBP (AAK24164)
EF hand domain protein (NP_421548)
mll5457 (BAB51906)
Acid shock protein (AAB69346)
EF hand domain protein (NF01724660)

2
4
3
4
4
6
2
2
2
2
4
2
2
4
3
2
2
2
3
4
3
3
3
2

Bradyrhizobium japonicum
Rhodopseudomonas palustris
Pseudomonas savastanoi
Pseudomonas syringae
Xanthomonas axonopodis
Rhizobium etli
Streptomyces coelicolor
Thermobifida fusca
Colwellia psychrerythraea
Streptomyces coelicolor
Streptomyces coelicolor
Bacteroides fragilis
Bacteroides thetaiotaomicron
Saccharopolyspora erythrea
Streptomyces ambofaciens
Cupriavidus necator
Ralstonia solanacearum
Caulobacterr crescentus
Caulobacterr crescentus
Streptomyces coelicolor
Caulobacter crescentus
Mesorhizobium loti
Brucella melitensis
Desulfovibrio vulgaris

Bll6206 (NF01146006)
Hypothetical protein CC1180 (NP_419996)
Hypothetical protein (NF01644848)
EF hand domain protein (NF01553463)
mlr9645 (BAB54835)
Hypothetical protein (NF01900066)
Dockerin and cellulose-binding (NF00465242)
Calcium-binding EF-hand precursor (NF02500531)
EF-hand domain protein (NF01444486)
Dockerin domain (NF00464378)
Slr0366 protein (NF00423899)
Autotransporter adhesin (NF01147763)

2
4
3
2
2
3
2
4
3
2
4
5

Bradyhizobium japonicum
Caulobacter crescentus
Rhodopirellula balti
Geobacter sulfurreducens
Mesorhizobium loti
Desulfotalea psychrophila
Clostridium acetobutylicum
Pseudomonas syringae
Pseudomonas syringae
Clostridium acetobutylicum
Synechocystis sp.
Vibrio vulnificus

Hypothetical protein (NF02421939)
Transaldolase (P72979)

2
2

Corynebacterium jeikeium
Synechocystis sp.

CaBP (NF02412314)

3

Pseudomonas fluorescens

Figure 3.4. Phylogenetic analysis of prokaryotic proteins containing multiple
EF-hand motifs ranging from 6 to 2. The 39 proteins can be classified into three
groups (see Section 3.5 for details).
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3.6. Possible roles of single EF-hands
The 358 predicted proteins containing single EF-hand motifs are in 162
complete or incomplete bacterial genomes in the PIR-NREF database
(http://pir.georgetown.edu/cgi-bin/nfspecies.pl). They are distributed across in the
majority of bacterial species (Table 3.4). These proteins are implicated in a wide
range of cellular processes such as drug resistance (multiple drug resistance
protein, multidrug efflux transporter), ion and nutrilites transporting (K +transporting ATPase B, Na+-solute symporter, hemin ABC transporter, cation
efflux system protein), nucleic acid modification and metabolism (tRNA
synthetase, ribonuclease G, exodeoxyribonuclease V gamma chain, RNA
polymerase beta subunit, ATP-dependent DNA helicase, DNA polymerase tau
subunit, DNA gyrase subunit A, DNA methyltransferase), transcriptional
regulation (transcriptional regulator), stress response (DnaK, acid shock proteins,
heat shock protein HspG), chemotaxis (CheV, histidine kinase HAMP region),
energy and nutrilites metabolism (GTP-binding protein, AMP nucleosidase,
aminotransferase, acetyltransferase), redox reaction (flavodoxin oxidoreductase ,
thio-disulfide

isomerase,

iron-sulfur

cluster

binding

protein,

thioredoxin

reductase), and cell wall modification and degradation (chitinase C, glycosyl
hydrolase, exopolysaccharide synthesis protein, probably secreted sialidase,
putative surface anchored protein).
Among all of these matches, ATP-binding cassette (ABC) transporter and
Shr are of particular interest considering their important roles in bacterial
activities and the possible implication of Ca2+ in the biological context. ABC
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transporter couples the hydrolysis of ATP to the transport of various molecules
including sugars, ions, antibiotics, and peptides across the cell membrane (124126). Shr in streptococcus encodes a large hydrophilic protein (putative Fe3+siderophore transport) that has no significant homologues in bacteria but shares
partial homology with eukaryotic receptors such as Toll and G-protein dependent
receptors. A leucine-rich repeat domain, an EF-hand domain, and two NEAT
domains are identified in Shr. Shr directly binds heme-proteins such as
hemoglobin, myoglobin, heme-BSA and the hemoglobin-heptoglobin complex
(127,128). The presence of a nearly perfect EF-hand domain in Shr raises the
possibility that Ca2+ may modulate its activity and represent a new type of Ca2+
regulated receptor involved in heme-protein binding and iron acquisition.
The single-handed EF-hand motifs were also observed in Arabidopsis
(129). These observations raise the possibility that the ubiquitous EF-hand motif
may function as an independent structural unit for Ca 2+ binding. To date, the
majority of known EF-hand motifs are coupled through the hydrophobic
interaction of the flanking helices (21,22,130,131). Our previous work has shown
that the isolated EF-loop III from CaM without the flanking helices in a host
protein is able to bind Ca2+ and remains monomer in solution (70), whereas
peptide fragments encompassing the helix-loop-helix EF-hand motifs were
shown to dimerize in solution (132-135). We hope that our prediction could spur
the exploration of the relationship between their function and Ca 2+ binding
capability.
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Table 3.4. List of potential prokaryotic EF-hand-containing proteins.
Accession
ID
NF01799660

Protein Name
Bifunctional protein

Sequence
Range
165-193

EF-hand
number
1

NF01800980

Hypothetical protein

134-162

1

NF00596974

AGR_C_660p

166-194

1

NF00854152

Hypothetical protein Atu0377

147-175

1

NF00853975

555-583

1

NF00854754

Potassium-transporting ATPase B
chain
Two component response regulator

273-301

1

NF00601861

AGR_C_1956p

288-316

1

NF02630316

Haloacid dehalogenase-like
hydrolase:E1-E2 ATPase-associated
region
DNA gyrase, subunit A precursor

556-584

1

501-529

1

227-255

1

NF02633157

Twin-arginine translocation pathway
signal precursor
TPR repeat precursor

343-371

1

NF02633311

Aminotransferase, putative

153-181

1

NF02145020

Prolyl-tRNA synthetase

220-248

1

Anaeromyxobacter
dehalogenans
Anaeromyxobacter
dehalogenans
Anaeromyxobacter
dehalogenans
Anaeromyxobacter
dehalogenans
Anaplasma marginale

NF02630616
NF02632976

+

Organism
Acinetobacter sp.
ADP3
Acinetobacter sp.
ADP4
Agrobacterium
tumefaciens
Agrobacterium
tumefaciens
Agrobacterium
tumefaciens
Agrobacterium
tumefaciens
Agrobacterium
tumefaciens
Anaeromyxobacter
dehalogenans

NF00005240

Na :solute symporter

266-294

1

Aquifex aeolicus

NF02418698

Initiation factor 2:Small GTP-binding
protein domain
Regulatory protein, LysR:LysR,
substrate-binding
Amino acid-binding ACT:Prephenate
dehydrogenase
Hypothetical protein

712-740

1

Arthrobacter sp. FB24

188-216

1

Arthrobacter sp. FB24

325-353

1

Arthrobacter sp. FB24

129-157

1

Azoarcus sp. EbN2

57-85

1

Azoarcus sp. EbN3

NF02111329

AcrA/AcrE family putative membranefusion protein
Isoleucyl-tRNA synthetase

608-636

1

Azoarcus sp. EbN4

NF02599343

Hypothetical protein

333-361

1

Azotobacter vinelandii

NF02601050

Glycine cleavage system P-protein

678-706

1

Azotobacter vinelandii

NF01002531

229-257

1

Bacillus anthracis

NF01003358

Polysaccharide deacetylase-like
protein
Multidrug resistance protein, putative

174-202

1

Bacillus anthracis

NF01293886

Acetyltransferase, GNAT family

61-89

1

Bacillus anthracis

NF00452066

hypothetical protein pxo2_15

123-151

1

Bacillus anthracis

NF01293170

195-223

1

Bacillus anthracis

NF01968462

Oxidoreductase, short-chain
dehydrogenase/reductase family
Probable multidrug efflux transporter

174-202

1

Bacillus cereus

NF01692216

Isoleucyl-tRNA synthetase

583-611

1

Bacillus cereus

NF02763311

Polysaccharide deacetylase family
protein, putative
Acetyltransferase, GNAT family

229-257

1

Bacillus cereus

61-89

1

Bacillus cereus

NF02419170
NF02420554
NF02183774
NF02110613

NF01693845
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Accession
ID
NF01269023

Protein Name

Sequence
Range
195-223

EF-hand
number
1

Organism

191-219

1

Bacillus clausii

291-319

1

Bacillus halodurans

227-255

1

Bacillus licheniformis

216-244

1

Bacillus licheniformis

191-219

1

Bacillus subtilis

Bacillus cereus

NF00459033

3-oxoacyl-[acyl-carrier protein]
reductase
3-oxoacyl-[acyl-carrier-protein]
reductase
Ribonuclease G (Cytosolic axial
filament protein)
Hypothetical protein (D-isomer specific
2-hydroxyacid dehydrogenase, NAD
binding domain)
Putative L-2,4-diaminobutyrate
decarboxylase
Hypothetical oxidoreductase yoxD

NF01847653

Probable multidrug efflux transporter

174-202

NF01850556

Acetyltransferase, GNAT family

61-89

1

Bacillus thuringiensis

NF02232249

Hypothetical protein

740-768

1

Bacillus thuringiensis

NF01852124

Short chain dehydrogenase

195-223

1

Bacillus thuringiensis

NF01982311

Hypothetical protein

9-37

1

Bacteroides fragilis

NF02360737

Putative glycosyl hydrolase

2

Bacteroides fragilis

NF01983199

K -transporting ATPase B chain

1087-1115
1123-1151
545-573

1

Bacteroides fragilis

NF01984037

Putative outer membrane protein

889-917

1

Bacteroides fragilis

NF02360881

67-95

1

Bacteroides fragilis

NF01247854

Putative AraC-family transcriptional
regulator
Putative outer membrane protein

856-884

1

NF01244792

Alpha-xylosidase

2

NF01247957

Hypothetical protein

1093-1121
1129-1157
57-85

NF01243332

K -transporting ATPase B chain

540-568

1

NF01632112

Ribonuclease G

309-337

1

NF01633060

Probable GTP-binding protein

120-148

1

NF01125245

BglX

745-773

1

NF01125387

5'-nucleotidase family protein

412-440

1

NF01125928

360-388

1

NF01356204

Solute binding protein of ABC
transporter for branched-chain amino
acids
Putative outer membrane protein

Bacteroides
thetaiotaomicron
Bacteroides
thetaiotaomicron
Bacteroides
thetaiotaomicron
Bacteroides
thetaiotaomicron
Bdellovibrio
bacteriovorus
Bdellovibrio
bacteriovorus
Bifidobacterium
longum
Bifidobacterium
longum
Bifidobacterium
longum

133-161

1

NF01357346

Putative exported protein

53-81

1

NF01358260

Putative exported protein

193-221

1

NF01360429

Potassium-transporting ATPase B
chain
Decorin binding protein B

582-610

1

94-122

1

Potassium-transporting ATPase B
chain
Potassium-transporting ATPase B
chain
Putative exported protein

582-610

1

582-610

1

Bordetella
parapertussis
Bordetella pertussis

198-226

1

Bordetella pertussis

NF02058262
NF00639248
NF01942957

NF01943135

NF01857138
NF01347842
NF01351614
NF01354467

+

+

Bacillus thuringiensis

1

Bordetella
bronchiseptica
Bordetella
bronchiseptica
Bordetella
bronchiseptica
Bordetella
bronchiseptica
Borrelia garinii
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Accession
ID
NF01143994

Protein Name
Bll5001 protein

Sequence
Range
92-120

EF-hand
number
1

NF01144916

Bll3714 protein

4088-4116

1

NF01146006

Bll6206 protein

2

NF01145264

Bsr4957 protein

28-56
77-105
28-56

NF01138884

Potassium-transporting ATPase B
chain

567-595

1

NF01145262

Bll5679 protein

2

NF02362000

Hypothetical protein

105-133
139-167
187-215

1

Bradyrhizobium
japonicum
Brucella melitensis

NF02362472

Chaperone protein DnaK

173-201

1

Brucella melitensis

NF00882038

213-241

1

Brucella melitensis

NF00882425

Cobalt-zinc-cadmium resistance
protein CZCD
Transporter

172-200

1

Brucella melitensis

NF00729490

Acid-shock protein, putative

2

Brucella melitensis

NF01092664

Hypothetical protein

63-91
120-148
191-219

1

Brucella melitensis

NF01013862

Exodeoxyribonuclease V beta chain

542-570

1

Buchnera aphidicola

NF00001599

Cell division protein ftsY homolog

20-48

1

Buchnera aphidicola

NF02558178

555-583

1

Burkholderia
cenocepacia

NF02562763

Haloacid dehalogenase-like
hydrolase:E1-E2 ATPase-associated
region
Pyridoxal-dependent decarboxylase

150-178

1

NF01994075

Hypothetical protein

100-128

1

Burkholderia
cenocepacia
Burkholderia mallei

NF01995267

AMP nucleosidase

136-164

1

Burkholderia mallei

+

1

Organism
Bradyrhizobium
japonicum
Bradyrhizobium
japonicum
Bradyrhizobium
japonicum
Bradyrhizobium
japonicum
Bradyrhizobium
japonicum

NF01997459

K -transporting ATPase, B subunit

556-584

1

Burkholderia mallei

NF01974439

Putative exported protein

110-138

1

NF01975408

547-575

1

NF01976188

Potassium-transporting ATPase b
chain
AMP nucleosidase

136-164

1

NF02692726

Iron-sulfur cluster binding protein

285-313

1

Burkholderia
pseudomallei
Burkholderia
pseudomallei
Burkholderia
pseudomallei
Campylobacter coli

NF02628440

Cj81-040 (Fragment)

130-158

1

Campylobacter jejuni

NF02271643

Dihydroorotase, putative

157-185

1

Campylobacter jejuni

NF00555721

539-567

1

Campylobacter jejuni

NF00556942

Potassium-transporting ATPase B
chain
Hemin ABC transporter

101-129

1

Campylobacter jejuni

NF02581023

Uncharacterized ACR, COG1427

169-197

1

Campylobacter lari

NF02581415

Iron-sulfur cluster binding protein

282-310

1

Campylobacter lari

NF02513884

Hypothetical protein

155-183

1

NF02514058

Hypothetical protein

48-76

1

NP_419996

hypothetical protein CC1180

96-124
120-148
197-225
221-249

4

Campylobacter
upsaliensis
Campylobacter
upsaliensis
Caulobacter
crescentus
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Accession
ID
NP_420996

Protein Name

Sequence
Range
36-64
77-105
191-219
33-61
59-87
294-322
319-337
547-575

EF-hand
number
3

Organism

NP_421029

EF hand domain protein

2

1

Caulobacter
crescentus
Caulobacter
crescentus
Caulobacter vibrioides

NP_421548

EF hand domain protein

NF00922900
NF00923077

Potassium-transporting ATPase B
chain
Hypothetical protein CC1180

96-124

1

Caulobacter vibrioides

NF00921487

Hypothetical protein CC2193

319-347

1

Caulobacter vibrioides

NF00921074

TonB-dependent receptor

282-310

1

Caulobacter vibrioides

NF00920950

EF hand domain protein

33-61

1

Caulobacter vibrioides

NF00919601

EF hand domain protein

36-64

1

Caulobacter vibrioides

NF00920207

dnaK-type molecular chaperone dnaK

173-201

1

Caulobacter vibrioides

NF00170276

Hypothetical protein CPn0045

460-488

1

NF01414521

566-594

1

NF01415832

Potassium-transporting ATPase B
chain
Flagellar hook-associated protein

130-158

1

NF01417084

Acid phosphatase

38-66

1

NF00462703

DnaK protein

184-212

1

NF00464732

4-32

1

NF00463611

General secretion pathway protein E,
ATPase
Membrane flavodoxin oxidoreductase

367-395

1

NF00464531

dockerin domain

394-422

1

NF00462598

Possible non-processive
endoglucanase family 5, secreted;
CelA homolog secreted; dockerin
domain
Probably secreted sialidase; several
ASP-boxes and dockerin domain

418-446
450-478

2

Chlamydophila
pneumoniae
Chromobacterium
violaceum
Chromobacterium
violaceum
Chromobacterium
violaceum
Clostridium
acetobutylicum
Clostridium
acetobutylicum
Clostridium
acetobutylicum
Clostridium
acetobutylicum
Clostridium
acetobutylicum

768-796
800-828

2

Clostridium
acetobutylicum

NF00465242

dockerin and cellulose-binding domain

NF00464378

dockerin domain

NF00872981

Probable thioredoxin reductase

805-833
837-865
647-675
679-707
628-656
660-688
662-690
696-724
367-395

2

NF00464704

Cellulase CelE ortholog; dockerin
domain
dockerin and cellulose-binding domain

1

Clostridium
acetobutylicum
Clostridium
acetobutylicum
Clostridium
acetobutylicum
Clostridium
acetobutylicum
Clostridium perfringens

NF01191711

Encapsulation protein capA

25-53

1

Clostridium tetani

NF01192507

Putative cardiolipin synthetase 2

436-464

1

Clostridium tetani

NF01190826

156-184

1

Clostridium tetani

NF01191088

RNA polymerase sigma factor for
flagellar operon fliA
Putative S-layer protein

438-466

1

Clostridium tetani

NF02636675

transcriptional regulator, LysR family

143-171

1

NF02635517

hypothetical protein CPS_0266

258-286

1

Colwellia
psychrerythraea
Colwellia
psychrerythraea

NF00464704
NF00461910

hypothetical protein CC2193

2

2
2
2

Caulobacter
crescentus
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Accession
ID
NF02635672

Protein Name

Sequence
Range
72-100

EF-hand
number
1

22-50

1

6-34
42-70
89-117

2

Organism

NF02637464

DNA polymerase III, gamma/tau
subunit
EF hand domain protein

NF02637914

EF hand domain protein

NF02638565

hypothetical protein CPS_4268

NF02638842

patatin-like phospholipase family
protein
TnpC protein

435-463

1

21-49

1

163-191

1

NF02423383

Conserved hypothetical secreted
protein
Putative surface-anchored protein

537-565

1

NF02421939

Hypothetical protein

2

NF02421622

ATP-dependent DNA helicase

136-164
304-332
287-315

NF02421112

Thiol-disulfide isomerase/thioredoxin
precursor
Calcium-binding EF-hand

59-87

1

70-98
136-164
426-454

2

Colwellia
psychrerythraea
Colwellia
psychrerythraea
Colwellia
psychrerythraea
Colwellia
psychrerythraea
Colwellia
psychrerythraea
Corynebacterium
efficiens
Corynebacterium
glutamicum
Corynebacterium
jeikeium
Corynebacterium
jeikeium
Corynebacterium
jeikeium
Corynebacterium
jeikeium
Cupriavidus necator

1

Cupriavidus necator

NF01120262
NF00925376

NF02492865

1

1

NF02493293

ATP-binding region, ATPaselike:Histidine kinase A, N-terminal

NF02493847

518-546

1

Cupriavidus necator

496-524

1

Cupriavidus necator

349-377

1

Cupriavidus necator

600-628

1

Cupriavidus necator

NF02274727

Fungal/archaeal/bacterial haem
catalase/peroxidase
Outer membrane autotransporter
barrel
Histidine kinase, HAMP
region:Bacterial chemotaxis sensory
transducer
ATPase, E1-E2 type:Potassiumtranslocating P-type ATPase, B subunit
hypothetical protein DET1403

195-223

1

NF02696634

Calcium-binding EF-hand

46-74

1

NF02697139

Glycine cleavage system P-protein

613-641

1

NF02274727

hypothetical protein DET1403

195-223

1

NF02650500

26-54

1

NF02648532

Similar to High-affinity K transport
system ATPase chain B precursor
Hypothetical protein precursor

120-148

1

NF00437343

Ribonuclease II family protein

88-116

1

NF00435709

Hypothetical protein DR0685

179-207

1

NF00438084

Hypothetical protein DR1404

14-42

1

NF00435967

Hypothetical protein DR2551

191-219

1

NF01898379

Hypothetical protein

161-189

1

Dehalococcoides
ethenogenes
Dechloromonas
aromatica
Dechloromonas
aromatica
Dehalococcoides
ethenogenes
Deinococcus
geothermalis
Deinococcus
geothermalis
Deinococcus
radiodurans
Deinococcus
radiodurans
Deinococcus
radiodurans
Deinococcus
radiodurans
Desulfotalea
psychrophila

NF02495396
NF02497227

NF02497778

+

65
Accession
ID

Protein Name

Sequence
Range

EF-hand
number

Organism

NF01900066

Hypothetical protein

3

Desulfotalea
psychrophila

NF01899559

1

NF01722462

Probable high affinity sulfate
transporter (SulP)
+
K -transporting ATPase, B subunit

277-305
384-412
491-519
560-588
539-567

1

Desulfotalea
psychrophila
Desulfovibrio vulgaris

NF01723330

EF hand domain protein

19-47

1

Desulfovibrio vulgaris

NF01724660

EF hand domain protein

2

Desulfovibrio vulgaris

NF01239980

1

Enterococcus faecalis

NF02746267

Glycosyl hydrolase, family
31/fibronectin type III domain protein
DnaK molecular chaperone

51-79
152-180
1162-1190
173-201

1

Erythrobacter litoralis

NF02746140

Hypothetical protein

97-125

1

Erythrobacter litoralis

NF02746586

Hypothetical protein

93-121

1

Erythrobacter litoralis

NF00704786

Hypothetical protein ECs5257

4-32

1

Escherichia coli

NF00695695

379-407

1

Escherichia coli

NF01134307

N-acetylmuramoyl-L-alanine amidase
amiB precursor
Rhamnulokinase

324-352

1

Escherichia coli

NF01744738

Putative glycosyltransferase

174-202

1

Escherichia coli

NF00692267

Resolvase family recombinase

6-34

1

Escherichia coli

NF01491630

Zn-dependent hydrolase

462-490

1

NF01492715

Protease

388-416

1

NF02148420

Hypothetical conserved protein

73-101

1

NF01553463

EF hand domain protein

2

NF01551775

EF hand domain/PKD domain protein

22-50
59-87
1723-1751

NF01553119

1363-1391

1

NF01553013

Salmonella virulence plasmid 65kDa B
protein
Potassium-transporting ATPase

552-580

1

NF01419166

Gll3319 protein

106-134

1

Fusobacterium
nucleatum
Fusobacterium
nucleatum
Geobacillus
kaustophilus
Geobacter
sulfurreducens
Geobacter
sulfurreducens
Geobacter
sulfurreducens
Geobacter
sulfurreducens
Gloeobacter violaceus

NF01422150

Glr3888 protein

757-785

1

Gloeobacter violaceus

NF01420350

Transaldolase

357-385

1

Gloeobacter violaceus

NF02258009

Cation efflux system protein

211-239

1

NF01345996

Cell division protein FtsZ

259-287

1

Gluconobacter
oxydans
Haemophilus ducreyi

NF01345965

Hypothetical protein

60-88

1

Haemophilus ducreyi

NF01744248

Adhesin

286-314

1

NF00736924

Hypothetical protein HI1594

179-207

1

NF02647744

Exodeoxyribonuclease V gamma chain

469-497

1

NF02647997

DNA translocase FtsK

290-318

1

NF01331967

Bacterial cell division topological
specificity factor MinE
Aconitate hydratase

51-79

1

Haemophilus
influenzae
Haemophilus
influenzae
Haemophilus
influenzae
Haemophilus
influenzae
Helicobacter hepaticus

404-432

1

Helicobacter hepaticus

NF01331990

1
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Accession
ID
NF00574925

Sequence
Range
290-318

EF-hand
number
1

Organism

248-276

1

Helicobacter pylori

405-433

1

Idiomarina loihiensis

62-90

1

Idiomarina loihiensis

NF02105366

DNA-directed RNA polymerase beta
subunit
RND family efflux system membrane
fusion protein
GntP family permease

335-363

1

Idiomarina loihiensis

NF02106157

Outer membrane protein

535-563

1

Idiomarina loihiensis

NF01526365

TnpR recombinase

29-57

1

Klebsiella pneumoniae

NF02267084

Iron-sulfur cofactor synthesis protein

113-141

1

NF02266040

Alpha-glucosidase

953-981

1

NF01324779

114-142

1

NF01585065

Cysteine sulfinate desulfinase/cysteine
desulfurase
Hypothetical protein

Lactobacillus
acidophilus
Lactobacillus
acidophilus
Lactobacillus johnsonii

330-358

1

Lactobacillus johnsonii

NF01210549

Cation transporting P-type ATPase

9339-367

1

NF01211534

Phosphoglucosamine mutase

234-262

1

NF00449250

111-139

1

NF02043787

Maltose ABC transporter substrate
binding protein
RNA polymerase beta' subunit

Lactobacillus
plantarum
Lactobacillus
plantarum
Lactococcus lactis

1365-1393

1

NF00628534

O-methyltransferase, SAM-dependent

132-160

1

NF02048951

DNA-directed RNA polymerase beta'
subunit
Hypothetical protein

1379-1407

1

12-40

1

Legionella
pneumophila
Legionella
pneumophila
Legionella
pneumophila
Leptospira interrogans

Potassium-transporting ATPase B
chain
Preprotein translocase SecY

548-576

1

Leptospira interrogans

41-69

1

Leptospira interrogans

543-571

1

Listeria innocua

NF00813533

Potassium-transporting ATPase B
chain 2
Lin0875 protein

48-76

1

Listeria innocua

NF00813673

Lin2223 protein

232-260

1

Listeria innocua

NF01748822

GGDEF domain protein

152-180

1

NF01746930

Transketolase

338-366

1

NF00812586

Lmo1869 protein

228-256

1

NF00604651

Mlr9645 protein

2

NF00606972

Mll5457 protein

2

Mesorhizobium loti

NF00610956

1

Mesorhizobium loti

NF02036858

Potassium-transporting ATPase B
chain
DNA gyrase, A subunit

129-157
152-180
69-97
102-130
551-579

Listeria
monocytogenes
Listeria
monocytogenes
Listeria
monocytogenes
Mesorhizobium loti

518-546

1

NF02038758

Hypothetical protein

209-237

1

NF01628109

GyrA

496-524

1

Methylococcus
capsulatus
Methylococcus
capsulatus
Mycobacterium avium

NF01628325

Hypothetical protein

76-104

1

Mycobacterium avium

NF00572083
NF02103893
NF02104158

NF01698417
NF01085961
NF00554020
NF00844705

Protein Name
Ulcer associated adenine specific DNA
methyltransferase
Hypothetical protein alpB

Helicobacter pylori
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Accession
ID
NF01324088

Protein Name

Sequence
Range
570-598

EF-hand
number
1

Organism

495-523

1

Mycobacterium bovis

Mycobacterium bovis

NF01321371

Potassium-transporting ATPase B
chain
DNA gyrase subunit A

NF00480640

probable DNA gyrase subunit A

916-944

1

Mycobacterium leprae

NF00484231

P450 heme-thiolate protein

335-363

1

NF00485681

570-598

1

NF01586715

Potassium-transporting ATPase B
chain
Mannitol-permease IIBC component

43-71

1

Mycobacterium
tuberculosis
Mycobacterium
tuberculosis
Mycoplasma mycoides

NF01587410

Hypothetical protein

9-37

1

Mycoplasma mycoides

NF00630859

119-147

1

Neisseria gonorrhoeae

NF01296409

Putative type II restriction
endonuclease NlaIV
DEAD/DEAH box helicase:HD domain

624-652

1

NF01294890

Hypothetical protein

6-34

1

NF01296468

Site-specific recombinase

215-243

1

NF02020754

544-572

1

NF02023298

Putative potassium transporter B
subunit
Hypothetical protein

Nitrosomonas
europaea
Nitrosomonas
europaea
Nitrosomonas
europaea
Nocardia farcinica

23-51

1

Nocardia farcinica

NF02024201

Putative resolvase

3-31

1

Nocardia farcinica

NF00818483

All5017 protein

190-218

1

Nostoc sp. PCC 7120

NF00819095

Alr7304 protein

3336-3364

1

Nostoc sp. PCC 7120

NF00817274

RND multidrug efflux transporter

87-115

1

Nostoc sp. PCC 7120

NF00817119

Asr1131 protein

45-73

1

Nostoc sp. PCC 7120

NF01061743

52-80

1

150-178

1

5-33

1

250-278

1

NF01831581

NADH-dependent flavin
oxidoreductase
Putative pyridoxal-dependent
decarboxylase
Hypothetical methylamine utilization
protein
Phosphoglycerate transport system
transcription regulator
Hypothetical protein

500-528

1

NF01833037

Hypothetical small protein A

21-49

1

NF01831267

Hypothetical protein

278-306

1

NF01423716

1476-1504

1

NF01426461

Similar to proteins involved in
antibiotics biosynthesis
Hypothetical protein

106-134

1

NF01427112

LsrR DNA-binding protein

13-41

1

NF01410240

Secretion activator protein, putative

35-63

1

NF02499786

carboxysome shell protein CsoS2

102-130

1

NF02499308

ornithine carbamoyltransferase

16-44

1

NF01372938

Hypothetical protein precursor

38-66

1

NF02498817

hypothetical protein PMN2A_0622

557-585

1

Oceanobacillus
iheyensis
Pectobacterium
atrosepticum
Photobacterium
profundum
Photobacterium
profundum
Photobacterium
profundum
Photobacterium
profundum
Photobacterium
profundum
Photorhabdus
luminescens
Photorhabdus
luminescens
Photorhabdus
luminescens
Porphyromonas
gingivalis
Prochlorococcus
marinus
Prochlorococcus
marinus
Prochlorococcus
marinus
Prochlorococcus
marinus

NF01776242
NF01829006
NF01830545
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Accession
ID
NF01854896

Protein Name

Sequence
Range
130-158

EF-hand
number
1

NF01010095

165-193

1

NF00582290

Similar to Histidine biosynthesis
protein
Chaperone protein htpG

404-432

1

NF00579604

TnpR protein (Fragment)

6-34

1

NF00585284

Hypothetical protein

79-107

1

NF00580099

Heat shock protein 66-kDa

187-215

1

NF00584502

Hypothetical protein

203-231

1

NF02412314

Calcium-binding protein

3

NF02409575

K -transporting ATPase, B subunit

24-52
60-88
98-126
551-579

NF01130810

Chaperone protein hscA homolog

187-215

1

Pseudomonas
fluorescens
Pseudomonas putida

NF00593298

Resolvase

6-34

1

Pseudomonas putida

NF01131075

Hypothetical protein

39-67

1

Pseudomonas putida

NF01128446

Glycine dehydrogenase

613-641

1

Pseudomonas putida

NF01131319

EF hand domain protein

143-171

1

Pseudomonas putida

NF02715683

calcium-binding protein

3

Pseudomonas
savastanoi

NF02713698

heat shock protein HtpG

101-159
134-162
180-208
405-433

1

NF02713796

hypothetical protein PSPPH_1452

119-147

1

NF02715540

990-1018

1

NF02713796

type IV pilus-associated protein,
putative
hypothetical protein PSPPH_1452

119-147

1

NF02518859

Calcium-binding EF-hand precursor

4

NF02518864

Heat shock protein Hsp90:ATP-binding
region, ATPase-like
Type IV pilus-associated protein,
putative precursor
Chaperone protein htpG

63-91
100-128
133-161
179-207
407-435

Pseudomonas
savastanoi
Pseudomonas
savastanoi
Pseudomonas
savastanoi
Pseudomonas
savastanoi
Pseudomonas
syringae

989-1017

1

405-433

1

NF02517892
NF01447618

Cobalamin biosynthesis protein CobN

+

1

1

NF01447738

Type IV pilus-associated protein,
putative

989-1017

1

NF01447731

Hypothetical protein

143-171

1

NF01444486

EF hand domain protein

4-32
316-344
391-419

3

Organism
Propionibacterium
acnes
Pseudomonas
aeruginosa
Pseudomonas
aeruginosa
Pseudomonas
aeruginosa
Pseudomonas
aeruginosa
Pseudomonas
aeruginosa
Pseudomonas
aeruginosa
Pseudomonas
fluorescens

Pseudomonas
syringae
Pseudomonas
syringae
Pseudomonas
syringae group
genomosp. 3
Pseudomonas
syringae group
genomosp. 3
Pseudomonas
syringae group
genomosp. 3
Pseudomonas
syringae group
genomosp. 3
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Accession
ID
NF02500531

Protein Name

Sequence
Range
63-91
100-128
135-161
179-207
35-63

EF-hand
number
4

Organism

NF01410240

Secretion activator protein, putative

1

Potassium-transporting ATPase B
chain
Hypothetical protein RSc1742

605-633

1

295-323

1

NF01530872

Calcium-binding EF-hand precursor

NF01643065

Similar to CaM-like protein-putative
secreted, membrane associated or
paryphoplasmic Ca(2+)-binding protein

74-102,
113-141
79-107
122-150
157-185
189-217
236-264
269-297
94-122
128-156
50-78

2

AAG21376

Putative calcium binding signal peptide
protein
Calsymin

Porphyromonas
gingivalis
Ralstonia
solanacearum
Ralstonia
solanacearum
Ralstonia
solanacearum
Rhizobium etli

NF00853288

1

Rhodopseudomonas
palustris
Rhodopirellula baltica

NF01643299

Hypothetical protein

257-285

1

Rhodopirellula baltica

NF01649307

Hypothetical protein

103-131

1

Rhodopirellula baltica

NF01643065

50-78

1

Rhodopirellula baltica

NF01644848

putative secreted, membrane
2+
associated or paryphoplasmic Ca binding protein
Hypothetical protein

3

Rhodopirellula baltica

NF01647263

Matrix metalloproteinase

214-242
340-368
417-445
516-544

1

Rhodopirellula baltica

NF01647900

Probable lipase/esterase

76-104

1

Rhodopirellula baltica

NF01643609

Alkaline phosphatase

1576-1604

1

Rhodopirellula baltica

NF01649041

42-70

1

Rhodopirellula baltica

NF01644544

Putative ABC transporter integral
membrane protein
Probable calmodulin

347-375

1

Rhodopirellula baltica

NF01644969

Hypothetical protein

71-99

1

Rhodopirellula baltica

NF01528433

Hypothetical protein precursor

64-92

1

:NF01529160

570-598

1

NF01530032

Potassium-transporting atpase b
chain, KdpB
Hypothetical protein precursor

26-54

1

NF01530456

Hypothetical protein

245-273

1

NF01530872

Calcium-binding EF-hand precursor

2

NF01531759

Glycosyl hydrolase

94-122
128-156
64-92

NF01532507

DUF218

94-122

1

NF02577387

DnaK protein

172-200

1

Rhodopseudomonas
palustris
Rhodopseudomonas
palustris
Rhodopseudomonas
palustris
Rhodopseudomonas
palustris
Rhodopseudomonas
palustris
Rhodopseudomonas
palustris
Rhodopseudomonas
palustris
Rickettsia felis

NF00849451
NF00850536

Calcium-binding EF-hand precursor

6

2

1

Pseudomonas
syringae
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Accession
ID
P06495

Protein Name

Sequence
Range
9-37
60-88
104-132
138-164
35-63

EF-hand
number
4

Organism

NF00806470

probable glycogen debranching protein

1

Salmonella enterica

NF02097096

35-63

1

Salmonella paratyphi

NF01911344

Putative glycogen debranching protein
homolog
Putative glycogen debranching protein

35-63

1

Salmonella typhi

NF00861463

Putative glycosyl hydrolase

35-63

1

NF01074234

35-63

1

NF01074109

Pyruvate formate-lyase 1 activating
enzyme
RTX toxin, putative

Salmonella
typhimurium
Shewanella oneidensis

461-489

1

Shewanella oneidensis

NF02205755

EF hand domain protein

30-58

1

Silicibacter pomeroyi

NF02206123

Type I secretion target repeat protein

7295-7323

1

Silicibacter pomeroyi

NF00616675

541-569

1

Sinorhizobium meliloti

NF00612473

Potassium-transporting ATPase B
chain
Hypothetical protein SMc01708

784-812

1

Sinorhizobium meliloti

NF00617441

Hypothetical protein SMb21413

137-165

1

Sinorhizobium meliloti

NF00431107

Transposase B

519-547

1

NF02262335

LysM domain protein

235-263

1

NF01789691

153-181

1

NF00433953

Putative dihydrolipoamide
dehydrogenase
Similar to Zn-dependent hydrolase

465-493

1

NF01166407

Secretory antigen SsaA

108-136

1

NF00434602

HMG-CoA reductase

297-325

1

NF02269390

Tn554, transposase B

519-547

1

NF01165622

Hydroxymethylglutaryl-CoA reductase

297-325

1

NF01167423

Hypothetical protein SE0148

85-113

1

NF01165840

Hypothetical protein SE0787

465-493

1

NF02607639

299-327

1

NF02608469

Capsular polysaccharide synthesis
enzyme CapE
Homoserine dehydrogenase

393-421

1

NF02663555

Similar to unknown protein

465-493

1

NF01048375

Proteinase, putative

626-654

1

NF01049107

Hypothetical protein gbs1919

194-222

1

NF01049640

Hypothetical protein gbs1489

371-399

1

NF01113363

Hypothetical protein gbs1332

210-238

1

NF00439678

Putative type II restriction
endonuclease

263-291

1

Staphylococcus
aureus
Staphylococcus
aureus
Staphylococcus
aureus
Staphylococcus
aureus
Staphylococcus
epidermidis
Staphylococcus
epidermidis
Staphylococcus
epidermidis
Staphylococcus
epidermidis
Staphylococcus
epidermidis
Staphylococcus
epidermidis
Staphylococcus
haemolyticus
Staphylococcus
haemolyticus
Staphylococcus
haemolyticus
Streptococcus
agalactiae
Streptococcus
agalactiae
Streptococcus
agalactiae
Streptococcus
agalactiae
Streptococcus
thermophilus

Calerythrin

Saccharopolyspora
erythrea
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Accession
ID
NF01280369

Protein Name

EF-hand
number
3

Organism

Hypothetical protein

Sequence
Range
9-37
88-137
137-165
24-52

NF01277143

1

NF01281064

Putative chitinase C

413-441

1

NF01278333

555-583

1

NF01277145

Putative high-affinity potassium
transport system
Putative calcium binding protein

6-34

1

NF00543258

Putative calcium binding protein

2

NF00549617

Putative calcium-binding protein

NF00550219

Putative calcium binding protein

NF00543851

567-595

1

NF00548721

ChiC (Chitinase C) (Putative secreted
protein) (Fragment)
Potassium-transporting ATPase B
chain
SCO5464 protein

10-38
60-88
9-37
60-88
98-126
132-160
9-37
60-88
103-131
137-165
415-443

Streptomyces
avermitilis
Streptomyces
avermitilis
Streptomyces
avermitilis
Streptomyces
avermitilis
Streptomyces
coelicolor
Streptomyces
coelicolor

6-34

1

NF00543475

Hypothetical protein SCO4859

126-154

1

NF00928474

Hypothetical protein spyM18_1868

523-551

1

NF01861114

525-553

1

NF01223601

Putative Fe -siderophore transport
protein
Putative PBP 5 synthesis repressor

63-91

1

NF00442096

Penicillin-binding protein 3

167-195

1

NF01965281

Hypothetical protein

196-224

1

NF02172090

Transaldolase

358-386

1

NF02171539

Carboxyl-terminal protease

152-180

1

P72797

Transaldolase

2

NF00423899

Slr0366 protein

NF00424738

Cation or drug efflux system protein

333-361
356-384
171-199
277-305
383-411
489-517
87-115

NF00425666

Sulfate adenylyltransferase

99-127

1

NF00968263

28-56

1

NF02549883

Septum formation inhibitor-activating
ATPase
calcium-binding EF-hand

2

NF01023077

transaldolase

61-89
97-125
356-384

NF00578072

50S Ribosomal Protein L4

1-28

1

NF00549644

Putative calcium binding protein

3+

4

Streptomyces
avermitilis

4

Streptomyces
coelicolor

1

Streptomyces
coelicolor
Streptomyces
coelicolor
Streptomyces
coelicolor
Streptomyces
coelicolor
Streptococcus
pyogenes
Streptococcus
pyogenes
Streptococcus
pyogenes
Streptococcus
pneumoniae
Symbiobacterium
thermophilum
Synechococcus
elongatus
Synechococcus
elongatus
Synechocystis sp.

4

Synechocystis sp.
PCC 6803

1

Synechocystis sp.
PCC 6803
Synechocystis sp.
PCC 6803
Thermoanaerobacter
tengcongensis
Thermobifida fusca

1

Thermosynechococcus
elongatus
Thermus thermophilus
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Accession
ID
NF01703216

Protein Name

EF-hand
number
1

Organism

Hypothetical conserved protein

Sequence
Range
240-268

NF00723911

Hemolysin-related protein

54-82

1

Vibrio cholerae

NF00722357

Hypothetical protein VCA0849

3164-3192

1

Vibrio cholerae

NF01185821

FlgA

125-153

1

Vibrio fischeri

NF02302098

Iron-regulated protein FrpC

344-372

1

Vibrio fischeri

NF01230959

Chemotaxis protein CheV

133-161

1

NF01234459

Putative outer membrane protein

42-70

1

NF01147763

Autotransporter adhesin

2

NF01149533

Multidrug resistance efflux pump

1196-1224
2841-2869
128-156

Vibrio
parahaemolyticus
Vibrio
parahaemolyticus
Vibrio vulnificus

1

Vibrio vulnificus

NF01147763

Autotransporter adhesin

5

Vibrio vulnificus

NF01147228

FOG: Ankyrin repeat

887-915
990-1018
1093-1121
1196-1224
2841-2869
310-338

1

Vibrio vulnificus

NF01150679

ATPase component of various ABCtype transport system
Multidrug resistance efflux pump
Hypothetical protein

353-381

1

Vibrio vulnificus

128-156
214-242

1

16-44

1

16-44

1

Wolbachia sp. wMel

NF01189636
NF00981304

exopolysaccharide synthesis protein
ExoD-related protein
Exopolysaccharide synthesis protein
ExoD-related protein
Metallopeptidase
Calcium-binding protein

Vibrio vulnificus
Wolinella
succinogenes
Wolbachia sp. wMel

1
4

Xylella fastidiosa
Xanthomonas
axonopodis

NF01010603

NodB-like protein

56-84
38-66
74-102
112-140
143-171
662-690

1

NF00974448

Hypothetical protein XCC0163

30-58

1

NF00977416

Polysaccharide deacetylase

714-742

1

NF00974241

Hypothetical protein XCC1206

172-200

1

NF02292841

EF hand domain protein

617-645

1

Xanthomonas
campestris
Xanthomonas
campestris
Xanthomonas
campestris
Xanthomonas
campestris
Xanthomonas oryzae

NF02292473

Phage-related protein

342-370

1

Xanthomonas oryzae

NF02292388

Polysaccharide deacetylase

662-690

1

Xanthomonas oryzae

NF02294838

Hypothetical protein

88-116

1

Xanthomonas oryzae

NF02293741

Hypothetical protein

505-533

1

Xanthomonas oryzae

NF01189016

Hypothetical protein

36-64

1

Xylella fastidiosa

NF02140272

DnaK molecular chaperone

173-201

1

Zymomonas mobilis

NF02139509

Hypothetical protein

51-79

1

Zymomonas mobilis

NF02139489

Hypothetical protein

58-86

1

Zymomonas mobilis

NF02139845

Putative RTX family exoprotein

2479-2507

1

Zymomonas mobilis

NF01149533
NF01411038
NF01840495
NF01840821

Thermus thermophilus
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3.7. Evolutionary perspectives on EF-hand proteins
The classification and evolution of EF-hand proteins was first analyzed by
Kretsinger et al (11,136-138). A dendrogram of the EF-hand proteins has been
published previously. Since then, more EF-hand subfamilies, especially pseudoEF-hand proteins, have been revealed. To analyze the potential evolutionary
scenario of the EF-hands, particularly pseudo EF-hands, phylogenetic analysis
was carried out with updated pseudo EF-hand members and the canonical EFhand proteins in this study on the basis of sequence alignments (Fig. 3.5).
The pseudo EF-hand N-J tree revealed three major groups assuming that
they are evolved from a common ancestral protein. The largest group consists of
two closely-related subgroups, one with S100A2, S100A3, S100A4, S100A5, and
S100A6 and the other with S100A1, S100P, S100B, S100Z, and S100A10. It is
interesting to note that S100A10, separating early from other members in its
subgroup, loses the capacity to chelate Ca2+ ion with mutations and deletions at
the Ca2+ liganding positions in both canonical and pseudo-EF-hand motifs. The
small phylogenetic distance between S100A2, S100A3, S100A4, S100A5, and
S100A6 is consistent with the clustered organization of these genes (139).
Additionally, S100A2, S100A3, S100A5, and S100A6 have been proposed to
coordinate Zn2+ with varying affinity (140-143). The second major group is
comprised of S100A8, S100A9, S100A12, trichohyalin, and MRP-126 from
chicken. All of these proteins (except for trichohyalin) are excreted to the
extracellular space, where Ca2+ concentration is at the millimolar level (144).
Their common targets are the cytoskeletal or cell membrane proteins. In addition,
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the proteins in this group are associated with pro-inflammatory functions by
inducing chemotaxis or secretion of pro-inflammatory mediators. Interestingly,
members in this group possess the Zn2+-chelating motif His-x-x-x-His at the C
termini, with possible involvement of an upstream glutamate (145). The third
major group consists of S100A7, S100A11, S100A11P, S100A15, S100H, and
repetin. Repetin contains an N-terminal S100-like domain and central tandem
repeats of glutamine-rich sequence (94). It is involved in epidermal differentiation.
Repetin is separated early from other members in the group. The other members
(S100A13 and S100A14, S100A16 and S100A17, and S100G and hornerin) form
three minor groups. They are rather diverse and no valuable evolutionary clues
can be inferred at present. Repetin, trichohyalin, and hornerin belong to the
“fused gene” family. A proposed evolutionary pathway for hornerin involves the
fusion of an S100-like Ca2+-binding protein with an ancestral epidermal structural
gene containing tandem repeats that reside in the same chromosomal locus
1q21 (94,146).
The canonical EF-hands are ubiquitously distributed across eukaryote,
bacteria, and archaea. The gene replication could also be tentatively used to
explain the appearance of penta- (calpain subfamily) and hexa-EF-hands
(calretinin and calbindin D28k), both of which have distinct phylogenetic
pathways (Fig. 3.5) (147,148). The abundant single-handed EF-hand-like motifs
found in the genomes of bacteria could provide clues for the origin of the
prototypical EF-hand (4,25,149,150). The evolutionary mobile single Ca2+ binding
loop first present in the ancestral protein could be “transplanted” to several
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locations of the host protein or to several host proteins (5,151).
In contrast to the canonical EF-hands, our study shows that the pseudo
EF-hands are exclusively found in vertebrates with tissue- and cell-specific
expression profiles and are not predicted in the bacteria genomes. The lowest
organism containing pseudo EF-hand reported thus far is the spiny dogfish
(Squalus acanthias) with a pseudo EF-hand protein that is closely related to
S100A1 (13). Thus, it is reasonable to postulate that pseudo EF-hands are
phylogenetically younger and have a shorter history than canonical EF-hands.
Although more evidence is required to confirm this postulation, the current
observation in natural proteins that pseudo EF-hands always pair with canonical
EF-hands but canonical EF-hands do not necessarily pair with pseudo EF-hands
also indicate that pseudo EF-hands appear later than the canonical EF-hands.
Genomic study on human and rat S100 proteins has also indicated the recent
origin of the S100 subfamily (13,139). It has been hypothesized that the evolution
of pseudo EF-hands might be achieved by domain swapping through gene
duplication or exon recombination from a CaM-type protein with subsequent loss
of two of the four EF-hands (13). Then, evolutionary divergence of EF-hands
follows, thereby creating the sequence diversity of pseudo EF-hands. During this
process, pseudo EF-hands become distant relatives of canonical EF-hand and a
number of pseudo EF-hands (S100B, S100A2, S100A3, S100A5, S100A6,
S100A7, S100A12) acquire the ability to bind other metal ions such as Zn 2+ or
Cu2+ to further adapt to the tissue-specific temporal-spatial requirements(100).
They evolved largely varied Ca2+ affinity from nM to mM to meet the versatile
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Figure 3.5. Phylogenetic analysis of the EF-hand protein family. The unrooted
N-J tree was generated on the basis of multiple sequence alignments of 27
typical proteins containing pseudo EF-hand motifs and 22 proteins with
canonical EF hand motifs. (Circle: canonical EF-hand; Square: pseudo EFhand; Solid: bind Ca2+; Open: do not bind Ca2+ or Ca2+ binding capability is
unknown).
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requirements in various cellular compartments (140,141,143,152,153).

3.8. Summary
With more and more EF-hand Ca2+ binding proteins being discovered and
characterized in bacteria, archaea, and eukaryotes, structural and functional
knowledge of the EF-hand proteins has expanded steadily in recent years. The
EF-hand-like proteins contain Ca2+-binding sequences that closely resemble the
canonical EF-hand motif yet with diversified flanking structural elements. An easy
and straightforward searching method to identify both canonical and pseudo EFhands has been established based on our modified patterns. In addition to being
supplementary to the signatures PS00018 and PS00303, the newly developed
patterns convey information on the flanking structural contents with higher
accuracy and sensitivity. Screening of the prokaryotic genome information
revealed 397 entries of putative EF-hand proteins (467 motifs) implicated in a
variety of cellular activities. The results enable us to envision possible scenarios
regarding the evolutionary history of EF-hands. The pseudo EF-hands are likely
to be phylogenetically younger than canonical EF-hand motifs. The prediction of
Ca2+ binding motifs in bacteria genomes is helpful for the exploration of the role
of Ca2+ and Ca2+ binding proteins in bacteria. Moving toward our goal of
advancing calciomics, we have also carried out the prediction studies on other
genomes, such as viruses (see Chapter 4), with our prediction method. This will
further enable us to better understand the role of Ca2+ in diverse biological
systems.
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4. Ca2+, Ca2+-binding proteins and virus infection

Ca2+, “a signal for life and death”, is one of the most important second
messengers in transducing cellular signals. It plays a central role in the regulation
of a number of cellular processes, such as cell division, differentiation and
apoptosis (3). The versatile speed, amplitude and spatial-temporal patterning of
Ca2+ in eukaryotic cells controls vital biological processes by finely modulating
the activity of a repertoire of signaling components including cellular receptors,
ion channels, pumps, exchangers, Ca2+ buffers, Ca2+ effectors, Ca2+-sensitive
enzymes and transcription factors in different cellular compartments (Fig. 4.1)
(154).
Being extremely adept at hijacking the host cellular machinery, viruses
have been extensively reported to interfere with the Ca2+ signaling pathways or
Ca2+-dependent processes, and thereby, achieve their optimal infectivity to
produce progenies. The interplays between viruses and Ca2+, in general, fall into
three major categories: 1) viral particles or viral proteins directly or indirectly
disturb the Ca2+ homeostasis by altering membrane permeability and/or
manipulating key components of the Ca2+-signaling repertoire; 2) a number of
important structural or nonstructural viral proteins directly bind to Ca2+ for
structural integrity or optimal functions; 3) virus-host interactions that require
cellular Ca2+-regulated proteins or processes. This chapter, which aims to
stimulate more future studies on the role of Ca2+ in virus infection, is focused on

79

Ca2+ channels
(ROC/SOC/VOC/TRP)

PMCA

GPCR
Tat

RTK

gp120
NCX

Ca2+ effectors (e.g. CaM, S100)
Ca2+ buffers (e.g. calreticulin, calbindin D9K)
Ca2+-sensitive enzymes (e.g., CaMKI-IV, calpain)
HBx

IP3R
2B

Golgi
Complex

Nef
IP3R

SPCA

RyR

SERCA

p13II

Uniporter

NCX/HCX

Mitochondria

2B
RyR

ER/SR
Genes transcription
(NFAT, CREB, DREAM)

Nucleus

Figure 4.1. Examples of virus-induced perturbations on Ca2+ homeostasis. The
versatile speed, amplitude and spatial-temporal patterning of Ca2+ in eukaryotic
cells controls vital biological processes by precisely yet flexibly modulating the
activity of a repertoire of signaling components including cellular receptors, ion
channels, pumps, exchangers, Ca2+ buffers, Ca2+ effectors, Ca2+-sensitive
enzymes and transcription factors in different cellular compartments. A variety
of viral proteins (e.g., Tat, gp120 and Nef of HIV-1, p13II of HTLV-1, HBx of
HBV, 2B protein of coxsachievirus,) can disturb the sophisticated intracellular
Ca2+ homeostasis by interacting with these key Ca2+ signaling components.
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such interplays that have been observed in almost every step of a typical viral life
cycle by featuring recent discoveries in the roles of Ca2+ in virus infection.

4.1. Effects of viral infections on Ca2+ homeostasis
The intracellular Ca2+ homeostasis is controlled by an array of
components in the Ca2+-signaling toolkit (154). The Ca2+ signal is derived from
two sources: the extracellular medium or the internal stores (Fig. 4.1). The entry
of Ca2+ across the plasma membrane, usually triggered by stimuli that include
membrane depolarization, mechanical stretch, external agonists, depletion of
internal stores and intracellular messengers, is mediated by some particular
cellular receptors and Ca2+ channels. The mobilization of Ca2+ from the internal
store in response to Ca2+ itself or intracellular messengers, is primarily mediated
by the IP3 receptors (IP3R) and the ryanodine receptors (RyR). Five distinct
pumping

mechanisms

(the

plasma

membrane

Ca2+-ATPase,

the

sarcoplasmic/endoplasmic reticulum Ca2+-ATPase (SERCA), the secretory
pathway Ca2+-ATPase (SPCA), the Na+/Ca2+ exchanger (NCX), and the
mitochondrial uniporter) are responsible for sequestering Ca 2+ from the cytosol
by transport Ca2+ either to an external medium or into different cellular
compartments (154).
The Ca2+ signaling system requires the exquisite choreography of the
Ca2+-signaling toolkit (Ca2+ “signalsomes”) and undergoes constant remodeling
to meet the specific spatio-temporal requirements. This flexibility, on the one
hand, provides sufficient opportunities for the host cells to adjust to the virus
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infection. On the other hand, viruses are adept at utilizing the universal Ca 2+
signal to create a tailored cellular environment that meets their own demands.
The development of a variety of cell-permeable Ca2+ indicators (e.g., the
acetoxymethyl ester forms of Fura-2, Fluo-4 and Indo-1) and genetically
targetable fluorescent indicators (e.g., pericam and aequorin) provide solid
foundation for the quantitative measurements of cellular Ca 2+ signal changes in
response to virus infection or the treatment of viral proteins. A detailed summary
of virus-induced cellular Ca2+-signaling alterations are listed in Table 4.1. Instead
of exhaustively describing every virus that disturbs the Ca 2+ homeostasis, this
review will highlight several important viruses that are well-documented to alter
the cellular Ca2+-signaling system.
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Table 4.1. Virus-induced alterations on cellular Ca2+ homeostasis.
Virus

[Ca2+]
Alteration

Caused by

Mechanisms

Cellular effects

Model
System
(Ca2+ probe)

References

(+) ssRNA viruses
Coronaviridae
SARS-CoV

↑[Ca2+]CYT

Spike protein ↑Ca2+ influx
due to ER
stress

↑COX-2 expression
via PLC pathway

HEK293T
(Fura-2 AM)

(155)

Flaviviridae
HCV

↑[Ca2+]MIT

Core protein

Mitochondrial
Ca2+ uniporter

↑mitrochondrial
ROS production

(156)

ER stress,
↑Calreticulin,
impaired
SERCA
activity
ER Ca2+
leakage
Functions as
Ca2+ channel

Induces apoptosis

Isolated liver
mitochondria
(Rhod-2 AM)
Huh7
(Pericam)
Huh7
(erAEQ)

Jurkat T
(Fura-2 AM)
Artificial
membrane

(158)

Huh7

(160)

UHCV 57.3
(Fura-2 AM)

(161)

Mouse spleen
(45Ca)

(162,163)

↓[Ca2+]ER

↑[Ca2+]CYT

DV

↑[Ca2+]CYT

p7

↑[Ca2+]CYT

NS5A

↓[Ca2+]ER

Virus
infection

↑[Ca2+]CYT

virus
infection

Activate NFAT
pathway
Channel activity
inhibited by
amantadine
↑ER Ca2+
Activates NF-κB and
efflux
STAT-3, ↑ ROS
2+
↑ER Ca
Upregulates PP2A
release
and inhibits IFN-α
pathway
↑Ca2+ influx
Enhances the
induced by CF cytotoxic activity

(157)

(159)
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Virus
JEV

Picornaviridae
Poliovirus

[Ca2+]
Alteration

Caused by

Togaviridae
SFV

Stimulate neutrophil
activation

virus
infection

↑Ca2+ influx
induced by
MDF

↑[Ca2+]CYT

Virus
infection

Voltagesensitive Ca2+
channels
↑Ca2+ influx

↑[Ca2+]CYT,
↓[Ca2+]ER,
↓[Ca2+]MIT,
↓[Ca2+]GOL
↑[Ca2+]CYT,
↓[Ca2+]ER,

HRV2

Cellular effects

↑[Ca2+]CYT

2BC
Coxsachie B3
virus

Mechanisms

↑[Ca2+]CYT

↑Ca2+ influx;
Pore
formation on
ER and Glogi
membrane
Virus
↑Ca2+ influx;
infection and ER Ca2+
2B protein
leakage
Virus
↑Ca2+ influx
infection
2B

↑[Ca2+]CYT, Virus
↑[Ca2+]MIT
infection
(<5
h),
↓[Ca2+]MIT
(>5 h)

↑Ca2+ influx;
Impaired
mithochonrial
permeability

Model
System
(Ca2+ probe)
Mouse

References
(164)

HeLa
(Fura-2 AM)

(165)

HeLa
(Fluo-3 AM)
HeLa
(Fura-2 AM,
organelletargeted AEQ)

(166)

Facilitates vRNA
replication and virus
release
Channel blockers
inhibit virus
replication and
release

HeLa
(Fura-2 AM)

(169)

HeLa T
(Fluo-4 AM)

(170)

Impaired electron
transport

CEC and
isolated
mithochondira
(45Ca)

(171)

Suppresses
apoptotic host cell
response

(167,168)
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Virus
Sindbis virus

[Ca2+]
Alteration

Caused by

Mechanisms

Cellular effects

Model
System
(Ca2+ probe)
N18
(Fura-2 AM)

References

↓[Ca2+]CYT
(5 h)

Virus
infection

virus-induced
apoptosis is
dependent on viral
replication

↑[Ca2+]CYT

Virus
infection

Activate TREM-1

Neutrophils
(Fluo-4 AM,
Fura-2 AM)

(173)

Reduces voltagedependent Ca2+currents
Activates
neutrophils

Hippocampal
neurons
(Fluo-4 AM)
Neutrophils
(Fura-2 AM,
45
Ca)

(174)

Viral yield is
inhibited by
verapamil
Maximizes viral
fusion

MA104, BGM
(45Ca)

(177)

Human
erythrocyte
ghosts (obelin)
Chicken
erythrocyte
(45Ca)
Hippocampal
neurons

(178)

(172)

(-) ssRNA viruses
Filoviridae
Ebola virus and
Marburg virus

Orthomyxoviridae
Influenza A virus
↑[Ca2+]CYT
(>6 d)

Paramyxoviridae
Measles virus

Sendai virus

Mumps virus

Virus
infection

↑ER Ca2+
efflux via IP3R

↑[Ca2+]CYT

Virus
infection

↑IP3 (PLC
pathway)

↑[Ca2+]CYT

Virus
infection

↑[Ca2+]CYT

Virus
infection

↑[Ca2+]CYT

Virus
infection

↑Ca2+ influx

↓[Ca2+]CYT

Virus
infection

↓Ca2+ influx

Inducing rounding
and fusion of
infected cells
Reduces voltagedependent Ca2+
currents

(175,176)

(179)

(180,181)
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Virus

[Ca2+]
Alteration

Caused by

Model
System
(Ca2+ probe)

Mechanisms

Cellular effects

References

Interacts with
IP3R

Promotes T cell
activation via NFAT
pathway
Decreases storeoperated Ca2+
influx; Involves SH3mediated interaction
Increases TNF-α
production

Jurkat T
(Fluo-3, Furared AM, AEQ)
Differentiated
HL60
(Fura-2 AM)

(182)

PBMC
(Fluo-3 AM)

(184)

Induces
neurotoxicity

Rat
hippocampal
slices
(Calciumorange AM)
Fetal neurons
and astrocytes
(Fura-2 AM)

(185)

Microglia cells
(Indo-1)

(187)

PBMC
(Fluo-4 AM)

(188)

(+) ssRNA viruses with DNA intermediates
Retroviridae
HIV-1

↑[Ca2+]CYT

↑[Ca2+]CYT

Nef

Tat

↑Ca2+ influx
via DHP
receptor
↑Ca2+ influx
via NMDA
receptor
↑Ca2+ influx
via glutamate
receptor;
↑ ER Ca2+
release via
IP3R
↑Ca2+ influx

Increases IP3
production; Induces
neurotoxicity

Stimulates cytokine
and chemokine
production
Mutation C31W in
subtype C Tat
reduces Ca2+ flux

(183)

(186)
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Virus

[Ca2+]
Alteration

Caused by

Mechanisms

↓[Ca2+]CYT

↑[Ca2+]CYT

gp120

Blocks the Ltype Ca2+
channels
↑Ca2+ influx
via L-type
Ca2+ channels
↑Ca2+ influx
↑Ca2+ influx

↑[Ca2+]i

↑[Ca2+]CYT

HTLV-1

↑[Ca2+]CYT

↑Ca2+ influx
gp120/gp160 ↑Ca2+ release
from caffeinesensitive
Ca2+ store
virus
infection
virus
infection
P12I
↑ ER Ca2+
release via
IP3R; ↑Ca2+
influx

Cellular effects
Reduces glutamate
and ATP-induced
[Ca2+]CYT increase
Inhibits NK cell
function
Induces
neurotoxicity
Activates CD4+ T
cell signaling
Potentiates NMDAinduced Ca2+
response
Induces cytotoxicity
Alters ion secretion
in the intestine and
causes watery
diarrhea

Induces T-cell
hyporesponsiveness
Activates T cells via
NFAT pathway

Enhances p300
transcription

Model
System
(Ca2+ probe)
Glial cells
(Fura-2 AM)

References
(189)

NK cells
(Fura-2 AM)

(190)

Fetal neurons
and astrocytes
(Fura2-AM)
CHO-745, T
cells
(Fluo-4 AM)
Embryonic
neurons (Indo1)
Synaptosomes
(Fura2-AM)
HT-29-D4
(Fura2-AM)

(191)

H9

(196)

PMBC, MT4,
Jurkat T
Jurkat T (Indo1, Fura-2 AM)

(197)

(192)

(193)

(194)
(195)

(198)

(199)
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Virus

Reoviridae
Rotavirus

[Ca2+]
Alteration

Caused by

Cellular effects

↓[Ca2+]MIT

P13II

↑Mitochondrial Induces apoptosis
membrane
permeability

↑[Ca2+]CYT

Virus
infection

↑PM
permeability;
↓ER Ca2+ pool
↑PM
permeability;
↑ER Ca2+
release via
PLC pathway
↑Ca2+ influx
via L-type
Ca2+ channels
↑ ER Ca2+
release via
IP3R; ↑Ca2+
influx

NSP4

CAV

Mechanisms

↑[Ca2+]CYT

Virus
infection

↑[Ca2+]CYT

VP1

Tunicamycin and
brefeldin A inhibits
↑[Ca2+]CYT
Facilitates virus
entry and
maturation

Model
System
(Ca2+ probe)
Isolated
mithochondria
(CalciumGreen)

References
(200-202)

HT29, MA104
(45Ca, Fura-2
AM)
Caco-2
(Quin-2 AM)

(203)

HT29, MA104
(Fura-2 AM)

(205)

HEK293, sf9
(Fura-2 AM)

(206)

Lymphocytes

(207)

HMEC-1
(Fura-2)

(208)

(204)

ssDNA viruses
Parvoviridae
B19
dsDNA viruses
Herpesviridae

Activation of
ICRAC

Exhibits PLA2-like
activity
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Virus
CMV

[Ca2+]
Alteration
↑[Ca2+]CYT

Caused by

Mechanisms

Cellular effects

UL37x1

↑ ER Ca2+
release

Blocks apoptosis
and induces
mitochondrial fission

Virus
infection

↑Ca2+ influx
↑ ER Ca2+
release via
IP3R; ↑Ca2+
influx via
voltage-gated
channels

Inhibited by
nifedipine and
verapamil
Triggers FAK
phosphorylation

HHV-1/2

↑[Ca2+]CYT

Virus
infection

Virus
infection

KSHV

↑[Ca2+]CYT
(H2O2induced)
↑[Ca2+]CYT

K1

vMIP I/II

EBV

↑[Ca2+]CYT

Interacts with
SH2containing
proteins
↑Ca2+ influx

K7

↑ ER Ca2+
release

Virus
infection

↑Ca2+ influx
Ca2+ channels

Model
System
(Ca2+ probe)
Fibroblast
(CalciumOrange, Fluo3)
Fibroblast

References
(209)

(210)

CaSki, Vero
(Fura-2 AM)

(211)

H2O2 enhances
virus release

FI cells
(Fura-2 AM)

(212)

Activates T cells

293T(Indo-1)

(213)

Induces signal
transduction and
chemotaxis
Associates with
CAML to inhibit
apoptosis
Activates B cells;
Inhibited by
verapamil or
diltiazem

THP-1, K562
(Indo-1 AM)

(214)

BJAB
(Indo-1 AM)

(215)

B95-8
(Quin-2)

(216)
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Virus

[Ca2+]
Alteration
↓[Ca2+]CYT

Polyomaviridae
SV40

HPV-18

Poxviridae
Vaccinia virus

Caused by
LMP2A

↑[Ca2+]CYT

↑[Ca2+]CYT

Virus
infection

↑[Ca2+]CYT

Virus
infection
A38L

↓[Ca2+]CYT Virus
(agonistinfection
induced)
dsDNA viruses with RNA intermediates
Hepadnaviridae
HBV
↑[Ca2+]CYT HBx

Mechanisms

Cellular effects

Blocks BCR

Blocks B cell signal
transduction

↑Ca2+ influx
via
capacitative
channels
Promotes
progression of
tumorigenicity

Model
System
(Ca2+ probe)
BJAB
(Indo-1)

References
(217)

SV3T3
(AEQ)

(218)

Keratinocytes

(219)

MA104, BGM
(45Ca)

(177)

BS-C-1
(45Ca)

(220)

↓PLC
production or
activity

Viral yield is
inhibited by
verapamil
Increases PM
permeability;
decreases
production of
infectious viral
particles
Alter agonistinduced Ca2+
homeostasis

BS-C-1
(Fura-2 AM)

(221)

Intracellular
Ca2+ store
release

Transactivates JNK
and MAPK
pathways

CHL-X
(Fura-2 AM)

(222)

↑Ca2+ influx
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Virus

[Ca2+]
Alteration

Caused by

Mechanisms

Cellular effects

↓Mitochondrial Induces apoptosis
Ca2+ uptake;
Impaired
PMCA activity
Mitochondrial Activated PyK2
Ca2+ leakage

2+

2+

2+

2+

Model
System
(Ca2+ probe)
HepG2, HeLa
(organelletargeted AEQ)
HepG2

References
(223)

(224)

2+

2+

Abbreviations: [Ca ]CYT, cytosolic Ca concentration; [Ca ]ER, endoplasmic reticulum Ca concentration; [Ca ]MIT, mitochondrial Ca
2+
2+
2+
2+
concentration; [Ca ]GOL, Golgi complex Ca concentration; [Ca ]i, intrasynaptosomal Ca concentration; SARS-CoV, severe acute respiratory
2+
syndrome-associated coronavirus; COX-2, cyclooxygenase-2; HCV, hepatitis C virus; SERCA, sarcoplasmic/endoplasmic reticulum Ca -ATPase;
PP2A, protein phosphatase 2A; IFN, interferon; erAEQ, ER-targeted aequorin; NFAT, nuclear factor of activated T cells; DV, dengue virus; CF,
cytotoxic factor; JEV, Japanese encephalitis virus; MDF, macrophage derived neutrophil chemotactic factor; HRV2: human rhinovirus 2; SFV,
Semliki Forest virus; TREM, triggering receptors expressed in myeloid cells; CEC: primary chicken embryo cells; PLC, phospholipase C; IP 3R,
inositol 1,4,5-triphosphate receptor; HIV, human immunodeficiency virus; Nef, negative factor; Tat, transactivator of transcription; DHP,
dihydropyridine; PBMC, peripheral blood mononuclear cell; TNF, tumor necrosis factor; NK, natural killer cell; NMDA, N-methyl-D-aspartic acid,
2+
2+
HTLV, human T-lymphotropic virus; PM, plasma membrane; CAV, chicken anemia virus; CRAC, Ca release activated Ca channel; PLA2,
phospholipase A2; CMV: cytomegalovirus; HHV, human herpesvirus; FAK, focal adhesion kinase; KSHV, Kaposi's sarcoma-associated
2+
herpesvirus; CAML, Ca -modulating cyclophilin ligand; EBV, Epstein-Barr virus; LMP2A, latent membrane protein 2A; HPV, human papillomavirus;
2+
HBV, hepatitis B virus; JNK, ; MAPK, ; PMCA, plasma membrane Ca -ATPase; PyK2, proline-rich tyrosine kinase-2;
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Hepatitis C virus. Hepatitis C virus (HCV), one of the major causative
agents of hepatitis with a single-stranded positive-sense RNA genome, belongs
to the Flaviviridae family. HCV infection has been shown to decrease the ER
Ca2+ concentration and activate ER stress by upregulating the protein
phosphatase 2A (PP2A), leading to the inhibition of interferon alpha signaling.
Three viral proteins, the core protein, NS5A and p7, have been found to interfere
with the cellular Ca2+ signaling.
HCV core protein, which induces apoptosis in Huh7 cells, has been
recently reported to induce ER Ca2+ depletion by impairing the function of
SERCA2 (157). The core protein also increases mitochondrial ROS production
and Ca2+ uptake partially by stimulating the activity of mitochondrial Ca 2+
uniporter (156). It can also lead to the elevation of cytosolic Ca2+ concentration
due to ER Ca2+ leakage, and thereby activates the NFAT pathway in Jurkat T
cells (158). All these findings indicate that the core protein potently modulates the
apoptosis of HCV-infected cells and is possibly responsible for chronic liver
disease and tumor transformation.
The nonstructural protein NS5A, which is embedded on the ER membrane,
has been shown to alter the intracellular Ca2+ levels with increased ER Ca2+
efflux. The released Ca2+ can be readily taken by mitochondria and increase the
production of mitochondrial oxidants. As a consequence, the NS5A functions as
a transcriptional transactivator to induce the activation of NF-κB and STAT3
(160).
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Another viral protein p7, a small hydrophobic uncharacterized protein on
the ER membrane, has been found to form hexamers and function reminiscent of
a Ca2+ ion channel on artificial lipid membrane (159). The reconstituted channel
can be blocked by amantadine or long-alkyl-chain iminosugar derivatives. This
finding raises the possibility that p7 might be responsible for the flow of Ca2+ from
ER to the cytoplasm.

Enterovirus.

Poliovirus

and

coxsachievirus

are

two

typical

enteroviruses in the picornaviridae family that contains a positive-sense ssRNA.
The single RNA genome encodes four structural proteins (VP1-4) and ten
nonstructural proteins (2Apro, 2B, 2C, 3A, 3B, 3Cpro, 3Dpol, 2BC, 3AB, and 3CDpro).
Among these, the 2BC protein of poliovirus has been shown to induce an
increase in cytosolic Ca2+ concentration, possibly via the voltage-sensitive Ca2+channels 2 or 3 h postinfection. This time point is coincident with a period during
which the viral proteins are actively synthesized (165). The 2B protein of
coxsakievirus leads to the decrease of Ca2+ concentrations in subcellular
compartments, such as mitochondria, Golgi complex and ER, by forming pores
on these membranes and subsequently increasing Ca 2+ efflux from these
organelles. The substantial decrease of Ca2+ in ER and Golgi complex has been
correlated with the inhibition of protein trafficking pathways, and thus downregulating host anti-viral immune response (225). More interestingly, the
perturbation of Ca2+ homeostasis by the 2B protein induces the inhibition of

93
apoptotic cell response triggered in early infection and serves to provide the virus
a suitable time window for viral RNA replication and protein synthesis (166-169).

Human immunodeficiency virus type 1 (HIV-1). HIV, the etiological
agent of acquired immune-deficiency syndrome (AIDS), contains a 9.2 Kb singlestranded RNA genome that encodes for polyproteins processed into matrix
protein, capsid protein, nucleocapsid (NC), gp 120, gp41, protease, reverse
transcriptase, integrase and p6, as well as six accessory proteins (Vif, Vpr, Nef,
Tat, Rev and Vpu). Three HIV-1 proteins, namely gp120, Nef, and Tat, have
been individually shown to alter the Ca2+ homeostasis in HIV-infected cells.
Gp120, one of the envelope glycoproteins that forms the HIV-1 surface
spikes, is essential for the attachment of HIV to the membrane immunoglobulin
CD4 and viral entry into host cells. The processing of the precursor protein gp160
into gp120 and gp41 has been shown to be a Ca 2+-dependent process (226).
Furthermore, gp120 is capable of inducing neurotoxicity by increasing Ca 2+ influx
into the cytoplasm of fetal neurons and astrocytes via Na +/H+ exchangers, L-type
voltage-sensitive Ca2+ channels and NMDA receptors (191,193). Gp120 can also
induce the elevation of Ca2+ in presynaptic terminals of rat cortical synaptosomes
(194) and in the cytoplasm of human intestinal epithelial cells HT-29-D4 (195).
These findings suggest that drugs that block gp120-induced intracellular Ca2+
changes in the human brain might be potential candidates for the treatment of
HIV-1 dementia and enteropathy.
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Nef, a highly conserved accessory protein among primate lentiviruses,
plays a major role in the down-regulation of immunologically relevant cell surface
protein CD4 and MHCI (227). In addition, Nef has been demonstrated to induce
cytosolic Ca2+ increase through its interaction with IP3R residing on ER
membrane, and subsequently promotes the T cell receptor-independent
activation of the NFAT pathway in Jurkat T cells (182). The activated NFAT, a
transcriptional factor responding to the low-amplitude intracellular Ca2+
oscillations, can further promote the viral gene transcription and replication (228).
The increase in cytosolic Ca2+ is also demonstrated in differentiated
myelomonocytic HL60 cells (183). The elevation in the intraceullular Ca2+ storage
seems to decrease store-operated Ca2+ influx and might be associated with Nefrelated pathophysiology. In addition, it is interesting to note that a Src-like
protein-tyrosine kinase (PTK) coimmunoprecipitates with both Nef and the IP3R.
Given this, it is hypothesized that Nef might modulate the activity of the IP 3R
activity via its interaction with the Src-like PTK (183).
Tat, the HIV transcriptional transactivator, is mainly responsible for the
regulation of the viral gene expression and replication. Tat has been reported to
either increase or decrease cytosolic Ca2+ in mainly two types of cells: the
immune cells and neuronal cells. Mediated by the L-type Ca2+ channel DHP
receptors, Tat has been shown to promote extracellular Ca 2+ influx to the
cytoplasm and stimulate the production of TNFα in primary human monocytes
(184). In comparison, the treatment of NK cells with HIV Tat blocks the
phenylalkylamine-sensitive L-type Ca2+ channels and impairs the cytotoxic
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function

mediated

by

NK

cells,

thus

exacerbating

progressive

immunosuppression during HIV infection (190). The increase in cytosolic Ca2+,
due to either increased Ca2+ influx via NMDA type glutamate receptor or the
release of Ca2+ from IP3-sensitive internal stores via IP3R, is observed in both
fetal neurons, astrocytes and microglia cells (185-187). The Tat-induced
dysregulation of intracellular Ca2+ leads to neurotoxicity and contributes to HIVrelated dementia.
Taken together, these three HIV-1 proteins function in concert to alter
intracellular Ca2+ signaling and further regulate T cell activation, apoptosis and
cell proliferation.

Human T-lymphotropic virus type 1 (HTLV-1). HTV -1, also called adult
T-cell lymphoma virus type 1, is a human retrovirus that causes adult T-cell
leukemia/lymphoma,

HTLV-I-associated

myelopathy,

and

Strongyloides

stercoralis hyper-infection. The 8.5 Kb, single-stranded RNA genome encodes
the gag, pol, pro and env genes, as well as five accessory proteins (p12I, p13II,
p21Rex, p27I, p30II and) and two regulatory proteins (Tax and Rex). HTLV-1
dysregulates the Ca2+ signaling mainly through two accessory proteins: p12I and
p13II.
The accessory protein p12I, residing on the membrane of ER and Golgi
complex, increase cytosolic Ca2+ by triggering Ca2+ release from ER possibly via
IP3R, and meanwhile, enhances Ca2+ influx through Ca2+ release-activated Ca2+
channels (198). The elevated basal intracellular Ca2+ leads to the activation of
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nuclear factor activated T-cell (NFAT) mediated transcription, and thus promoting
lymphocyte activation to support early viral infection. p12 I has also been shown
to interact with Ca2+-responsive protein, p300, to mediate various transcription
factors (199) and further promote lymphocyte survival.
The other accessory protein p13II is an 87-amino-acid mitochondrial
protein that can cause swelling and depolarization of mitochondria by increasing
inner membrane permeability to cations, such as Ca 2+, Na+ and K+ (200). Such
changes are believed to be responsible for promoting ceramide- or Fas ligandinduced apoptosis in T lymphocytes expressing p13II (201).
Thus, the two viral accessory proteins that are targeted to different cellular
compartments function independently to modulate apoptosis and proliferation of
infected cells.

Rotavirus. Rotavirus, a member of the reoviridae family that contains
double-stranded RNA genomes, is the major etiological agent of viral
gastroenteritis in young children. Ca2+ plays a key role in the morphogenesis,
replication and pathogenesis of rotavirus (229). Rotavirus-infected MA104 and
HT29 cells have been shown to exhibit a progressive elevation of cytosolic Ca 2+
due to increased membrane permeability (205). The entry of Ca2+ is partially
blocked by L-type voltage-sensitive Ca2+ channel blocker metoxyverapamil
(D600). More importantly, the permeability pathway is selectively permeable for
the passage of divalent ions that include Ca2+, Ba2+, Sr2+, Mn2+ and Co2+, but is
impermeable to the trivalent cations La3+ and Cr3+. Such metal ion selectivity is
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observed commonly in divalent cation channels in both excitable and
nonexcitable cells (230). Other mechanisms that involve both phospholipase C
(PLC)-dependent and PLC-independent pathways have also been shown to
account for intracellular Ca2+ increase (206,231). The exogenous NSP4, which
can induce diarrhea in rodent pups, increases cytosolic Ca2+ concentration via
the activation of PLC and the resultant ER Ca2+ depletion through IP3R (206). In
contrast, endogenously expressed NSP4 in Sf9 cells and HEK293 alters the ER
membrane permeability and causes a sustained increase of cytosolic Ca 2+
concentration that is independent of the PLC pathway (206,231). In this regard,
further investigation is needed to elucidate the mechanisms underlying the
alteration of intracellular Ca2+ homeostasis in rotavirus-infected cells.

Herpesviruses. An increase in intracellular Ca2+ has been observed in
epithelial and T cells infected with HHV-1, HHV-2 (211), HHV-4 (Epstein-Barr
virus, EBV) (216,217), HHV-5 (cytomegalovirus, CMV) (210), and HHV-8
(Kaposi’s sarcoma-associated herpesvirus, KSHV) (213-215). The alteration in
Ca2+ signaling leads to a variety of cellular responses in cells transfected with
different HSV.
Exposure of epithelial cells (CaSki and Vero) with HHV-1 and HHV-2 has
been shown to result in a rapid and transient increase in intracellular Ca2+ by
triggering ER Ca2+ release via IP3R, but not Ca2+ influx through plasma
membrane. Such change in turn triggers FAK phosphorylation 5-10 min following
virus exposure (211). Notably, FAK phosphorylation has been demonstrated to
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promote actin cytoskeleton reorganization and virus trafficking. In this way,
altered Ca2+ signaling is directly linked to the phosphorylation event and plays a
central role in facilitating early events in HHV-1/HHV-2 invasion.
Epstein-Barr virus (EBV), or HHV-4, is the etiological reagent for infectious
mononucleosis and a number of malignant diseases, such as Burkitt’s lymphoma
and nasopharyngeal carcinoma. It has been shown that EBV infection can induce
a rise in intracellular Ca2+ due to increased Ca2+ influx from the extracellular
space (216). The rise in intracellular Ca2+, which is associated with protein kinase
C traslocation from the cytosol to membrane bound compartments and the
activation of B lymphocytes, can be blocked by verapamil, a L-type Ca2+-channel
blocker (232).

The EBV latency-associated gene product latent membrane

protein 2A (LMP2A) has been shown to function as a negative modulator of the
activation of B lymphocytes by binding to the Src family kinases Lyn and Syk
(233). Such interaction is responsible for blocking the Ca2+ mobilization in B
lymphocytes and inhibiting the induction of lytic infection of EBV, and thus
evading the host immune clearance of EBV infection (217).
Infection of fibroblast cells by cytomegalovirus (CMV), or HHV-5, has been
shown to induce more than 2-fold increase in cytosolic Ca2+ (210). The rise can
be further blocked by nifedipine and verapamil, indicating that L-type Ca2+
channel might contribute to the intracellular Ca2+ increase. Moreover, a CMVencoded protein pUL37x1, which is capable of trafficking from ER to
mitochondria, can induce Ca2+ release from the ER store with concomitant
morphological changes, such as cell rounding, cell swelling, actin cytoskeleton
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reorganization and mitochondrial fission (209). The altered Ca2+-signaling is
further linked to the antiapoptotic activity of pUL37x1.
Kaposi’s sarcoma-associated herpesvirus (KSHV), also called HHV-8, is
the etiological agent of Kaposi’s sarcoma and closely associated with primary
effusion lymphoma and multicentric Castleman’s disease (234,235). Alteration in
Ca2+-signaling has been most often reported in cells expressing K1, K7 and viral
macrophage inflammatory protein (vMIP) -I and –II, all of which are abundantly
expressed during lytic phase of the viral life cycle. The KSHV K1 protein is a
lymphocyte receptor-like protein that can transduce external stimuli to elicit
downstream signaling pathways and induce cytokine production through its
cytosolic immunoreceptor tyrosine-based activation motif (ITAM). By interacting
with cellular Src homology 2-containing proteins including Lyn, Syk, p85, PLCγ2,
and RasGAP, the expression of K1 protein leads to the intracellular Ca 2+
immobilization and the subsequent activation of NFAT and AP-1 pathways (213).
The K7 protein is a mitochondria-targeted protein expressed during the lytic
replication of KSHV. K7 has been shown to enhance ER Ca 2+ release through its
interaction with the cellular Ca2+-modulating cyclophilin ligand and further inhibit
apoptosis (215). Thus, the lytic K7 protein protects KSHV-infected cells from
apoptosis and allows the completion of the viral lytic replication. vMIP-1 and
vMIP-II are chemokine homologs involved in the signal transduction and
chemotaxis of monocytes and T lymphocytes Both proteins are capable of
inducing transient Ca2+ mobilization by activating the CC chemokine receptor 5 in
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K562 cells. In addition, vMIP-1 can induce Ca2+ signal through its interaction with
CC chemokine receptor 8(214).

HBV. HBV is a para-retrovirus that infects 3-6% of the world’s population.
The multifunctional hepatitis B virus X protein (HBx) has been shown to alter the
Ca2+ signaling to benefit viral replication and core assembly. Upon HBx
expression, the intracellular Ca2+ increases due to Ca2+ release from ER and
mitochondria. The rise in cytosolic Ca2+ triggers the activation of a Ca2+dependent proline-rich tyrosine kinase-2, which in turn activates the Src kinase
and up-regulates reverse transcription (224). More strikingly, such effects exerted
by HBx can be substituted with simple increase in cytosolic Ca 2+, suggesting a
fundamental requirement of Ca2+ for HBV replication and infection. More than
that, the increased Ca2+ by HBx has also been shown to enhance the HBV core
assembly (40). Treatment of transfected HepG2 cells with the cell-permeable
Ca2+-chelator BAPTA-AM and cyclosporine A results in reduced HBV capsid
assembly, whereas the application of thapsigargin, a strong inhibitor of the
sarcoplasmic/endoplasmic reticulum Ca2+-ATPase (SERCA), increased HBV
core assembly. Overexpression of HBx has been further demonstrated to
stimulate caspase-3-dependent cleavage of the plasma membrane Ca2+-ATPase
(PMCA), a pump that extrudes Ca2+ from cytoplasm to extracellular environment.
HBx is also linked to apoptosis by inducing morphological changes and reducing
Ca2+ uptake in mitochondria (223).
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4.2. Viral Ca2+-binding proteins
Ca2+ plays important roles in the replication cycle of some of viruses
through its direct interactions with viral proteins. For some viruses, such as
polyomaviruses (33,34), rotavirus (36,38,39,236), hepatitis B virus (40), turnip
crinkle virus (41,42) and tobacco mosaic virus (33,43), Ca2+ is required to
maintain the structural integrity and/or the proper assembly of virions. Ca 2+ is
required for cell fusion mediated by human immunodeficiency virus type 1
envelope glycoprotein gp 160 (44,45). For influenza B virus, the binding of Ca2+
has been reported to enhance the stability of the virion associated neuraminidase
and to promote its enzymatic activity (46,237). To date, the majority of the
reported viral CaBPs are structural proteins, including both capsid proteins and
envelope proteins.
According to the location of Ca2+-coordinating residues, Ca2+-binding sites
can be primarily divided into two types: discontinuous and continuous Ca2+binding sites. Both types of Ca2+-binding sites have been found in different
families of viruses (Table 4.2).

Discontinuous viral Ca2+-binding sites
In discontinuous Ca2+-binding sites, Ca2+-coordinating ligand residues that
are distantly separated in the primary sequence or originate from different
polypeptides approximate in space to form Ca 2+-binding pockets. By searching
through the Protein Data Bank (PDB), such Ca2+-binding sites have been most
frequently found in the coat protein of both RNA viruses (e.g., enteroviruses,
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rhinovirus, sobemoviruses and rotavirus) and DNA viruses (e.g., parvoviruses
and polyomaviruses), as well as in the NSP4 of rotavirus and the neuraminidase
of Influenza viruses (Table 4.2).

Coat protein
The binding of viral coat protein to Ca2+ ions have been seen in some plant
viruses (such as Sobemoviruses, Tobamoviruses and some viruses in the family
of Tombusviridae), as well as a number of animal viruses including the
picornaviruses, rotavirus, parvoviruses and polyomavirus (Table 4.2). In these
viruses, Ca2+ ions are required for the efficient assembly and/or disassembly of
viral particles. In the extracellular milieu, the Ca2+ concentration is maintained at
millimolar level, whereas the Ca2+ concentration drops ~100-1000 fold in the
cytoplasm. The viruses can make use of the much lower cytosolic Ca 2+
concentration to initiate the uncoating event (238,239). Upon entry into the host
cells, the viral particles undergo swelling or “solubilization” due to the repulsive
forces between negatively charged residues that are otherwise neutralized by the
bound Ca2+. The incorporated Ca2+ ions may situate between the interacting
interfaces of capsid subunits (Fig. 4.2A) or sit on the symmetric threefold or
fivefold axis (Fig. 4.2B). Moreover, the numbers of bound Ca2+ and coordinating
geometry of the Ca2+-binding sites also differ for different viruses. Representative
examples can be found in both plant and animal viruses that have icosahedral or
helical (e.g., tobacco mosaic virus) capsids (Table 4.2).
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Figure 4.2. Examples of viral Ca2+-binding proteins with determined 3D
structures. (A), 3D representation of the icosahedral asymmetric unit of the
cocksfoot mottle virus capsid and the location of the incorporated Ca2+ ions
(PDB code: 1ng0). The assembling unit is formed by three subunits, A (blue),
B (green) and C (red) that are chemically identical but slightly different in
conformational arrangement. Ca2+ situates between the interfaces of
neighboring subunits (A-B, A-C or B-C). The solid pentagon, triangle and oval
represent five-, three-, and two-fold axes of the icosahedron. (B), Ca2+ ion
located on the fivefold axis of the capsid of human rhinovirus 3 (HRV3) (PDB
code: 1rhi). The icosahedral capsid of HRV3 is composed of 60 copies of
each of the four capsid proteins VP1 (blue), VP2 (green), VP3 (red) and VP4
(black). VP1, VP2 and VP3 are exposed to the external surface of the viral
particle, whereas VP4 lines in the internal surface. A Ca 2+ ion is found situated
on the fivefold axis of the capsid and is coordinated by 5 oxygen atoms from
the main chain carbonyl group of S1141 on VP1 (enlarged area). (C), The core
Ca2+-binding pocket in the oligomerization domain of NSP4 from rotavirus
(PDB code: 2o1j). The domain self-assembles into a paralleled tetrameric
coiled-coil. Chains A, B, C and D are shown in blue, green, orange and red,
respectively. The Ca2+ ion is coordinated by six oxygen atoms from the side
chains of Q123 on chains A to D, as well as the side chains of E120 on chains A
and C. In addition, the E120 on chains B or D form salt bridges with the residue
R119 on the neighboring chains A or C. (D), The 3D structure of neuraminidase
of influenza B virus (PDB code: 1nsb). The cartoon only represents half of the
tetrameric form of this enzyme. Three Ca2+-binding sites are found in two
identical subunits, A (blue) and B (red). Each subunit contains one octahedral
Ca2+-binding site (upper panel). Another site (lower panel), coordinated by the
fourfold symmetry-related E167.
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Table 4.2. Roles of Ca2+ in the life cycle of virus and viral Ca2+-binding proteins (CaBPs).
Virus

Roles of Ca2+

(+)
ssRNA
viruses
Dengue Virus
Virus release
Human rhinovirus Virus stability; acidinduced uncoating
Coxsackievirus
A21
Coxsachievirus B3
HAV
STNV

Capsid stability

Rubella virus

↑viral protease stability

TBSV

↑virus swelling

TCV

Virus movement

SeMV

Capsid stability and
assembly
Capsid stability and
assembly
Capsid stability and
assembly
Capsid stability and
assembly

CfMV
RYMV
SCPMV

Capsid stability
Virus attachment
Capsid stability

Viral CaBPs
(proposed Ca2+-binding site)

Methods
(Kd, µM)

Reference

Capsid proteins [PDB code: 1rhi; 1v9u]
(D1137[HRV1A]; S1141[HRV3];Site 1:
N1141; Site 2: E3200[HRV14])
VP1 [PDB code: 1z7s]
(S1021/S1024/T1022/N1067)
VP1 (D1133); VP3 (D3203)

X-ray

(240)
(170,241,242)

Cryo-EM

(243)

X-ray

Coat protein [PDB code: 2buk]
(Site 1: E25/S61/Q64/D194;
Site 2: D55; Site 3:T138)
NSP (D1206/S1208/D1210/T1012/D1217)

(244)
(245,246)
(247-249)

X-ray;
Fluorescence
(Eu3+: 0.0011)
Fluorescence;
(250)
NMR
(La3+: 14; Tb3+:
47; Ca2+: 247 )
X-ray;
(251-253)
Cryo-EM
X-ray
(41,42,238)

Coat protein [PDB code: 2TBV]
(aa 149-155; 181-186)
Coat protein
(D155/D157/K160/E127/D199)
Coat protein [1smv]
(D145/D149/Y205/N267/N268)
Coat protein [1ng0]
(D136/D139/L196/N252/L253)
Coat protein [1f2n]
(D126/D129/V182/N237/T238)
Coat protein [4sbv]
(D138/D141/F199/N259/L260)

X-ray

(254)

X-ray

(255)

X-ray

(142)

X-ray

(256,257)
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Virus

Roles of Ca2+

TMV

Capsid stability and
assembly

RCNMV

Capsid stability

TNV

Capsid stability and
assembly

(-) ssRNA viruses
Ebola virus

Hantavirus
Influenza A virus
Influenza B virus
Parainfluenza
viruses
Sendai virus

Triggers
conformational
change; ↑fusion with
PM
↑N-N interactions
↑enzymatic activity and
virus fusion
↑thermostability and
enzymatic activity
Enzymatic activity

Viral CaBPs
(proposed Ca2+-binding site)
Coat protein

Coat protein
(aa 93-99; 125-130)
Coat protein [1c8n]
(Site 1: D160/D163/T219/N275;
Site 2: N93/S94/S173/N175)
GP/fusogenic domain

N protein
(aa 401–412)
Neuraminidase [PDB code: 3nn9]
(D293/G297/N347/D324)
Neuraminidase [PDB code: 1nsb ]
(Site 1: E167; Site 2:
D292/T296/D323/G343/G345)
HN protein [PDB code: 1z4v; 1v2i; 1e8t]
(D250/S253/A255/A285)

Virus morphogenesis;
envelope protein
transportation;
Within the core of
Phosphoprotein 320-433 [PDB code: 1ezj]
tetrameric coiled coil
(N389)
↑fusion
protein
RSV
synthesis and
syncytium formation
(+) ssRNA viruses require DNA intermediates

Methods
(Kd, µM)
X-ray;
Electrode
(Ca2+: ~100)
Cryo-EM

Reference
(33,43)

(258)

X-ray

(259)

CD

(260)

(261)
X-ray

(262-266)

X-ray

(46,237)

X-ray

(267-269)
(270-272)

X-ray

(273)
(274)
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Virus
HIV-1

ASV
BLV
dsRNA viruses
IBDV
Rotavirus

Roles of Ca2+
Triggers
conformational change
(α-helix→β sheet);
↑virus fusion to PM
Virus fusion to PM
gp160 processing
virus attachment and
cell fusion
Alters enzymatic
activity
↑gp51 and p24
synthesis
Capsid stability and
assembly
Virus maturation and
stability
Capsid stability;
assembly

NSP4 oligomerization
ssDNA viruses
CPV/FPV

dsDNA viruses
Adenovirus 7

capsid stability and
assembly

Virus internalization

Viral CaBPs
(proposed Ca2+-binding site)
gp41 N-terminal fusion peptide

Methods
(Kd, µM)
IR

(275)

gp41628-683
(aa 628-648)

Fluorescence
(Ca2+: 40)

(44,276)

Reference

(226,277)
(45,278,279)
Integrase [PDB code: 1svi]
(D64/D121)

X-ray

(280,281)
(282)

VP2 [PDB code: 2gsy; 2df7]
(D31/D174)
VP7
(aa 270-282)
VP6 [PDB Code: 1qhd]
(Site 1: Y248/N250; Site 2:
D340/161/E134/D337; Site 3: D62/Q47;
Site 4: D286/N266; Site 5:
E379/D380/Q383/Q268)
NSP4 [PDB code: 1g1i; 2o1k]
(E120/Q123)

X-ray

VP2 [PDB code: 1c8d; 1c8g]
(Site 1: D373/D375/G362/G363; Site 2:
D237/D239; Site 3: D237/D240/D405)

(283,284)
(38,39,229)

Cryo-EM

(285)

X-ray

(286)

X-ray

(287,288)

(289)
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Virus

Roles of Ca2+

BKV

Capsid stability

MPyV

Capsid assembly

SV40

Assembly, cell entry
and nuclear entry

BFDV

Capsid assembly

Viral CaBPs
(proposed Ca2+-binding site)
VP1
(Site 1: E331; Site 2: D346)
VP1
(aa 266-277)
VP1
(Site 1: E46/E48/S213/E216/E330;
Site 2: E157/E160/K214/E216/D345)
VP1
(aa 237-248)

dsDNAviruses with RNA intermediates
HBV
Core assembly and
virus replication
Others
Bacteriophage
φX174

Trigger conformational
change; virus assembly

Bacteriophage G4

Virus assembly

Bacillus
subtilis Adsorption;
phage 41c
penetration;
Intracellular phage
development
fd and M13 virus
Lateral aggregation and
bundle formation

F protein
(Site 1:
G1321/D1421/M1424/S1426/Q1004
Site 2: S1001/N1002);
G spike protein
(Site 3: D2117)
F protein [PDB code: 1gff]
(A1321/N1322/D1421/M1424/S1426)

Methods
(Kd, µM)
Cryo-EM

Reference
(290)

45

(31)

X-ary

(34,291,292)

45

(293)

TEM

(40)

X-ray

(294,295)

X-ray

(296)

Ca binding

Ca binding

(297)

EM

(298,299)
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Abbreviations: Kd, dissociation constant; HAV, hepatitis A virus; STNV, Satellite tobacco necrosis virus; NSP, nonstructural protein; TBSV, tomato
bushy stunt virus; EM, electron microscope; TCV, turnip crinkle carmovirus; SeMV, Sesbania mosaic virus; CMV, cocksfoot mottle virus; RYMV,
rice yellow mottle virus; TMV, tobacco mosaic virus; RCNMV, Red clover necrotic mosaic virus; PM, plasma membrane; GP, envelope glycoprotein;
CD, circular dichroism spectroscopy; HN: Hemagglutinin-neuraminidase; N protein, nucleocapsid protein; PDB, protein data bank; RSV,
respiratory syncytial virus; HIV, human immunodeficiency virus; IR; infrared spectroscopy; BLV, bovine leukemia virus; IBDV, infectious bursal
disease virus; CPV, canine parvovirus; FPV, feline panleukopenia virus; MPyV, Murine polyomavirus; SV40, simian virus 40; BFDV, budgerigar
fledgling disease virus; HBV, hepatitis B virus; TEM, transmission electron microscope.
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The virion of cocksfoot mottle virus (CfMV), which belongs to the genus
Sobemovirus with a single-stranded, positive-sense RNA genome, has an
icosahedral capsid composed of 180 copies of coat protein monomers
assembled in T=3 quasi-equivalent symmetry (255). These monomers, all of
which contain 253 amino acids, have a jelly-roll β-sandwich topology and exhibit
three slightly different conformations, denoted as quasi-equivalent positions A, B
and C (Fig. 4.2A). The subunits A, B and C are assembled as asymmetric units
that eventually form the icosahedral capsid. Three Ca 2+ ions, each incorporated
between the interacting surfaces of subunits (A-B, B-C and A-C), function as
reusable “glue” to stick adjacent subunits together and stabilize the capsid. Each
Ca2+ ion is coordinated by Oδ1 of residues Asp136 and Asp139 from one subunit
and the main chain carbonyl oxygen of Leu 196, Oδ1 of Asn252, and the C-terminal
carboxyl oxygen from the other interacting subunit (Fig. 4.2A). Such Ca2+-binding
sites seem to adopt an octahedral geometry with only five ligands and an
average Ca-O distance of 2.4 Å (142,254,255).
The incorporation of Ca2+ ions into the capsid is also observed in the animal
viruses with either RNA or DNA genomes. In human rhinovirus 1A (HRV1A),
HRV3 and HRV14, Ca2+ ions are located at the five-fold axes of the icosahedral
capsids (Fig. 4.2B). The metal ions are coordinated with the oxygen atoms from
the main chain carbonyl group of Asn1141 and S1141 in five copies of the
symmetry-related VP1 of HRV14 (241) and HRV3 (242), respectively. In HRV1A,
the Ca2+ coordinates with the Oδ1 of Asp1137 of fivefold-related VP1 (300). With
two additional oxygen atoms from water molecules above or below the metal ion
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as coordinating ligands, the Ca2+-binding pocket forms a pentagonal bipyramidal
geometry with Ca-O distance ranging from 2.3 Å to 3.1 Å. In HRV14, another
Ca2+ ion with similar property coordinates with the Oε1 of Glu 3200 and situates
itself on the threefold axis of the capsid. Similar to HRV14, each asymmetric unit
of the icosahedral capsid of Coxsachievirus B3, which belongs to the genus
enterovirus in the picornaviridae family, contains two Ca2+ ions, with one interacts
with Oδ1 of Asp3203 from VP3 on the threefold axes and the other involves watermediated interaction with the fivefold-related residues Asp1133 on VP1 (244).
Three Ca2+ ions are incorporated in the ssDNA virus bacteriophage φ174. Site 1
is located approximately 10 Å from the threefold axis and is coordinated with six
ligands from the main chain of Glu1321, Asp1421, Met1424, S1426 and the side chain
of Gln1004 and Asp1421 in the F protein. Site 2 in the F protein and Site 3 in the G
spike protein situate on the threefold of and fivefold axes, respectively. The Ca 2+
ion at Site 1 is functionally important for the injection of viral DNA into the host
cells, whereas the binding of Ca2+ ions to Site 2 and Site 3 on the axes stabilize
the capsid (294,295).
The ssDNA parvoviruses, feline panleukopenia virus (FPV) and canine
parvovirus (CPV), bind three and two Ca2+ ions, respectively (287). CPV was
discovered in 1978 as a host range variant of FPV. Both FPV and CPV contain a
pH-dependent dual Ca2+-binding site that is separated by 4.6 Å. The largest
structural difference between these two viruses is confined to a flexible surface
loop (aa 359-375) in the capsid protein VP2 that could possibly interact with host
cellular surface molecules. This loop forms a third Ca 2+-binding site in FPV, but
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not in CPV. The binding of Ca2+ to this particular site causes conformational
changes in VP2 and seems to influence the host range of different parvoviruses
(287).
The binding of Ca2+ to the capsid of dsDNA viruses is best exemplified in
simian virus 40, a small DNA virus that belongs to the polyomaviridae family.
Mutations at the Ca2+ binding ligands lead to defects in capsid assembly at
nonpermissive temperature (301). Even after the formation of virus-like particles
(VLPs), the Ca2+ mutants are much less infectious than the wild type virus. More
interestingly, some of the mutants fail to enter the cell (e.g., E330K in Site 1) or
enter the nucleus (e.g., E157A-E160A and E216K in Site 2) due to its incapability
to bind Ca2+ and subsequent premature VLP dissociation. Thus, the binding of
two Ca2+ ions to the dual Ca2+ binding site on VP1 are essential for the assembly
of the icosahedral capsid, as well as the cellular and nuclear entry (34,292).

NSP4 of rotavirus
The NSP4 of rotavirus, a transmembarne glycoprotein primarily embedded in
the membrane of endoplasmic reticulum (ER) of rotavirus-infected cells, is
required for the budding of immature viral particle into the ER lumen and thus
plays a central role in the morphogenesis of rotaviruses (229). The NSP4 also
functions as an enterotoxin and triggers the ER Ca 2+ release, eventually resulting
in gastrointestinal symptoms (36,231). The NSP4 itself has been revealed to
contain a core Ca2+-binding site when it oligomerizes into a functional homotetramer (286). The Ca2+ ion is coordinated by the side chains of four Gln123 and
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two Glu120 residues from four neighboring identical polypeptides (Fig. 4.2C). This
Ca2+-binding site appears to stabilize the tetrameric state of NSP4 in the
extracellular space and the cytoplasm, where the Ca 2+ concentration could be
increased by 5 folds after rotavirus infection (206).
.
Neuraminidase of Influenza viruses
The neuraminidase of influenza viruses catalyses the cleavage of the
glycosidic linkages between the terminal silica acid residues and the adjacent
carbohydrate moieties on the surface of infected cells. This activity is required for
the release of virus from the cell surface. Two distinct Ca 2+-binding sites are
found in the neuraminidase (237,264). One high-affinity site (Fig. 4.2D) is close
to the active site and adopts an octahedral geometry with six coordinating ligands
from the carboxyl group of the side chains of Asp323, the carbonyl groups of the
main chains of Gly343, Gly345, Thr296, Asp292 and one molecule of water. This
Ca2+-binding site is conserved among influenza A virus (262,264), influenza B
viruses (237) and the parainfluenza virus (268). The other relative low-affinity site
is located on the fourfold axis of the tetrameric neuraminidase. The high-affinity
Ca2+-binding site is needed for the thermostability of the enzyme and optimal
enzymatic activity; whereas the low-affinity site has been postulated to hold the
tetramer together (46).
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Continuous viral Ca2+-binding sites
Continuous Ca2+ binding sites are best characterized by the 29-residue
the EF-hand motifs, where the Ca2+ ions are coordinated by seven oxygen atoms
from the sidechain carboxyl or hydroxyl groups (loop sequence positions 1, 3, 5,
12), the main chain carbonyls (position 7), and a bridged water (position 9) by
adopting a pentagonal bipyramidal geometry (302). The helix-loop-helix EF-hand
moiety is one of the most widely used motifs in proteins and is ubiquitously
distributed across bacteria, archaea, and eukaryotes (6,138). Upon binding to
Ca2+, this motif may undergo conformational changes that enable Ca2+-regulated
functions, as seen in Ca2+ effectors such as calmodulin (CaM) and troponin C
(TnC) or Ca2+ buffers such as calreticulin and calbindin D9k. While the majority of
the known EF-hand CaBPs contain paired EF-hand motifs, single nuclear EF
hands have also been discovered in bacteria and eukaryotes (5,6). The recently
reported ER Ca2+ sensor, stromal interaction molecule 1, has been confirmed to
function as a monomer in the presence of Ca2+ (303).
Though EF-hands have been found abundantly in eukaryotes and
bacteria, literatures on EF-hand or EF-hand like Ca2+-binding motifs in virus
proteins are, nevertheless, scarce, possibly due to lack of accurate prediction
methods and robust validating methodologies. A thorough search in PubMed with
the key words “EF-hand and virus” only results in 4 examples of viral EF-hand or
EF-hand like motifs: the NSP protease domain (DASPDGTGDPLD) of rubella
virus (250), the VP1 (DENGVGPLCKGE) of polyomavirus (31), the VP7 outer
capsid protein (DITADPTTAPQTE) of rotavirus (39), and the transmembrane
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protein gp 41 of HIV-1 (44). The binding of Ca2+ to these sequences either
enhances the protein stability or promotes the enzyme activity.
Our laboratory has developed a pattern search method to predict
continuous

Ca2+-binding

sites

from

genomic

information

(http://www.chemistry.gsu.edu/faculty/Yang/Calciomics.htm). This bioinformatic
tool has been successfully applied to predict and analyze potential bacterial EFhand and EF-hand like Ca2+-binding motifs at genome-wide level (Chapter 3) (6).
Given the diversity of viral genomes and its close association with host cells that
are abundant with the EF hand motif, it would be surprising to find only 4 cases.
Driven by that, we initiated a comprehensive search for potential viral EF-hand
motifs by screening all viral genomic information that is available on the protein
database Swiss-Prot/TrEMBL. With our developed method, along with the pattern
PS00018 (http://ca.expasy.org/prosite/PDOC00018) from Expert Protein Analysis
System (ExPASy) proteomic server, we have detected a number of additional
potential EF-hand motifs (summarized in Table 4.3), though the Ca 2+-binding
capability of these sequences remain to be experimentally verified. The 93
putative EF-hand or EF-hand-like motifs are found in the genomes of almost 80
different viruses, spreading throughout the majority of virus families. Almost all of
these matches are found to be single EF-hand motifs except for two EF-hand or
EF-hand-like motifs detected simultaneously in the envelope protein of HIV-1 and
the immediate-early protein RSP40 of pseudorabies virus. These putative viral
EF-hand-containing proteins are involved in a wide range of viral or cellular
events, such as viral adsorption and fusion (neuraminidase of Influenza A virus,
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Sendai virus and human parainfluenza virus 1; envelope glycoprotein of HIV-1;
spike protein of rat coronavirus, murine hepatitis virus and bovine ephemeral
fever virus; glycoprotein B of feline herpesvirus 1), virion assembly and
disassembly (coat protein of beet yellow stunt virus, papaya ringspot virus and
African horse sickness virus), viral precursor protein processing (nonstructural
protease of rubella virus), viral nucleic acid modification and replication (mRNAcapping enzyme of alphavirus; RNA-directed RNA polymerase of tobamovirus,
respiratory syncytial virus, and influenza A virus; DNA methylase of sulfolobus
virus; DNA polymerase of nucleopolyherosis virus and human herpesvirus 2) and
transcriptional regulation of viral genes (ICP0 of bovine herpesvirus 1; IE63 of
human herpesvirus 3; ICP4 of equine herpesvirus 1). In addition, the functions of
almost 20% of these matched proteins remain uncharacterized. We hope that our
prediction would serve as a prelude to more extensive searching for additional
viral Ca2+-binding proteins that are closely associated with virus-host interacting
events.
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Table 4.3. Putative EF-hand and EF-hand-like Ca2+-binding motifs predicted in virus genomes.
Virus

Accession ID

EF-hand motifs
(+) ssRNA viruses
MHV
Rat coronavirus
Rubella virus
VEEV

Q5ICX2/Q83331
Q9IKD1
P13889
P36327

WEEV

P13896

Sindbis virus

P27283

SFV

P08411

RRV

P13887

SqMV
SBLV
Nora virus

P36341
Q8JW06
Q27YG9

Tobamovirus
(RMV/TMV/TVCV/YoMV)
TTV

Q1L1D7/Q88604/
Q88920/Q66220
A1XIP9/A6NA62

BSBMV
BYSV
PRV
SMoV
(-) ssRNA viruses

Q9IF43
Q65858
Q98WK3
Q8UYV9

Protein name

Match
Ranges

Sequences
1 2 3 4 5 6 7 8 9 10 11 12

Spike protein
Spike protein
NSP (Protease)
NSP (mRNA-capping
enzyme nsP1)
NSP (mRNA-capping
enzyme nsP1)
NSP (mRNA-capping
enzyme nsP1)
NSP (mRNA-capping
enzyme nsP1)
NSP (mRNA-capping
enzyme nsP1)
Movement protein
3a protein
Replication
polyprotein
RNA polymerase
Polyportein/
RNA polymerase
29K protein
Coat protein
Coat protein
Polyprotein

727-738
726-737
1206-1217
401-412

D N STEQ SV DA
D N STEQ SV DA
DASPDGTGDP
DQEDERPLGL

399-410

DLDDEKELGV R E

402-413

DLDNEKMLGT R E

402-413

DLDDEKPLGV R E

402-413

DLDNEKMLGT R E

218-229
52-63
462-473

NNSGDNEVEF S E
NLSSDNRLNF I D
NKSPDKSVTI E D

1358-1369/
1362-1373
1535-1546/
196-207
222-233
11-22
50-61
1388-1399

C
C
L
R

D
D
D
D

D LDS TQAME I L E
DVSSSKMLDL S E
DDDGDGVVGD D D
D S S ASQ TMTA K D
D K D N DGAC D G N D
DKDGDRWVAK D E
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Virus
HRSV-A

Accession ID

P28887/O36635/
Q82021/Q82027
HRSV-B
P24567/O42062
BRSV
P33454/Q77KZ1
PPRV
Q4PIR9/Q91QS4
BEFV
P32595/Q56I18
Puumala virus
Q6QTA9
NDV
A0SZV5
Influenza A virus
Q1I0S8
Q0P290
(+) ssRNA viruses require DNA intermediates
HIV-1
Q2PNG6
Q2PN97
Q2PN98
A1Z0A9
Q6EJM9
Q8AF19
P19549/Q03807
Q1G4R9
Q1HSZ5
Q2NN71
Q1HSY3
Q1HT34
Q1HT21
QIHT20
Q2PN97
Q6QBL0
Q6QUE1
Q71129
Q71313

Protein name
RNA Polymerase
(subunit L)
Phosphoprotein
Phosphoprotein
Phosphoprotein
Spike protein
RNA polymerase
RNA polymerase
Neuraminidase
Neuraminidase
Envelope protein

Match
Ranges
1557-1568

DMNTSDLLCV L E

229-240
229-240
74-85
400-411
1975-1986
1529-1540
68-79
68-79

DNDSDNDLSL D D
DESSDNDLSL E D
DMSPEDNLGF R E
DKNEDGYIDI Q E
DSDEDDDVSQ L D
NHDGSHQLAD T D
NISNTKIVNV Q D
NINNTNVVAG K D

29-41
29-41
29-41
132-143
28-39
139-150
141-152
151-162
137-148
137-148
143-154
155-166
149-160
147-158
147-158
32-43
34-45
24-35
17-28

DNSTEGTVGG G E
NTSTGGTVGG G E
NNSTGGTVGG G E
DLNTTNTINS S D
NTNNSRIMEG G E
NSSSENKMEI G E
NNSSGGTVEK E E
NNSSGQIMEK G E
NSSSGKMMEE G E
NSSSERTMEK G E
NSSRGKMMEK G E
NNSGGGTVEE R E
NNSSGRTMEE R E
NNSSGRTIEE R E
NTSSTGGTVG G E
NNNSEGRIER G E
NTSSEGMVEK G E
NNSSGKLIEL G E
NSSDEGKIEK G E

Sequences
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Virus
CYMV
dsRNA viruses
PsV-F
AHSV-6

Accession ID

Protein name

Match
Ranges
129-140

NRDHEQLCEV V E

Sequences

Q91B26

Putative protein

Q4G3H1
Q64913

Capsid protein
VP6 protein

294-305
144-155

DEDRSDLLTT L D
NDDATRNVGS S E

P04864/P24840
P27437

Coat protein VP1
Coat protein VP1

658-669
653-664

SANMSRIVTY S D
SANMSRIVTY S D

Q8B4N1/Q65858/
Q8QUT8/Q1X6P8/
Q71G61
Q6YH54/Q6GZT5
Q677V5
P28925
Q86665/Q90050

Putative Phosphatase

80-91

DMSQDGFVNY Q D

Orf2-like protein
Purative protein
ICP4
Glycoprotein B

DPDASHVMQT D E
DINNSQIITV S D
DSDPTHRLGS D E
DFDEEKLMQA R E

WSSV

Q8JNB7/
Q8JNC2

ORF2735/
ORF4162

CPV

Q80DU9/Q8QMS8

A27L

Squirrelpox virus
Ectromelia virus
MOCV-1
Nucleopolyhedrovirus
(AgMNPV/Cfdef/CfNMPV)

Q1HTR0
Q9PXN5
Q98173
Q06KP7/Q6VTX1/
Q7TLX0

C3R
C11R
MC002L
Putative protein

327-338
31-42
733-744
871882/
876-887
312323/
281-292
383394/
57-68
22-33
32-43
251-262
6374/6172/
61-72

ssDNA viruses
FPV
MEV
dsDNA viruses
Megalocytivirus
(RBIV/DGIV/ISKNV/OSGIV/R
SIV)
Ranavirus (ATSV/FV-3)
LCDV
EHV-1
FeHV-1

DDDDDDDCEG M D

DDDDDDVIDD D D

DDDTDGELES K D
NRNSTHKIQE N E
NTNENGAMSS A E
DDNNGRCCNV V D/
D D SAN R CC S V V D
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Virus

Accession ID

Protein name
Alk-exo
A208R
EsV-1-56
Adenine-specific DNA
methylase
Putative protein
Putative protein

Match
Ranges
350-361
214-225
333-344
151-162

NLNESQTLSL S
DDDSDDDIND N
DVSGNDLLNV S
DDDAEGYIGT W

18-29
85-96

D I S D T N V L AA A E
DSSSSQEVTI P D

Sequences
E
D
D
E

Granulovirus
PBCV-1
ESV
Sulfolobus virus

Q84528
Q9J3U5
Q684G2

Archaeal BJ1 virus
AFV-2

A0ZYT1
Q573C5

HZV-1

Q8JKJ1

Microtubuleassociated-like protein

423-434

DTDGSNDLAK L D

Others
ABV

A4ZUC5

ORF188

169-180

DPNQNQTISE S E

24012414
929-942

D D D Q D G D R R RALYD

EF-hand-like motifs
(+) ssRNA viruses
EEEV

Q306W6

NSP

CSFV
(-) ssRNA viruses

P19712

Genome polyprotein

Influenza A virus

Q6XV43
P21427/Q0A2K9/
O89750/Q0A2Q7
P16017

385-398
294-306

DKDSNGVQDIIDND
DPSHEGEGIPLYD

281-293

DYSSEGIEDLVFD

Q783Y1/P19758/
P03425/Q88261

Neuraminidase
RNA polymerase
subunit P2
Hemagglutininneuraminidase
Hemagglutininneuraminidase

281-293

DYSSDGIEDLVLD

Q64929

VP4 core protein

263-276

D V SADG LKGTIEW E

HPIV-1
Sendai virus
VHSV
dsRNA viruses
AHSV-4

DCNRDGVVISTEGE
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Virus

Accession ID

(+) ssRNA viruses require DNA intermediates
HIV-2
P24103
MPMV
P07567
dsDNA viruses
BoHV-1
P29128

HHV-1

P10211/P06347

HHV-2

P07918

HHV-3

P09255

HHV-6
HHV-7
CeHV-9

Q01350
P52520
Q04548

PRV

P24827

P24381
EBV

P12977
P03210

BmNPV
SlNPV

P41712
O57030

Protein name

Match
Ranges

Sequences

Negative factor Nef
Gag polyprotein

181-194
133-146

DTSQEGEDTETDTE
DSDDEGAKSSSLQD

Trans-acting
transcriptional protein
ICP0
Glycoprotein B
precursor
DNA polymerase

287-300

DSDSEGSEDDSWSE

824-837

DASGEGEEGGDFDE

675-688

DDDEDGDEDGDERE

Transcriptional
transactivator IE63
Protein U3
Protein U3
Glycoprotein E
precursor
Immediate-early
protein RSP40

164-177

DSDDDGSTPSDVIE

284-297
299-311
40-53

D N D E D G R PR F VAE
D N D PDGN LTF IAE
DMDEDGVYGDDIQD

224-237

DEDEEGEEEEDEEE

335-348
77-90

DEDEDGEGEEGGKD
DGDGDGDSSGDEDD

711-724
492-505

DESGEGSDTSEPCE
DEDEDGSEDGEFSD

955-967
422-435

DDDDDGCDSSDSE
DEDENGSGGDDDDD

Serine/threonineprotein kinase
Nuclear antigen 3
Putative protein
BRRF2
DNA polymerase
DNA-directed RNA
polymerase beta chain
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Abbreviations: MHV, murine hepatitis virus; VEEV, Venezuelan equine encephalitis virus; WEEV, western equine encephalitis virus; SFV, Semliki
forest virus; RRV, Ross river virus; SqMV, squash mosaic virus; SBLV, spring beauty latent virus; RMV, ribgrass mosaic virus; TMV, tobacco
mosaic virus; TVCV, turnip vein-clearing virus; YoMV, youcai mosaic virus; TTV, tomato torrado virus; BSBMV, beet soil-borne mosaic virus; BYSV,
beet yellow stunt virus: PYV, papaya ringspot virus; SMoV, strawberry mottle virus; HRSV, human respiratory syncytial virus; BRSV, bovine
respiratory syncytial virus; PPRV, peste-des-petits-ruminants virus; BEFV, bovine ephemeral fever virus; NDV, Newcastle disease virus; HIV,
human immunodeficiency virus; BSV, banana streak virus; DBV, dioscorea bacilliform virus; CYMV, citrus yellow mosaic virus; GVBV, gooseberry
vein banding virus; KTSV, kalanchoe top-spotting virus; PsV-F, penicillium stoloniferum virus; AHSV, African horse sickness virus; FPV, feline
panleukopenia virus; MEV, mink enteritis virus; RBIV, rock bream iridovirus; DGIV, dwarf gourami iridovirus; ISKNV, infectious spleen and k idney
necrosis virus; OSGIV, orange-spotted grouper iridovirus; RSIV, red sea bream iridovirus; ATSV, ambystoma tigrinum stebbensi virus; FV, frog
virus; LCDV, lymphocystis disease virus; FeHV, feline herpesvirus; EHV, equine herpesvirus; WSSV, white spot syndrome virus; CPV, cowpox
virus; MOCV, mollucum ontagiosum virus; AgMNPV, anticarsia gemmatalis nuclear polyhedrosis virus; Cfdef, choristoneura fumiferana defective
polyhedrosis virus; CfNMPV, choristoneura fumiferana nuclear polyhedrosis virus; PBCV, paramecium bursaria chlorella virus; ESV, ectocarpus
siliculosus virus; AFV, acidianus filamentous virus; HZV, heliothis zea virus; ABV, acidianus bottle-shaped virus; EEEV, Eastern equine
encephalomyelitis virus; CSFV, classical swine fever virus; HPIV, human parainfluenza 1 virus; VHSV, viral hemorrhagic septicemia virus; MPMV,
Mason-Pfizer monkey virus; BoHV, bovine herpesvirus; HHV, human herpesvirus; CeHV, Cercopithecine herpesvirus; PRV, pseudorabies virus;
EBV, Epstein-Barr virus ; BmNPV, Bombyx mori nuclear polyherosis virus; SlNPV, spodoptera littoralis nuclear polyherosis virus.
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4.3. Ca2+ dependent virus-host interactions
Compared to the scarcity of reported viral Ca2+-binding proteins, the host
cells are abundant with cellular Ca2+-binding proteins. Accordingly, viral proteins
might utilize a number of important cellular Ca2+-binding proteins as alternative
strategies in its response to the versatile and universal Ca2+ signals (listed in
Table 4.4). These proteins are widely distributed in the extracellular matrix
(fibulin-1), cytoplasm (annexin, calmodulin, and S100) and endoplasmic
reticulum (ERC-55, calreticulin and calnexin).
Rubella virus. Rubella virus (RUB), a positive-sense single-stranded RNA
virus of the Togaviridae family, is the causative agent of German measles. The
RUB genome consists of two open reading frames: one for nonstructural proteins
and the other for structural proteins (capsid, glycoprotein E1 and E2). Both
glycoproteins E1 and E2 have been demonstrated to interact with two Ca2+binding ER chaperones, e.g., calreticulin and celnexin (304). The 46-KDa
calreticulin consists of three domains, a globular N domain, a P domain rich in
proline residues, and an acidic C-terminal tail domain. The N and P domains are
responsible for the chaperone function and the highly acidic C-terminal tail is
involved in buffering Ca2+ storage with high capacity (20-30 mol Ca2+ /mol protein)
(305). Calreticulin mainly functions as a molecular chaperone to facilitate the
folding of a number of proteins. Its activity is influenced by changes in the ER,
such as the concentration of Ca2+ and ATP. Calnexin is a membrane-bound Ca2+binding ER chaperone that retains incorrectly or incompletely folded proteins
(306). During posttranslational modification, virtually all glycoproteins associate
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with these two chaperones. Both proteins can promote folding, oligomerization
and suppress degradation. They work in concert as the “quality control” for the
secretory proteins. By differentially interacting with E1 and E2, calreticulin and
calnexin have been established to control the transport of these two
glycoproteins. Since glycoproteins associate with calreticulin and calnexin with a
prolonged duration (>60 min), the maturation of RUB glycoproteins has been
proposed to be the rate limiting step of the transport of glycoproteins from ER to
Golgi complex (304).
In addition, the 3’ end of the RUB genomic RNA stem-loop (SL) structure,
which is essential for the initiation of negative-strand RNA synthesis, has also
been found to interact with the N domain of the autophosphorylated calreticulin
(307). Several possibilities have been postulated to interpret the necessity of
such interaction: 1) the interaction might promote viral RNA replication or
translation, thus ensuring a productive infection of RUB, and 2) calreticulin-bound
viral RNA might be compartmentalized to escape the surveillance of the host
immune system. However, the exact biological consequence of the RNA SLcalreticulin interaction is not clear (308).

HIV-1. HIV-1 and several HIV-1 encoded gene products have been
demonstrated to interact with cellular Ca2+-binding proteins including annexin II,
calmodulin, calreticulin and calnexin.
Annexin II, traditionally thought of as a Ca2+-dependent phospholipidbinding protein expressed in monocytes, microglia and macrophages, is
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implicated

in

membrane

trafficking,

endosomal

formation

and

vesicles

aggregation (309). It has been shown that the HIV polyprotein precursor p55GAG
interacts with annexin II in macrophages. However, the Gag-annexin II interaction
is only seen in productively infected macrophages but not in quiescently infected
cells. Such interaction localizes at the limiting membranes of late endosomes, the
site where HIV assembly and budding takes place. Depletion of annexin II is
further shown to be responsible for the destabilization of lipid rafts and
subsequent abortion of HIV assembly. In addition, annexin II is reported to
promote

HIV

entry

into

macrophage

through

its

interaction

with

phosphatidylserine in the viral particles (82).
CaM is a small (148 amino acids; MW: 16.7 KDa) and acidic (pI: ~4.0) EFhand Ca2+-binding protein that is ubiquitously expressed in eukaryotic cells. It
consists of two globular and autonomous domains, each of which contains two
helix-loop-helix EF-hand motifs. Through its binding to Ca2+ and the concomitant
conformational changes, CaM is capable of transducing the intracellular Ca2+
signal changes into divergent cellular events by targeting to an array of cellular
proteins (14,310). Two HIV proteins, Nef and gp160 have been demonstrated to
interact with calmodulin in a Ca2+-dependent fashion. Nef is a myristoylated
protein expressed in early infection of HIV. Nef has been shown to downregulate
the cell surface receptors CD4 and MHCI, and alter T lymphocyte signaling
pathways. The latter effect is partially associated with its ability to strongly
interact with CaM with an apparent dissociation constant of 13.7 nM (311). The
CaM-targeting sequence in Nef is further narrowed down to a 20-amino-acid N-
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terminal basic domain that shares high similarity with the myristoyl group of a
neuron-specific protein kinase C substrate, NAP-22 (311,312). Besides Nef, the
viral envelope protein gp160/gp41 has been shown to interact with CaM
(313,314). Two C-terminal CaM-targeting sequences in gp41 are shown to bind
to CaM with dissociation constants of 31-41 nM (315). Such interaction is
speculated to disrupt the anti-apoptotic CaM signaling pathway by either
reducing the amount of free cytosolic CaM or changing its subcellular localization
(315). The similar CaM-targeting sequence is also detected in simian
immunodeficiency virus gp41 (316). Adding more complexity to the scenario, the
Gag gene products of HIV have been shown to interact with CaM (317). The N
terminus of p17 contains two contiguous CaM-binding sites, each of which binds
CaM with affinities of ~10-9 M. In view of the diverse roles of Ca2+/CaMdependent signaling pathways, the interaction between all these HIV proteins
with CaM are expected to play multiple roles to fit the HIV life cycle in response
to altered Ca2+ signals.
The newly synthesized HIV envelope glycoprotein gp160 has been shown
to interact with both calreticulin and calnexin to form a transient ternary structure,
and thereby facilitates the folding and maturation of HIV glycoproteins (318).

HTLV-1. The Tax protein of HTLV-1 is primarily located in the nucleus and
functions as a transcriptional transactivator. Nevertheless, the Tax protein can be
also exported to cytoplasm to interact with a number of host transcription factors
including NF-κB. This nuclear transport process possibly involves the interaction
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of Tax with the Ca2+-binding protein calreticulin (319). Interestingly, the
calreticulin-mediated nuclear transport is dependent on Ca2+ (320). It has been
reported that Ca2+-loaded calreticulin does not support nuclear export of leucinerich NES-containing proteins. However, calreticulin restores the nuclear export
capability after treatment with EGTA. It still remains to be tested whether this
property has effects on the subcellular distribution of Tax. In addition to Tax, the
viral protein P12I has been shown to interact with the ER-resident Ca2+-binding
chaperones, calreticulin and calnexin (321). This interaction is expected to
facilitate the folding of p12I and to modulate the level of Ca2+ storage. Another
possible role of such interaction is to retain calreticulin-MHCI complexes in the
ER or cis-Golgi, thereby blocking its association with β2-microglobulin and the
trafficking of this protein complex (322).

HPV. The HPV E6 protein, a small polypeptide of approximately 150
amino acids, plays multiple roles in HPV infection. E6 has been found to possess
oncogenic activity by stimulating immortalization of human keratinocytes and
transforming established fibroblasts (323). By targeting p53, Bak and Myc for
degradation, E6 protein is capable of inhibiting apoptosis of infected cells.
Moreover, yeast two-hybrid screening studies reveal that the oncogenic HPV E6
protein interacts with two cellular Ca2+-binding proteins, fibulin-1 and ERC-55.
Fibulin-1 is a Ca2+-binding extracellular matrix protein that has been
implicated in cellular motility modulation, cellular transformation and tumor
genesis. The E6 protein has been demonstrated to interact with fibulin-1 in COS-
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7 cells transiently transfected with E6 from cancer-related HPV 16 or the
transforming bovine papillomavirus type 1 (BPV-1) (324). Interestingly,
overexpression

of

fibulin-1

inhibits

E6-mediated

cellular

transformation,

suggesting that the fibulin-1 serves as a tumor suppressor. The two-hybrid assay
further localizes the interacting region in fibulin-1 to amino acids 343-483, which
covers an important region (amino acids 356 to 440) that is involved in the selfassociation, Ca2+-binding and fibronectin-binding events. Given that, it has been
postulated that the interaction between the oncogenic E6 protein and fibulin-1
disrupts theses functions and further inactivate the inhibitory effect of fibulin-1 on
cell migration and invasion.
The caner-related HPV and BPV-1 E6 proteins also bind a hexa-EF-hand
Ca2+-binding protein, ERC-55, that resides in the endoplasmic reticulum (325).
Biochemical and biophysical studies further map the interacting region in ERC-55
to a stretch of 25 amino acids in the fourth EF-hand motif that is capable of
binding Ca2+ and folds into the typical helix-loop-helix conformation (326). The
exiting helix of the EF-hand motif (residues L21, F24, L25 and D27), but not the
Ca2+-binding loop and the entering helix, is further found to be fully responsible
for this interaction. The biological role of this interaction still remains uncertain.

HBV. The HBV Pol protein plays multiple roles in virus replication by
signaling the encapsidation and degradation of pgRNA, priming reverse
transcription and catalyzing both RNA- and DNA-dependent DNA synthesis (327).
Besides its association with host cellular factors such as Hsp60, Hsp70, Hsp90

128
and p23, Pol interacts with a Ca2+-modulated protein, p11 or S100A10 (328). The
p11 protein is capable of recruiting HBV Pol to PML nuclear bodies, a region that
is of vital importance for cell proliferation, differentiation and antiviral responses.
This interaction is affected by intracellular Ca2+ concentration. Treatment of cells
with valinomycin, a drug that promotes Ca2+ influx, leads to a decrease of these
proteins in the nuclear bodies; whereas the blocking of Ca 2+ influx by EGTA
results in a marked increase of Pol-p11 complex in the nuclear bodies. Thus, it is
expected that the virus would favor a higher cytosolic Ca 2+ environment to avoid
host antiviral activities. Indeed, as mentioned above, the HBx protein induces an
increase in the cytosolic Ca2+ concentration by reducing mitochondrial Ca2+
uptake and impairs the activity of PMCA (223) .
The small hepatitis B surface antigen (HBsAg) has been demonstrated to
specifically bind to human liver annexin V, a Ca2+-dependent phospholipid
binding protein present on the plasma membrane of human hepatocytes (329).
The binding process, with a dissociation constant of 1.7 nM, has proven to be
dependent on Ca2+.

Other viruses. Tobacco mosaic virus (TMV) is a positive-sense, singlestranded RNA virus that infects plants, especially tobacco and other members of
the plant family Solanaceae. The TMV cell-to-cell spread is mediated by the
movement protein (MP), which is responsible for the transport of the viral
genomic

RNA

through

plasmodesmata.

The

Ca2+-sequestering

protein

calreticulin has been implicated in this process through its interaction with MP
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(330). Overexpression of calreticulin interferes with the normal targeting of MP
and further delays the cell-to-cell viral movement.
Sendai virus is a negative-stranded RNA virus that belongs to the
paramyxoviridae family. Two envelope glycoproteins, the fusion protein (F) and
the hemagglutinin-neuraminidase (HN), mediate the virus entry into host cells.
Both proteins undergo maturation by interacting with different chaperones during
their transport through the ER and the Golgi complex (331). These two proteins
have been reported to interact with ER chaperones with different kinetics due to
difference in their oligomeric state and posttranslational processing. The F
precursor protein, which is a type I integral membrane protein that can be
cleaved into two active subunits linked by disulfide-bonds, only shows transient
interaction with calnexin (t1/2 = 8 min). The HN protein, a type II integral
membrane protein that functions as a tetramer, exhibits a slower kinetics by
sequentially interacting with Bip, calnexin and calreticulin to ensure the folding
and assembly quality (331).
Bluetongue virus, a double-stranded RNA arbovirus of the genus Orbivirus
in the reoviridae family, causes catarrhal fever in ruminants that are of
economical importance. The nonstructural protein NS3 has been shown to
interact with a host cellular protein S100A10 or p11, which harbors an N-terminal
pseudo EF-hand and a C-terminal canonical EF-hand Ca2+-binding motif. Two
p11 as the light chain components, along with two heavy chains composed of
annexin II, form the tetrameric calpactin complex. The calpactin complex is
closely associated with Ca2+-dependent exocytosis and secretory pathways (332).
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Since NS3 also interacts with outermost protein (VP2) of assembled virions, the
BTV NS3 is proposed to bring the virions together with the calpactin complex via
p11, and further directs the virus to the cellular exocytic machinery. Such
interaction provides a new mechanism for the virus to make use of this cellular
exocytosis pathway for nonlytic release of progeny virions assembled within the
cell.
Direct interaction between annexin II and viral glycoprotein is also
observed in CMV. The binding of annexin II to the CMV glycoprotein B protein
(gpUL55) appears to be a Ca2+-dependent process (333).

Similar to its

interaction with HIV, annexin II also enhances the binding and fusion of CMV to
phospholipid membranes, thereby maximizing its infectivity (334).

4.4. Summary
We have summarized here the majority of the known mechanisms
underlying virus- or viral proteins-mediated alterations in intracellular Ca2+
signaling events. The remodeled Ca2+ signaling network postinfection is closely
associated with virus fusion and entry, viral gene replication and expression,
virus maturation and release, and cellular transformation. Our predictions also
result in a number of EF-hand-containing viral proteins that are worthy of further
studies with respect to their Ca2+ binding capability and physiological relevance.
The intensive association of viral proteins with cellular Ca 2+-binding proteins adds
even more complexity to the Ca2+-dependent virus-host interaction. A major
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challenge in the future will be to integrate all aspects of the Ca 2+-virus interplay
and capture the entire picture of viral calciomics.
Table 4.4. Interactions between cellular Ca2+-binding proteins and viruses.
Viral molecular
identity
p55GAG

Virus
HIV-1

Facilitates virus entry and
fusion in macrophages

(335)

glycoprotein B

CMV

Enhances binding and fusion
to membranes

(333,336)

Annexin V

Small HBsAg

HBV

Participates in initial steps of
HBV infection

(336)

Calmodulin

Nef

HIV-1

Alters T lymphocyte signaling
pathway

(311,312)

gp 160/gp41

HIV-1

Disrupts CaM signaling
pathway

(315)

gp 41

SIV

(316,337)

HIV-1

(317)

Cellular
CaBP
Annexin II

p17
Calreticulin/
calnexin

GAG

Consequences of interaction

E1 and E2

RUB

Viral RNA

RUB

MP

TMV

Regulates cell-to-cell virus
movement

(330)

F, HN

SeV

(331)

gp160

HIV-1

Mediates maturation of
glycoproteins
Facilitates protein maturation

I

P12

HTLV-1

Tax

HTLV-1

ERC-55

E6

HPV

Fibulin-1

E6

HPV

S100A10
(p11)

pol

HBV

NS3

BTV

Regulates viral glycoprotein
maturation

Reference

(304)
(307)

(318)
(198)

Facilitates viral protein
folding; possibly mediates the
interaction with MHCI

(319)

(325)
Regulates cell migration and
invasion
Inhibits viral replication

(324)

Mediates nonlytic virus
release

(338)

(328)

Abbreviations: HIV, human immunodeficiency virus; CMV, cytomegalovirus; HBV, hepatitis B
virus; SIV, simian immunodeficiency virus; RUB, rubella virus; SeV, Sendai virus; TMV, tobacco
mosaic virus; HTLV, human T-cell lymphotropic virus; HPV, human papillomavirus; EBV, EpsteinBarr virus; BTV, bluetongue virus.
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5. Probing the metal-binding properties of rubella virus
nonstructural protease

5.1. Molecular biology of rubella virus (RUB)
Rubella virus (RUB), the only member of the genus rubivirus in the
Togaviridae family, is the causative agent of a disease called as rubella or
German measles. RUB is an enveloped, single-stranded positive-polarity RNA
virus with a genome size of 9,762 nucleotides (Fig.5.1). The RUB genome
contains two long open reading frames (ORFs): a 5’-proximal ORF or NSP-ORF
(41 to 6,389 nt; 2,116 amino acids; MW: 240 kDa) that encodes the nonstructural
protein (NSP) involved in viral RNA replication, and a 3’-proximal ORF or SPORF (6,512 to 9,700 nt; 1,063 aa; MW: 110 kDa) that encodes for one capsid
protein (C) and two envelope glycoproteins (E1 and E2) (339,340). Multiple
sequence alignments of the RUB NSP ORF against other positive-stranded RNA
virus

genomes

revealed

a

number

of

conserved

domains,

namely,

methyltransferase (M), protease (P), helicase (H), replicase (R), and a prolinerich region (G) as well as an X domain (X) showing high homology to the Appr-1p processing enzyme (339,341). Upon uncoating and release of viral mRNA after
entry into host cells, the NSP-ORF is immediately translated into a polypeptide
precursor (P200), which is subsequently self-cleaved by its protease domain
(termed the nonstructural or NS protease) at a cleavage site mapped between
residues G1301 and G1302 into two products (P150 and P90) involved in viral

133

Figure 5.1. Genomic organization of RUB and viral protein processing. The
RUB genome consists of two ORFs, one encoding nonstructural proteins
(NSP) and the other encoding structural proteins (SP). Upon uncoating and
release of viral mRNA after entry into host cells, the NSP-ORF is immediately
translated into a polypeptide precursor (P200), which is subsequently selfcleaved by its protease domain (termed the nonstructural or NS protease) at
a cleavage site mapped between residues G1301 and G1302 into two mature
products (P150 and P90) involved in viral RNA replication. The SP-ORF
polypeptide translated from the 24S subgenomic mRNA is eventually cleaved
into three proteins, a capsid phosphoprotein and two envelope glycoproteins
that form the spike complexes on the surface of the virion.
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RNA replication in association with late endosomal or lysosomal membranes.
The NS protease has been reported to be a Zn 2+-dependent papain-like cysteine
protease with C1152 and H1273 constituting the catalytic dyad (342-346).
Metalloproteins constitute almost one third of all known proteins and viral
metalloproteins are both common and the target of antiviral drug development
(347-349). In the present study, we report our prediction of a single EF-hand
Ca2+-binding motif within the NS protease domain of RUB (section 5.2).

To

confirm this prediction, the binding loop was grafted into a scaffolding protein,
CD2 domain 1, and the minimal metal binding domain of the NS protease was
bacterially expressed and both were found to bind Ca 2+ or its trivalent analogs
Tb3+ and La3+. We also found that mutagenesis of critical Ca2+ binding residues
negatively impacted virus infectivity and rendered the activity of the NS protease
temperature sensitive. This is the first demonstration of an EF-hand Ca2+-binding
motif in a virus-encoded protein. Moreover, with the minimal metal binding
domain that also contains a putative Zn2+-binding cysteine-rich motif, we have
further carried out conformational and functional studies of this polypeptide and
its cysteine mutants (section 5.3).

5.2. Identification of a Ca2+-binding domain in RUB NS protease
5.2.1. Prediction of the EF-hand Ca2+-binding motif and homology modeling
of the RUB NS protease
By taking advantage of the sequence alignment of currently available EFhand proteins and considering the structural context of the Ca2+-binding loop, we
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generated a series of patterns for the prediction of EF-hand proteins (6). Using
this

prediction

method

(http://www.chemistry.gsu.edu/faculty/Yang/Calciomics.htm), we detected one
putative EF-hand Ca2+-binding motif (aa 1197-1225) within RUB NS protease,
interwined with the partially characterized cysteine-rich Zn2+-binding motif (Fig.
5.2A) (346). This putative Ca2+-binding motif shared high homology with wellknown EF-hand proteins such as calmodulin and calcyphosine (Fig. 5.2B). In
canonical EF-hand Ca2+-binding motifs, the bidendate ligand residue at the loop
position 12 is either a Glu (95%) or an Asp (5%). Considering its longer side
chain and closer distance to the metal ion, Glu at this position (as seen in
calmodulin) ensured a stronger binding affinity for Ca 2+ than Asp. This predicted
motif contained an Asp at loop position 12, similar to the first EF-hand in
calcyphosine, regulatory light chain of myosin (350,351), and sarcoplasmic Ca2+binding protein (352) that exhibited relatively weaker Ca2+-binding affinities.
Prediction of the secondary structure elements revealed that the Ca 2+-binding
loop was flanked by two helices, as observed in most EF-hand CaBPs (16). The
predicted Ca2+-binding motif is highly conserved among the eight genotypes of
RUB for which sequence of this region is available, including all of the Ca2+binding coordination ligands (Fig. 5.2B).
Since the three dimensional structure of a viral papain-like cysteine
protease, the leader protease of foot-and-mouth-disease virus (FMDV), has been
determined (353,354), it provides an excellent template for homology modeling of
the NS protease of RUB. Pairwise sequence alignment of the leader protease of
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1143 Minimal metal binding domain 1252

Figure 5.2. A putative EF-hand Ca2+-binding motif in RUB NS protease. (A)
Schematic representation of the RUB genome organization and domain
locations. The protease contains at least one Zn2+-binding site as well as a
putative EF-hand Ca2+-binding motif. It has been proposed that the residues
C1152 and H1273 constitute the catalytic dyad (stars). The minimal metalbinding domain RUBCa (aa 1143 to 1252) is bacterially expressed and used in
this study. (B) Sequence alignment results of putative EF-hand Ca2+-binding
motif RUBCa in the protease domain with calmodulin and calcyphosine. The
motif remained conserved in both clades I and II of RUB. Boldface residues
represent the potential Ca2+-coordinating residues. NCBI or GenBank
accession numbers are: CaM_EF1 and CaM_EF2 (calmodulin, P62158);
CAYP_hum and CAYP_rab (calcyphosine from human, Q13938; rabbit,
P41150). (C) Homology modeling of RUB NS protease. The leader protease of
FMDV (pdb code 1qmy, chain A), a papain-like cysteine protease with a highresolution structure available, is chosen as the template for homology
modeling. The active site consists of C1152 and H1273 (shown as sticks). The
predicted EF-hand Ca2+-binding motif, located on the opposite side, is
highlighted in blue with the calcium ion shown as a cyan sphere. The cysteine
(green) and tryptophan (magenta) residues in the protease domain are shown
as sticks.
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FMDV (pdb code: 1qmy) with the RUB NS protease revealed 12.1% sequence
identity and highly similar secondary structure arrangement. Based on the
sequence alignment results, a homology model of the RUB NS protease has
been generated using the program SWISS-MODEL (Fig. 5.2C). With the program
GG (85), we further detected a potential Ca2+-binding pocket around the
predicted EF-hand Ca2+-binding motif in this model structure, indicating the
perfect agreement of the prediction made on the basis of both primary sequence
and the predicted 3D structure of RUB NS protease.

5.2.2. Probing the metal binding properties of RUB NS protease by grafting
To dissect the Ca2+ binding capability of the putative Ca2+-binding motif
and meanwhile, to circumvent the difficulty encountered in purifying the cysteinerich protease domain and the interference from Zn2+ binding, we grafted the
predicted 12-residue Ca2+-binding loop (aa 1206-1217) into a non-Ca2+-binding
scaffold protein CD2.D1. As seen in Fig.5.3A, CD2 is a cellular adhesion
molecule composed of nine β-strands with Ig-like fold. We inserted the Ca2+binding loop from the RUB NS protease into CD2.D1 (named as CD2.RUBCa)
between S52 and G53 within the loop of strands C’’ and D. Three glycines at each
side of the loop serve as linkers to provide sufficient conformational freedom for
the grafted Ca2+-binding loop and to minimize perturbation on the host protein
while allowing the inserted loop to retain its capability of chelating Ca 2+ (60,6870).
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Figure 5.3. Grafting the predicted EF-hand Ca2+-binding loop into
CD2.D1 and formation of metal-protein complex. (A), Model structure of
the engineered protein CD2.RUBCa. The Ca2+-binding loop (black) from
the RUB NS protease (a.a. 1206-1217), with two glycines on the left and
three glycines on the right rendering flexibility, is grafted to the loop
which connects strands C’’ and D. The model structure is built using the
automated comparative protein modeling server SWISS-MODEL.
Aromatic residues Trp (black) are shown as sticks. The Ca2+ ion is shown
as a sphere. Intrinsic Trp fluorescence emission spectra (B) and far UV
CD spectra (C) spectra of CD2 (open circle) and engineered protein
CD2.RUBCa (closed circle) are compared to examine the perturbation of
insertion on the scaffold protein CD2.D1. Buffers consists of 10 mM Tris,
10 mM KCl, pH 7.4. (D), Electrospray mass spectra of CD2 with grafted
EF-loop from RUB NS protease (P) in the presence of a 5-fold molar
excess of TbCl3 (+156).
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A variety of spectroscopic methods confirmed that the structure of the
CD2.D1 had not been perturbed by the inserted loop either in the absence or
presence of metal ions. The Trp intrinsic fluorescence spectrum of CD2
overlapped with that of CD2.RUBCa, both of which exhibited the emission
maximum at 325 nm and a shoulder peak at 313 nm (Fig. 5.3B). The far-UV CD
spectra of CD2.RUBCa remained similar to that of CD2.D1 alone with a deep
trough at 216 nm, characteristic of typical β-sheet elements (Fig. 5.3C). The
differences observed could be primarily from the inserted 12-residue loop and
flanking triple-glycine linkers. The two dimensional 1H NMR further showed that
the majority of the dispersed signals in the fingerprint regions of the TOCSY and
NOESY spectra of CD2.RUBCa were located at the same positions as that of
CD2, suggesting that the integrity and packing of the host protein frame are
maintained after the insertion of the Ca2+-binding loop from RUB NS protease. In
general, the insertion of the foreign acidic sequence did not cause major
conformational changes of the host protein, and the overall fold of CD2.RUBCa
remained similar to that of CD2.D1. The ability of the grafted protein (calculated
MW: 12712.9 Da) to form 1:1 metal/protein complexes was revealed by ESI-MS.
As shown in Fig. 5.3, the molecular mass of the engineered protein CD2.RUBCa
agreed well with theoretical mass. The presence of 5-fold excess of Tb3+ led to
the emergence of a new peak with additional masses of 156. Similar results were
also obtained for La3+. This provides the foundation for measuring the intrinsic
metal-binding affinity with a minimized contribution from protein conformational
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change and minimal influence of the host protein environment on the grafted EFhand loop (69).

5.2.3. Obtaining the metal binding affinities of grafted Ca2+-binding loop by
FRET and NMR
The spectroscopic silence of Ca2+ makes it extremely challenging to
investigate the Ca2+ binding properties directly. Therefore, lanthanides are
frequently used to probe Ca2+-binding sites due to their similar ionic radii (Ca2+:
1.00 Å; Tb3+: 0.92 Å; La3+: 1.03 Å) and metal coordination chemistry. In
CD2.RUBCa, the four aromatic residues in the host protein and their distances
(<20 Å) to the inserted binding pocket made it possible to monitor the binding of
Tb3+ using FRET (Fig. 5.3A). As shown in Fig. 5.4A, the addition of increasing
amounts of CD2.RUBCa to 10 µM Tb3+ resulted in an increase of Tb3+ emission
fluorescence intensity at 545 nm when excited at 282 nm, suggesting the
formation of a metal:protein complex. However, the addition of both CD2.D1 and
the engineered protein with two mutated ligands (D5A/D12A) had substantially
weaker enhancement than that of CD2.RUBCa, suggesting that the mutant lost
its specific Tb3+ binding capability. This study further confirmed that Tb3+ bound
to the inserted binding loop involving ligands D5 and D12. By monitoring the
changes of Tb3+ emission enhancement of fixed amount of proteins as a function
of Tb3+ concentrations (Fig. 5.4A) and by assuming a 1:1 (Tb3+ to protein) binding
model, a dissociation constant (Kd) of 47 ± 4 µM was obtained for CD2.RUBCa.
In addition, the dissociation constant of Ca2+ was indirectly estimated by metal
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Figure 5.4. Obtaining metal-binding affinity using aromatic residue sensitized
Tb3+-FRET and 1D 1H NMR. (A), Tb3+ fluorescence enhancement at 545 nm
due to resonance energy transfer (excited at 282 nm) as a function of protein
concentrations of CD2 (open diamond), CD2.RUBCa (closed circle) and its
mutant D5A/D12A (open circle). (B), Tb3+ titration of CD2.RUBCa. Normalized
fluorescence intensity was plotted as a function of the Tb 3+ concentration. The
inset showed the Ca2+ competition titration curve of CD2.RUBCa (1.5 μM)
preincubated with 40 μM Tb3+ in 20 mM PIPES, 10 mM KCl, pH 6.8. (C), La3+
titration of CD2.RUBCa monitored by 1D 1H NMR. Some resonances (arrows)
at amide regions of 1D 1H NMR spectra of CD2.RUBCa (0.2 mM) shifts with
the increased concentrations of La3+ (from bottom to top: 0, 39.2, 113.2, 214.3,
442.2, 360.7, 605.1, 929.1, and 1411.2 μM, respectively) in 20 mM PIPES, 10
mM KCl at pH 7.4. (D), the chemical shift change at different resonant regions
as a function of the concentration of La3+.
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ion competition assay, in which 1.5 µM of CD2.RUBCa with 40 µM Tb 3+ were
titrated with increasing amounts of Ca2+ in excess. As shown in the inset of
Figure 3B, the Tb3+ fluorescence emission maximum at 545 nm decreased due to
the competition between Tb3+ and Ca2+ for the grafted metal binding site, which
gave an apparent dissociation constant of 395 ± 135 µM and a real dissociation
constant of 214 ± 73 µM according to Eq. 3.
1D 1H NMR was conducted to monitor the La3+-induced chemical shift
changes of CD2.RUBCa as a function of La3+ concentration. Several resonances
such as those at 7.97, 6.98, 6.79, and 2.67 ppm (Fig. 5.4C) gradually shifted or
sharpened as the La3+ concentration increases, indicating a single binding
process. The La3+-binding affinity, with an average of 14 ± 7 µM, was obtained by
plotting the chemical shift of these peaks as a function of La 3+ concentration (Fig.
5.4D).

5.2.4. Metal selectivity of the isolated EF-hand Ca2+-binding motifs from
RUB NS protease
Competition assays based on Tb3+-FRET have been used as a convenient
method to probe the binding capacity of physiologically competing metal ions
(e.g. 100 mM K+ and 10 mM Mg2+) to EF-hand Ca2+-binding proteins, such as
calmodulin (355) and galactose-binding protein (356). As seen in Fig. 5.5A, a
significant decrease in Tb3+-FRET elicited from Tb3+-loaded CD2.RUBca was
only observed with following the addition of 1 mM Ca2+ or 0.1 mM La3+ (another
Ca2+ analog, as discussed above). However, the addition of 100 mM K + or 10
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Figure 5.5. Metal selectivity of the engineered protein CD2.RUBCa. (A),
Metal competition assay. The addition of 1.5 µM CD2.RUBCa to free Tb3+ (40
µM) solution resulted in the increase of fluorescence intensity at 545 nm by
over 20 folds due to the binding of Tb3+ to the protein and the resultant FRET.
100 mM K+, 10 mM Mg2+, 1 mM Ca2+, and 0.1 mM La3+, were subsequently
added to individually prepared solutions containing 40 µM Tb3+ and 1.5 µM
CD2.RUBCa. (B), Amide region of 1D 1H NMR spectrum of CD2.RUBCa with
sequential addition of 100 mM K+, 10 mM Mg2+, and 1 mM Ca2+. Resonances
that exhibited changes are indicated by arrows.
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mM Mg2+ led to only a slight decrease (<10%) in the intensity of Tb 3+
fluorescence. To further clarify whether the engineered protein CD2.RUBCa
exhibited selectivity for Ca2+, we monitored the 1D 1H NMR spectrum with
sequential additions of K+, Mg2+ and Ca2+. As shown in Fig. 5.5B, while excess
K+ and Mg2+ did not result in any changes in the chemical shifts, Ca 2+ was able to
specifically induce changes of chemical shifts in the main chain amide proton
region even in the presence of 100 mM K+ and 10 mM Mg2+. These results
clearly demonstrate that CD2.RUBCa is capable of binding Ca 2+ with selectivity
over Mg2+ or K+, similar to other known EF-hand proteins such as calmodulin
(357,358).

5.2.5. Oligomeric states of the grafted EF-hand motif
The EF-hand motifs tend to occur in pairs in most well-characterized EFhand-containing Ca2+-binding proteins (359). To clarify whether the predicted EFhand motif is capable of undergoing dimerization in solution, we further grafted
the 29-residue helix-loop-helix EF-hand motif to CD2.D1 (denoted as
CD2.RUBCa.EF). Pulsed-field gradient NMR (PFG-NMR), a valuable technique
for the study of molecular motions and measurement of the dimensions of
molecules in solution (360), was then applied to determine the oligomeric state of
the grafted EF-hand motif from the RUB NS protease. As shown in Fig 5.6, the
1D 1H NMR signals corresponding to internal standards (dioxane and PIPES)
and proteins decayed as the field strength increased. Small molecules (dioxane
[88 Da] and PIPES [335 Da]) had a significantly faster decay than the protein
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samples (12 KDa). The integrated areas of resonances corresponding to
dioxane, PIPES and the Ca2+-free or Ca2+-loaded engineered protein
CD2.RUBCa.EF were fitted using equation 6 with R2 > 0.999. The obtained
diffusion constants for dioxane, PIPES, apo-CD2.RUBCa.EF and Ca2+CD2.RUBCa.EF were 98.9 x 107 cm2/s, 61.9 x 107 cm2/s, 13.5 x 107 cm2/s and
13.4 x 107 cm2/s respectively. Using the reported hydrodynamic radius of dioxane
(2.12 Ǻ) as a reference of size, the effective hydrodynamic radii of
CD2.RBUCa.EF in the absence and presence of Ca2+ are 15.53 and 15.41 Ǻ,
respectively. Similar to our previous finding that the 12-residue EF-hand loop
from EF hand site III of calmodulin remain as a monomer (70), this piece of data
suggests that the isolated EF-hand motif remains as a monomer even after metal
binding in solution. However, we still cannot rule out the possibility that other
motifs in the protease might lead to oligomerization. These findings are
reminiscent of the ER-residing protein stromal interaction molecule 1 (STIM1)
that contains a single EF-hand. STIM1 is a 90-KDa type 1 single-pass
transmembrane protein that is believed to be one of the key components of store
operated Ca2+ entry (SOCE). The ER-luminal portion of STIM1 protein has a single EFhand motif and a sterile-alpha motif (SAM),. Biophysical studies on the luminal EF-SAM
domain of STIM1 reveal that ER Ca2+-depletion results in the oligomerization of EF-SAM
domain mediated by the SAM motif. In contradiction to the EF-hand pairing paradigm,
the protein remains as a monomer at high Ca2+ concentration (303).
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Figure 5.6. Determination of oligomeric states of the grafted EF-hand motif by
PFG NMR. (A), 1D 1H NMR signal decay (integrated area) as a function of
pulsed field gradient strength. (B), Diffusion constants and hydrodynamic radii
of samples in 20 mM PIPES-10 mM KCl, pH 6.8 at 25 ⁰C.

147
5.2.6. Using the Minimal Metal Binding Domain RUBCa for Metal-Binding
and Conformational Studies.
While our attempts to express the entire NS protease (aa 1000-1300 of
P150 were fruitless, we successfully expressed as a GST-fusion protein and
purified the minimal metal binding domain (RUBCa, aa 1143-1252, see Fig.
5.2A), which contains the Ca2+ binding loop, both catalytic residues, and the
ligands proposed to be involved in Zn2+ binding. Purified RUBCa was used to
characterize the predicted EF-hand Ca2+-binding motif in its native protein
environment. When purified RUBCa was reconstituted in the presence of Ca 2+
and subjected to ICP-MS to measure its metal content, it was found to bind Ca2+
with a molar ratio (Ca2+/protein) of 0.7 ± 0.2 to 1 (n=2).
RUBCa contains three Trp residues and according to the model of the
structure of the RUB NS protease (Figure. 5.2C), one of these aromatic residues,
W1153, is in close proximity to the predicted Ca2+-binding loop (3.5 Å). This
feature enabled us to probe the metal-binding properties of RUBCa using Tb3+FRET. As shown in Figure 5A, a significant enhancement of Tb3+ fluorescence
intensity was observed when Tb3+ was added to RUBCa, indicating Tb3+ binding
to the predicted loop. A Kd for Tb3+ of 3±1 μM was obtained (inset, Fig. 5.7A).
In comparison with the 355 nm for free Trp, the emission maximum of the
purified RUBCa blue-shifted to 339 nm, suggesting that at least some Trp in
RUBCa was partly shielded from the solvent though not fully buried inside the
hydrophobic core (Fig. 5.7B). The shoulder at 355 nm suggests that some Trp
residues were exposed to the solvent. No Ca 2+-induced emission peak position
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Figure 5.7. Metal ions titration of the minimal metal-binding domain RUBCa
monitored by aromatic residue sensitized Tb3+ fluorescence (A) and intrinsic
Trp fluorescence (B). (A), Normalized Tb3+ fluorescence spectra of RUBCa
with increasing concentration of Tb3+ (from bottom to top: 0, 1.0, 4.0, 9.9, 14.8,
19.6, 14.4 μM, respectively). The inset showed the Tb3+ fluorescence
enhancement at 545 nm due to energy transfer as a function of the
concentration of Tb3+. (B), Intrinsic Trp fluorescence emission spectra of
RUBCa (2.5 μM) with increasing concentration of Ca2+ (From top to bottom: 0,
49.8, 291.3, 566.0, 740.7 and 909.1 μM, respectively). Inset: the intrinsic Trp
fluorescence intensity plotted as a function of the concentration of Ca 2+. An
average dissociation constant of 316 μM was obtained by assuming a 1:1
binding model. The excitation wavelength was set at 282 nm. All the buffers
used in metal titration consist of 20 mM PIPES, 10 mM KCl, pH 6.8.
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change was observed. However, the addition of Ca2+ led to a decrease in the
emission intensity, indicating the local changes of the chemical environment
around the aromatic residues (Fig. 5.7B). By monitoring this intensity change, a
dissociation constant of 316 ± 4 µM for Ca2+ was obtained (Fig. 5.7B, inset),
which was in agreement with the Ca2+-binding affinity obtained using the grafted
protein CD2.RUBCa (Table 5.1).
Far UV CD was performed to reveal any possible changes of secondary
structure of RUBCa induced by Ca2+. As seen in Fig. 5.8A, the spectra of both
EGTA-treated and Ca2+-loaded RUBCa had two troughs at 222 and 206 nm,
indicating the existence of α-helical secondary structure. Using the program
DICHROWEB (66), the best fit of the CD spectrum of RUBCa indicated that
17.8% was α-helix and 19.5% was β-sheet, whereas the remainder was random
coil. In excess Ca2+, the CD signal of RUBCa at 208 nm and 222 nm was 5%
more negative than that of RUBCa in 1 mM EGTA and the DICHROWEBpredicted α-helix and β-sheet contents were 23.8% and 14.9%, respectively.
Thus, the observed gain in negative ellipticity could be attributed to the formation
of a higher degree of α-helical content induced by Ca2+ binding. The anionic
amphiphile ANS was further used as a hydrophobic probe to examine the
conformational properties of RUBCa. As shown in Fig. 5.8B, upon the addition of
RUBCa, the emission peak of ANS fluorescence blue-shifted from 510 nm to 500
nm and the maximal emission intensity increased by 30%, suggesting that part of
the hydrophobic regions of the purified RUBCa were exposed to the solvent and
thus accessible to ANS. The addition of excess Ca 2+ did not cause significant
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Figure 5.8. Ca2+-induced conformational changes and thermal unfolding of the
putative Ca2+-binding domain RUBCa. (A), Far UV CD spectra of RUBCa with 1
mM EGTA (open circle) or 1 mM Ca2+ (closed circle) in 10 mM Tris-HCl, 10 mM
KCl. Inset: Normalized CD signal at 222 nm plotted as a function of increasing
temperature (5-90 ºC) in the presence of 1 mM EGTA (open circle) or 1 mM
Ca2+ (closed circle). (B), Fluorescence emission spectra of 40 μM ANS (open
square) and ANS:RUBCa complex with 1 mM EGTA (open circle) or 1 mM Ca 2+
(closed circle). The excitation wavelength was set at 390 nm. The buffer
consists of 10 mM Tris-HCl, 10 mM KCl (pH 7.4).
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overlapping emission fluorescence spectra of RUBCa in the presence of 1 mM
EGTA or 1 mM Ca2+. Taken together, these data indicated that the binding of
Ca2+ induced a local conformational change, whereas the secondary structure
and hydrophobic surface were not significantly altered.
In order to gain more insight into the possible role of Ca2+ binding, thermal
unfolding was carried out by monitoring the CD signal change at 222 nm as a
function of temperature under Ca2+-depleted or Ca2+-loaded conditions. With
increasing temperature from 5 to 90 °C, RUBCa gradually underwent thermal
denaturation, leading to the decrease of CD signals. Compared with 1 mM
EGTA, the melting temperature (Tm) of RUBCa with Ca2+ increased from 37.7 ±
0.8 to 41.8 ± 0.4 °C (Fig. 5.8B). The observed increase of melting temperature
suggested that the binding of Ca2+ stabilized the overall structure of RUBCa
under physiological conditions (100 mM KCl).

5.2.7. Mutating the Potential Ca2+-Binding Ligands in Infectious cDNA
Clones and Replicons.
To determine if the binding of Ca2+ by the RUB NS protease is of
physiological significance, the D5A/D12A double mutant shown to abrogate
binding in CD2.RUBCa was introduced into the Robo502 infectious cDNA clone
of RUB (the mutant was termed Robo502 AA). Following transfection, the virus
titer obtained from Robo502AA was ~20-fold lower than from the Robo502 parent
(Fig. 5.9A), indicating that these residues with their potential Ca 2+ binding were
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Figure 5.9. Effects of mutations of the potential Ca2+-coordination ligands on
RUB replication. Transcripts from the WT infectious cDNA clone, Robo502, or
Robo502 AA containing the D1210A and D1217A mutations in the Ca2+-binding
loop, were used to transfect Vero cells. Culture fluid from the transfection
plate (P0) was harvested on day 7 post-transfection and passaged twice in
Vero cells (P1 and P2). The virus titer in the P0, P1, and P2 culture fluids was
determined by plaque assay in triplicate (A). Open bar: Robo502; Black bar:
Robo502AA. Representative plaques at each passage are shown in B. To
check for the generation of revertants in the Robo502AA population, four
plaques were picked from terminal plaque assay dilution plates from P1 (left,
C) culture fluid and after one round of amplification in Vero cells, the
sequence of the metal binding domain in the NSP was determined, as shown
in Panel C in comparison to the wt sequence.
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necessary for optimal RUB replication. Following two subsequent passages of
the transfected culture fluids, the Robo502AA titer rose to within threefold of
Robo502 (Fig. 5.9A and B). When four individual plaques from the first passage
of Robo502AA were amplified and the sequence of the NS protease determined,
three were found to have reverted to the wt sequence at both sites while the
fourth had reverted to the wt sequence at one site (Fig. 5.9C). Thus, the increase
in titer was due to reversion of the mutant sequences.
To prevent the accumulation of revertants, the AA mutation was also
introduced into the replicon, RUBrep/GFP, in which the SP-ORF is replaced with
the GFP reporter gene.

Following transfection, RUBrep/GFP replicates and

expresses GFP but does not spread from cell to cell. As shown in Fig. 5.10A,
RNA synthesis by RUBrep-AA/GFP was delayed by ~1 day post-infection in
comparison with the wt replicon. Concomitantly, GFP expression was similarly
delayed (data not shown). We also assayed P200 NSP precursor cleavage in
cells transfected with RUBrep-HA/GFP derivative, replicons expressing a P150
tagged with the HA epitope (71). These experiments were done at 6 hrs posttransfection, when translation from the input transcripts is detectable but
replication has not yet started. As shown in Fig. 5.10B, at 35 oC P200 to P150
cleavage was efficient in wt RUBrep-HA transfected cells, but only ~50% efficient
in RUBrepAA-HA/GFP-transfected cells. RUBrep-NS*-HA/GFP, a construct with
a C1152S substitution at the catalytic site unable to undertake cleavage, served as
an uncleaved control.

Given our biophysical measurements on RUBCa that

indicate that Ca2+ binding increased the Tm of RUBCa from 37.7 ⁰C to 41.8 ⁰C
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Figure 5.10. Replicon RNA synthesis and P200 cleavage in transfected Vero

cells. Vero cells were transfected with transcripts from RUBrep/GFP or
RUBrepAA/GFP containing mutations D5A and D12A (A) or from RUBrepHA/GFP or RUBrepAA-HA/GFP, which express an HA-epitope-tagged P150
(B). (A), Total cell RNA was extracted 1 to 4 days posttransfection, and
replicon plus-strand RNA species (G, genomic; SG, subgenomic) were
resolved by Northern blotting following agarose gel electrophoresis. (B),
Transfections were performed at 35°C or 39°C. Six hours posttransfection,
cells were lysed and the P200 precursor and P150 product were resolved by
Western blotting probed with anti-HA antibodies following SDS-PAGE (the
other product, P90, does not appear because it does not contain the HA
epitope). Cells transfected with a replicon containing a C1152S catalytic site
mutation (RUBrep-NS*-HA/GFP) that cannot mediate P200 cleavage served
as an uncleaved control.
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(Fig. 5.10B), we also did the experiment in cells transfected at 39 ⁰C. As shown in
Fig. 5.10B, wt replicon cleavage of the P200 precursor was more efficient than at
35 ⁰C, however, cleavage in AA mutant replicon-transfected cells could not be
detected, indicating that the mutant protease is temperature sensitive. Thus, not
only is Ca2+ binding important for NS protease activity, in the absence of the Ca 2+
binding the protease is rendered temperature sensitive.

5.2.8. Summary
Identification

of

Nonstructural Protein.

an

EF-Hand

Ca2+-Binding

Motif

in

a

Viral

In this report, we have presented one of the few

predictions and confirmations of a Ca2+-binding motif in a virus nonstructural
protein. Most other viral Ca2+-binding motifs occur in virion structural proteins and
of these, only the rotavirus VP7 outer capsid protein (DITADPTTAPQTE) (39),
the HIV-1 transmembrane protein gp 41 (44), and the polyomavirus VP1
(DENGVGPLCKGE) (31) contain EF-hand Ca2+-binding motifs. In a canonical
EF-hand Ca2+-binding motif, the coordination geometry in the loop is formed by
oxygen atoms from the sidechain carboxyl or hydroxyl groups (loop positions 1,
3, 5, 12), the main chain carbonyls (position 7), and a bridged water (position 9)
and the flanking sequences around the loop preferentially form a helical
secondary structure. The negatively-charged residue pairs at Z axis (loop
positions 5 and 12) are essential for the binding of cations (358). Examination of
the primary sequence of the motifs in the above-mentioned virion structural
proteins reveals that none of these are genuine canonical EF-hand Ca2+-binding
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moieties due to deviations in flanking sequence structural requirements (HIV gp
41), the length of the loop (13 residues instead of 12 in rotavirus VP7), and the
coordinating residues (V instead of D/E/N/Q/T/S at loop position 5 in
polyomavirus VP1). Thus, the Ca2+-binding motif in the RUB NS protease is the
first to be identified with a canonical EF-hand structure.
Interestingly, the same bioinformatics algorithm that successfully predicted
the Ca2+-binding loop in the RUB NS protease also predicted an EF-hand Ca2+binding motif in nsP1 of alphaviruses (Fig. 5.11A). nsP1 is one of the four
nonstructural proteins produced by alphaviruses and is involved in membrane
binding and has methyl/guanylyl transferase activity. We have grafted this loop
from Sindbis virus (SINV) into the CD2 scaffold and determined its Kd for Tb3+ as
16.4 M (Fig. 5.11B).

We are in the process of creating the corresponding

mutation from the RUBV loop in the SINV loop (E5I/E12I). If we find that this
mutation abrogates Ca2+ binding by the grafted SINV loop, it will be of great
interest to determine if infectivity is affected after we introduce mutations into a
SINV infectious cDNA clone.
Because of difficulty in expressing the entire NS protease, the metalbinding properties of this Ca2+-binding motif were probed by grafting the loop into
the scaffold protein CD2.D1 and by expressing the entire motif within the native
minimal metal-binding domain of the NS protease. Table 1 provides a summary
of the metal-binding affinities of the Ca2+-binding motif in both the engineered
CD2.RUBCa and the minimal metal binding domain, RUBCa. It is worth noting
that numerous studies of EF-hand calcium binding motifs have been made at the
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Figure 5.11. Prediction of a putative EF-hand Ca2+-binding motif in the nsP1 of
alphaviruses. (A), Location of predicted EF-hand Ca2+-binding motifs in rubella
virus and alphaviruses, both of which belong to the Togaviridae family. The EFhand Ca2+-binding motif in alphaviruses
is immediately next to the
methyltransferase domain of nsP1. VEEV, Venezuelan equine encephalitis
virus; WEEV, Western equine encephalitis virus; RRV, Ross River virus; SINV,
Sindbis virus ; SFV, Semliki Forest virus. (B), Grafting the 29-residue helixloop-helix EF-hand motif (red box, inset) from sindbis virus (SINV) to CD2.D1.
The engineered protein binds to Tb3+ with a dissociation constant of 16 μM.
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peptide or subdomain level (361-363). The Ca2+-binding affinity of the RUBCa
loop grafted into CD2 (214 μM) is weaker than the grafted EF loop I from
calmodulin (34 μM) (69), likely due to the presence of an Asp at the bidentate
position 12 of the loop rather than a Glu, which ensures a high Ca2+-binding
affinity due to its larger side chain and stronger interaction with Ca 2+.
Substitution of Glu at position 12 in CaM with Lys or Gln reduces Ca 2+-binding
affinity by 10-100 fold (361,364-366) while the substitution of Asp with Glu at
position 12 in the regulatory light chain of myosin leads to a 15-fold increase in
binding affinity (350). The Ca2+-binding motif

in the RUB NS protease also

exhibits selectivity for Ca2+ and La3+ in the presence of excess Mg2+ and K+,
similar to paired EF-hand Ca2+-motifs in Ca2+-binding proteins such as
calmodulin and troponin C (367).
Table 5.1. The metal-binding affinities of the engineered protein CD2.RUBCa and the
minimal metal-binding domain RUBCa.
Protein
CD2.RUBCa

RUBCa

Metal ions

Dissociation constants (Kd, µM)

a

Tb3+

47 ± 4

b

Ca2+

214 ± 73

c

La3+

14 ± 7

a

Tb3+

3 ±1

d

Ca2+
2+

Zn

316 ± 4
d
e

0.2 ± 0.1
0.8 ± 0.2

Results obtained from Tb3+-FRET assay a, Ca2+ competition assayb, 1D 1H NMR with
La3+ titrationc, metal titration monitored by intrinsic Trp fluorescenced and ANS
fluorescencee.
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Ca2+-Induced Local Conformational Change in the RUB NS Protease
and Its Potential Stabilizing Role. Since the expression and purification of the
entire NS protease was not achieved, conformational studies were done using
the RUBCa subdomain which contained both catalytic residues, the putative Zn2+
binding ligands and the EF-hand Ca2+-binding motif. Boundaries of the RUBCa
subdomain were chosen near unstructured or loop regions according to our
model (Fig. 5.2C) and within this model, the RUBCa subdomain had a wellfolded, globular structure.

We found that the RUBCa subdomain bound

stoichiometric amounts of Ca2+ and underwent metal induced local changes in
conformation. Ca2+ binding to RUBCa resulted in a modest decrease in its
intrinsic Trp fluorescence intensity without emission peak position shift. However,
the addition of Ca2+ did not significantly alter the secondary structure of RUBCa
as revealed by far UV CD. In addition, ANS binding suggested that no
hydrophobic surface was perturbed upon Ca2+ binding. These results indicate
that Ca2+ binding does not lead to a global conformational change of RUBCa. In
the RUB NS protease model structure, the predicted helix-loop-helix EF-hand
Ca2+-binding site is located at the exposed surface on the opposite side of the
active site C1152 and H1273 (Fig. 5.2C), consistent with our finding that Ca2+
binding to RUBCa did not induce global conformational changes. In the model,
the W 1153 residue is 3.5 Å, on average, away from the predicted EF-hand motif.
This proximity could lead to perturbation in the chemical environment around
W1153 upon metal-binding and thus the model is also consistent with our
observation of significant enhancement of Tb3+ fluorescence intensity in RUBCa
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due to Tb3+-FRET (Fig. 5.4A).

Finally, we found that the binding of Ca2+

increased the Tm of RUBCA from 37.7 to 41.8 °C indicating that Ca2+ binding
serves to stabilize the NS protease. Significantly, we found that a replicon with
two mutations in the EF-hand Ca2+ binding loop that abrogate metal binding by
the CD2.RUBCa chimera expressed a protease that was temperature sensitive
at 39oC, confirming this prediction. Such a stabilizing role for Ca2+ has been
observed in non-viral protease, such as subtilisin (368) and thermolysin (369). It
will be of interest to determine if the putative EF hand Ca 2+-binding motif in the
MT domain of the alphaviruses plays a similar stabilizing role.
Role of Ca2+ in the Replication Cycle of Rubella Virus. When the
double Ca2+ binding mutant was introduced into the Robo502 RUB infectious
cDNA clone, titers produced were ~20-fold lower than those produced by wt
Robo502, however during subsequent passaging, the mutant virus titer rose by
over 10-fold and sequencing of isolated virus plaques indicated that this was due
to reversion of the mutants to the wt sequence. In a replicon incapable of cell-tocell spread, the double Ca2+ binding mutant exhibited delayed RNA synthesis.
We finally showed that cleavage of the P200 nonstructural precursor was
impaired at 35 ⁰C and temperature sensitive at 39 ⁰C. While minus strand RNA
synthesis is catalyzed by the uncleaved precursor, the precursor must be
cleaved before plus strand RNA synthesis can occur (370). Thus, an impaired
cleavage is consistent with delayed plus strand RNA synthesis as observed with
the replicon and lower titers as observed with the infectious cDNA clone.
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However, ongoing (though delayed) RNA synthesis would lead to the generation
of revertants as observed with the infectious cDNA clone.
A submillimolar Kd for Ca2+ binding (~200-300 μM) was derived from both
CD2.RUBCa and RUBCa. In the cell, cytosolic Ca2+ concentrations range from
0.1-10 µM while the Ca2+ concentration in endosomes or lysosomes is as high
as 400-600 µM and is maintained in part by the proton gradient across lysosomal
membranes (371,372).

Presumably, in the replication complex the protease

resides on the cytosolic side of the lysosomal membrane, however release of
Ca2+ from the lysosome could result in local Ca2+ concentrations high enough for
binding. For example, in acidifying endosomes the uptake of extracellular Ca2+
(mM) is immediately accompanied by rapid release of Ca 2+ to the cytoplasm and
with an external [Ca2+] of 2 mM, the endocytosed Ca2+ may be sufficient to
increase the total cellular Ca2+ concentration by 2 μM per min (372). It is also
possible that association of the viral replicase proteins with late endosomal or
lysosomal membranes alters the Ca2+ gradient leading to a localized increase in
Ca2+ concentration. Nevertheless, given the weak Ca2+ binding affinity of the
Ca2+ binding loop, the protease is possibly inactive in the cytosol and must be
associated with the late endosomal or lysosomal membrane before encountering
Ca2+ concentration sufficient for binding. Thus, Ca2+ may play a role in regulating
the virus replication cycle by delaying the nonstructural precursor cleavage until it
is associated with late endosomal or lysosomal membranes and thus modulating
the synthesis of plus strand RNA. A similar situation has been shown to be the
case with rotaviruses whose NSP4 glycoprotein mediates an increase in

162
intracellular

Ca2+

concentration

which

modulates

transcriptase

activity
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5.3. Conformational and functional studies on a Zn2+-binding cysteine-rich
domain of RUB NS protease
Viral Zn2+-binding proteins include proteins that interact with nucleic acids
and are important in transcription and/or replication, such as UL52 of HSV-1, a
member of a helicase-primase complex (374), the nucleocapsid of retroviruses
(HIV-1 and murine leukemia virus) (375,376), the V protein of Sendai virus
involved in RNA editing (377), helicases of nidoviruses such as SARS
coronavirus and equine arteritis virus (378,379),and the NS5A replicase
component of hepatitis C virus(HCV) (380-382), and viral proteases, such as the
papain-like cysteine protease 2 of SARS coronavirus (383), nsp1 papain-like
cysteine protease of equine arteritis virus (a nidovirus)(384), the leader protease
of encephalomyocarditis virus (385), and the NS3 protease of HCV (386). Zn2+
has also been to be required in the RUB NS protease (345,346); however, the
binding ligands have yet to be identified.
Structural Zn2+ binding sites are generally coordinated by four cysteines
and histidines as ligands and based on our model structure of the RUB NS
protease, a cluster of cysteine residues (C1167, C1175, C1178, C1225, and C1227)
could potentially form a Zn2+ binding pocket, in which there is no histidine residue
nearby (Fig. 5.12).

We have expressed a subdomain of the NS protease,

RUBCa (aa 1143-1252 of P150), which contains all of the putative cysteine
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Figure 5.12. Cartoon representation of a cysteine-rich domain in RUB NS
protease. (A), Domain assignment of the RUB genome. The protease domain
contains at least one Zn2+-binding site as well as a putative EF-hand Ca2+-binding
motif (blue box). It has been proposed that the residues C1152 and H1273
constitute the catalytic dyad. The minimal metal-binding domain RUBCa (aa
1143 to 1252), encompassing both the Zn 2+- and Ca2+-binding motifs, is
bacterially expressed and used in this study. (B) Secondary structure prediction
of RUBCa and the location of Zn2+- and Ca2+-binding motifs. (C), Model structure
of RUBCa. A cluster of cysteine residues (shown as ball-and-stick) forms a
potential Zn2+-binding pocket. The EF-hand Ca2+-binding motif is shown in blue.
The aromatic residue W 1231 (magenta) situates close to the cysteine-rich region
and serves as a probe for Zn2+-induced conformational changes.
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residues involved in Zn2+ binding plus the EF-hand Ca2+ binding motif (Section
5.2), as a GST fusion protein and found that it could be cleaved and purified,
remained soluble after purification (Fig. 2.1), bound stoichiometric amounts of
Ca2+ and Zn2+, had a relatively well-folded structure, and underwent metal
induced changes in conformation.

Unfortunately, limited solubility of this

subdomain precludes structural analysis by NMR to identify the Zn 2+ binding
ligands. Therefore, the residues involved in Zn2+ binding will be identified by
mutating each cysteine in RUBCa individually to S (C1152, the catalytic site
residue, will be mutated to S as a negative control) and measuring Zn2+ content
by a modified PAR (4-(2-pyridylazo)resorcinol) colorimetric assay (387). The
P200 precursor cleavage in cells transfected with RUBrep-HA/GFP derivative,
replicons expressing a P150 tagged with the HA epitope and its cysteine mutants
will be similarly assayed as described in section 5.2.7.

5.3.1. Determination of Zn2+ contents in RUBCa and its cysteine mutants
In previous studies, C1175, C1178, C1227, H1204 and H1273 have been
assigned as candidate ligands involved in zinc binding on the basis of sitedirected mutagenesis and in vitro
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Zn binding assay (345,346). However, in the

model structure, we found that no histidine was present in close proximity to the
proposed cysteine-rich Zn2+-binding pocket. Hence, we solely focused on the
cysteine residues.
After purifying minidomain RUBCa and its mutants and removing
background metal ions by Chelex 100 resin, we determined the zinc content with

165
a colorimetric assay by using the dye

4-(2-Pyridylazo)resorcinol (PAR). The

protein-bound Zn2+ is released by protease K digestion. The released Zn2+ will
then form a Zn-(PAR)2 complex accompanied by a large increase in extinction
coefficient at 500 nm (Δε = 6.6×104 M-1 cm-1 at pH 7.0) (Fig. 5.13A) . The affinity
of PAR for Zn2+ is high with K1’=4.0×106 M-1 and K2’=5.5×105 M-1 at neutral pH
(387). In the presence of 100 μM PAR, 1-15 μM Zn2+ released from a protein is
converted rapidly (<3ms) and quantitatively to Zn-PAR complex (of which over 98%
of the zinc is in the 1:2 complex) with a ratio of [Zn-(PAR)2] to [Zn2+]free of ~2×104.
Shown in Fig. 5.13B is the zinc to protein molar ratio determined by this method,
with carbonic anhydrase as positive control ([Zn2+]/[P] = 0.88). Except for the WT
RUBCa ([Zn2+]/[P] = 0.69) and the mutant C1167S ([Zn2+]/[P] = 0.67), all the other
cysteine mutants (C1175S, C1178S, C1225S, C1227S, C1167S/C1175S, C1175S/C1178S,
C1167S/C1175S/C1178S, and C1225S/C1227S) showed significantly lower metal to
protein ratio ([Zn2+]/[P] = 0.08~0.29). With all of the five cysteine residues
substituted with serines (C5 mutant), the protein fails to bind zinc ions. Thus, it
seems that C1167 is not directly involved in the coordination of zinc ions in the
binding pocket.

5.3.2. Zn2+-induced conformational changes
RUBCa contains three Trp residues and according to the model of the
structure of the RUB NS protease (Fig. 5.12C), one of these aromatic residues,
W1231, is in close proximity to the proposed Zn2+-binding pocket. Aromatic residue
is highly sensitive to local or global conformational changes and this feature has
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Figure 5.13. Determination of protein-bound Zn2+ content by PAR assay. (A),
A PAR colorimetric assay is used to determine the Zn 2+ content in proteins.
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been utilized to probe Zn2+-induced structural changes. As shown in Fig. 5.14A,
the emission maximum of RUBCa blue-shifted from 339 nm to 336 nm with
concomitant increase of fluorescence intensity by at least 15%, indicating that the
aromatic residue W 1231 is surrounded by a more hydrophobic environment. By
monitoring this intensity change, a dissociation constant of 0.2 ± 0.1 μM for Zn2+
was obtained by assuming 1:1 binding (inset, Fig. 5.14A).
Zn2+-induced conformational change was further confirmed by ANS
fluorescence. The anionic amphiphilic ANS is often used as a hydrophobic probe
to examine the conformational properties of proteins. As shown in Fig. 5.13B,
upon the addition of RUBCa, the emission peak of ANS fluorescence blue-shifted
from 510 nm to 500 nm and the intensity increased by ~30%, suggesting that
some of the hydrophobic regions of the purified RUBCa were exposed to the
solvent and thus accessible to ANS. The addition of excessive amounts of Zn2+
caused redshift (by 2 nm) and ~10% decrease of the fluorescence intensity (Fig.
5.13B). This result suggests that the binding of Zn2+ leads to conformational
changes and the subsequent shielding of some hydrophobic regions from the
solvent in RUBCa. A dissociation constant of 0.8 ± 0.2 μM was obtained by
monitoring the ANS fluorescence intensity change as a function of Zn 2+
concentration (Inset, Fig. 5.14B). Taken together, these data implied that the
binding of Zn2+ induced significant conformational changes by rearrangement of
some hydrophobic regions.
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5.3.3. Effects of Cys-to-Ser mutations on protease cleavage
We further introduced the individual or combined cysteine to serine
mutation(s) into a RUBrep-HA/GFP replicon expressing HA-tagged P150 to
assay the P200 cleavage in Vero cells. These experiments were done at 6 hrs
post-transfection, when translation from the input transcripts is detectable but
replication has not yet started. As shown in Fig. 5.15, at 35 ⁰C P200 to P150
cleavage was efficient in wt RUBrep-HA transfected cells, as well as in RUBrepHA/GFP-C1167S transfected cells. Vero cells transfected with RUBrep-HA/GFP
constructs with single cysteine to serine mutations at residue 1175, 1178, 1225,
1227, similar to the construct with a C1152S substitution at the catalytic site that
served as an uncleaved control, were unable to undertake cleavage. In addition,
cleavage in Vero cells transfected RUBrep-HA/GFP constructs of multiple
cysteine to serine mutations (C1167S/C1178S, C1175S/C1178S, C1167S/C1175S/C1178S,
C1225S/C1227S, and the mutant C5S with all five cysteines mutated to serines) was
abolished (Fig. 5.15). This finding is largely consistent with our previous in vitro
co-transcription-translation assay, which demonstrated that single mutations of
C1175, C1178, C1227 could result in the loss of protease activity. However, in the in
vivo assay, C1167 was able to cleave the P200 precursor and C1225 was unable to
undertake the P200 precursor cleavage, which is exactly opposite to the
observations in the in vitro assay. This discrepancy would likely arise from the
difference in reaction conditions. Specifically, in vitro assay is carried out under
aerobic, non-reducing conditions that may not truly reflect the reducing
environment of cell-based assays. Given the high number of cysteines, a
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Figure 5.15. Effect of mutations of cysteines on P200 precursor cleavage. Vero
cells were transfected with transcripts from WT RUBrep/GFP or RUBrep/GFP
mutants containing single or multiple cysteine-to-serine substitutions. Six hours
posttransfection, cells were lysed and the P200 precursor and P150 product
were resolved by Western blotting probed with anti-HA antibodies following
SDS-PAGE (the other product, P90, does not appear because it does not
contain the HA epitope). Cells transfected with a replicon containing a C 1152S*
catalytic site mutation that cannot mediate P200 cleavage served as uncleaved
control. C3S: C1167/1175/1178S; C5S: C1167/1175/1178/1225/1227S.
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reducing environment is more favorable for Zn2+-binding and protein folding by
preventing formation of mismatched disulfide bonds. Given those, the in vivo
assay carried out in Vero cells would be more reliable and closer to the true
situation occurring in the cells.

5.3.4. Secondary and tertiary structure of RUBCa and its mutants
For site-directed mutagenesis studies, caution has to be taken for the
interpretation of the observed results, since there are always concerns regarding
whether single or multiple cysteine-to-serine mutations would disrupt the integrity
of the protein structure, and thus leading to loss of its function. To clarify this
point, we compared the secondary and tertiary structure of the minidomain
RUBCa and its cysteine mutants. As shown in Fig. 5.16, no significant difference
were detected among the far UV CD spectra and intrinsic Trp fluorescence
spectra of RUBCa and its mutants, C3S and C1225S/C1227S, suggesting the
structural integrity was retained after mutagenesis. Thus, it can be concluded that
the loss of proteolytic activity in the cysteine-to-serine mutants is due to its
compromised Zn2+ binding capability.

5.3.5. A possible iron-containing domain in RUBCa
During the expression and purification of the minidomain RUBCa, we
observed a striking brown color for the protein solution. A typical UV/Vis
spectrum of the purified RUBCa is shown in Fig. 5.16A. In addition to the main
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Figure 5.16. Far UV CD (A) and Trp fluorescence (B) spectra of 2 μM RUBCa
(○)and its mutants containing triple (C1167S/C1175S/C1178S, □) and double
(C1225/C1227S, ◊) cysteine mutations.
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peak at 280 nm, two additional peaks that are typical of iron-sulfur clusters, one
at 325 nm and the other at 420 nm, were recorded. In addition, the Fe to protein
ratios for GST-RUBCa (n=1) and RUBCa (n=1) determined by ICP emission
spectrometer were 0.05:1 and 0.18:1, respectively (Fig. 5.17). It is evident that
the bacteria-expressed minidomain contains Fe. The iron is so tightly bound to
the protein that it could not be chelated by EGTA, EDTA or citrate (Fig. 5.17A).
However, the addition of a strong reducing agent, sodium dithionite (Eo': ~−420
mV at pH 7), resulted in the decrease of absorbance at 420 nm (Fig. 5.17B),
suggesting the degradation of the iron-sulfur cluster. To narrow down the
cysteines that are involved in the formation of the FeS cluster, we further
examined the absorbance spectra of RUBCa Cys-to-Ser mutants. As shown in
Fig. 5.17C, the absorbance peak at 420 nm disappeared after substituting all of
the five cysteines with serines (C5S mutant). However, both the triple mutant
C1167/1175/1178S and the double mutant C1225/1227S retained a peak at 420 nm.
Given our findings at Sections 5.3.1-5.3.3, it seems that both Zn2+ and Fe2+ (or
Fe3+) ions are sharing or competing some of the cysteine ligands. In the future,
we will further map the exact ligands and further characterize the FeS cluster by
using Mössbauer spectroscopy and/or electron paramagnetic resonance
spectroscopy.
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D

Figure 5.17. Absorbance spectra and metal content of RUBCa. (A) UV/vis
spectrum of RUBCa (20 μM) with different chelators in 10 mM Tris-HCl at pH
7.5. (B) Gradual addition of 0.1 mg dithionite to the protein sample leads to
decrease of absorbance signals. (C) UV/Vis spectrum of RUBCa Cys-to-Ser
mutations. C3S, C1167/1175/1178S; C5S, C1167/1175/1178/1225/1227S. (D) Metal content
of GST, GST-RUBCa, and RUBCa determined by ICP emission spectrometry.
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5.3.6. Summary
In conclusion, site-directed mutagenesis studies carried out on the
bacterially-expressed minidomain RUBCa and the RUB replicon constructs have
defined an atypical CxxC(x)48CxC type of Zn2+ binding motif. The coordination of
Zn2+ by C1175, C1178, C1225, and C1227, with an affinity comparable to intracellular
Zn2+ level, is required for the proteolytic activity of the protease domain in P150.
The presence of Fe ions in the bacteria-expressed minidomain raises the
possibility that the protease domain could also be involved in the redox reactions.
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6. Prediction and identification of calmodulin binding sites
in gap junction protein connexins

6.1. Calmodulin as intracellular Ca2+ sensor
Ca2+, an important second messenger in eukaryotic cells, is regarded as a
“signal for life and death” (3,388). Temporal and spatial changes of the Ca2+
concentration in different compartments of cells affect the regulation of cellular
signaling, by modulating the activity of numerous Ca2+-binding proteins. Among
them, CaM is one of the most crucial players and is extensively studied due to its
ubiquitous expression in eukaryotes and its versatile ability to activate or inhibit
more than 100 functional enzymes, cellular receptors and ion channels
(14,53,56,389-394).
CaM is a small (148 amino acids; MW: 16.7 KDa) and acidic (pI: ~4.0) EFhand Ca2+-binding protein first identified in the brain and heart as cyclic
nucleotide phosphodiesterase activator protein (PAF) in the early 1960’s (48).
CaM consists of two globular and autonomous domains, each of which contains
two helix-loop-helix EF-hand motifs. Through its reversible or irreversible binding
to Ca2+, the resultant conformational changes and the interaction with target
proteins, CaM is capable of transducing the intracellular Ca2+ signal changes into
a myriad of divergent cellular events, such as cell proliferation, cell differentiation
and apoptosis (3).
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6.1.1 Binding of metal ions to CaM: affinity, cooperativity and specificity

Calcium binding affinities and cooperativity
The coordination of Ca2+ in EF-hand motifs is achieved by adopting a
pentagonal bipyramidal geometry with seven oxygen atoms from the sidechain
carboxyl or hydroxyl groups (loop sequence positions 1, 3, 5, 12), the main chain
carbonyls (position 7), and a bridged water (position 9). The Glu at position 12
serves as a bidentate ligand for the Ca2+ ion (Fig. 2A). In the coordination sphere,
liagnds at position 1 and 9 (bridged water) constitute the X axis; liagnds at
position 3 and 7 form the Y axis, whereas ligands at position 5 and 12 are located
along the Z axis (Fig. 1.3). Position 6 of the 12-residue EF-loop is always
occupied by a glycine and position 8 is highly reserved as a hydrophobic residue.
Residues at position 7-9 form an antiparallel β-sheet that is involved in the paring
of two adjacent EF-hands. The exiting helix begins at position 10.
More than 50 mutations within the EF-hand loops have been made to
study the key determinants of metal-binding affinities (361). The bidentate ligand
at position 12 is least tolerant of mutations. An X-ray crystallographic structure
that captures the conformational intermediate of CaM has been determined by
locking the N-terminal domain in a “closed” state with a disulfide bond between
residues 41 and 75. In this structure, the bidendate Glu residue within the Cterminal domains are about 6-7 Å farther away from its normal position to
coordinate Ca2+. The movement of Glu to a position 2.5 Å from the Ca 2+ is
required to couple the chelation of Ca2+ and the conformational change by
moving the exiting helix (395). Mutations of coordinating ligands, in general, lead
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to significant decreases in Ca2+-binding affinity or less selectivity towards other
metal ions with similar ionic radii. Based on studies of a series of mutants on site
III of CaM where additional acidic residues are introduced on either the X or Z
axis, Reid et al has proposed an “acid-pair” hypothesis to correlate the type of
chelating residues with calcium affinity (396,397). According to this hypothesis, a
higher Ca2+-binding affinity could be expected if the chelating ligands at X or Z
axis were paired by acidic residues. This simplified model could be used as a
guideline to predict Ca2+-binding affinity, while excluding the contribution of
nonchelating residues and cooperativity. The nonchelating residue at position 8
has been reported to play an important role in the maintenance of stability of
CaM. Browne et al reported that the substitution of the highly-conserved
hydrophobic residue at position 8 by Gly results in the destabilization of CaM
under both Ca2+-free and Ca2+-loaded states (398). These findings underscore
the importance of the antiparallel β-sheet that structurally links the neighboring
paired EF-hand Ca2+-binding sites. The conserved hydrophobic residue at
position 8 has been regarded as part of the “EF-hand β-scaffold” (395). In paired
Ca2+-binding sites, the bonding network forms a stable resonance structure that
involves the hydrogen bonding between residues at position 8, and the
interaction of the bound Ca2+ with the oxygen atoms from the main-chain
carbonyl at position 7 (Figs. 6.1A and B). Based on this particular structural
feature, an “EF-hand β-scaffold” model has been proposed by Grabarek to
explicitly explain the Ca2+-binding process in the EF-loop with two steps
(395,399). First, the position of Ca2+ is defined by the EF β-scaffold and the N-
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terminal part of the Ca2+-coordinating ligands. Subsequently, the C-terminal
bidentate ligand Glu in the EF-loop approaches the immobilized Ca2+ with
concomitant movement of the exiting F helix to complete the Ca 2+ coordination
(399).
The binding of Ca2+ to CaM exhibits a positive cooperativity with a Hill
coefficient of 1.8-2.5. Ca2+ binds to CaM in a sequential order: the C-terminal
domain (sites III and IV) is firstly occupied by two Ca2+ ions with an affinity about
10-7 M, followed by the binding of two additional Ca2+ ions to the “low-affinity” Nterminal domain (sites I and II) with the affinity around 10 -6. The rates of Ca2+
association to these Ca2+ binding sites range from 106 to 108 M-1S-1, whereas the
rates of Ca2+ dissociation is on the order of 10 to 103 S-1. The 10-fold difference
in the Ca2+-binding affinities between two domains, as well as the cooperative
binding of Ca2+ to each pair of sites, enables CaM to efficiently sense the narrow
range of cellular calcium concentration at rest and excited conditions, and thus
switching on/off Ca2+ signaling cascades by reversible interaction with target
proteins. The interaction of CaM with target proteins has been reported to
enhance Ca2+-binding affinities by 10-1000 fold (400,401) due to slower off-rates.
The free energy change (G) of Ca2+ binding to two coupled EF-hand motifs and
the accompanying Ca2+-induced conformational changes are governed by the
following equations:

GG1 G2 Gco o pGco n f
Gcoop  Gconf  RT ln



K macro 1K macro 2
K mi cro1K mi cro 2

where G1 and G2 are the intrinsic energy changes of each 1:1 metal-ligand
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binding process, Gcoop and Gconf are the energy contribution from cooperativity
between the two metal binding sites and the metal-induce conformational
changes, respectively. Four site specific binding constants (microscopic), K I, KII,
KI,II and KII,I, are used to describe the corresponding binding steps (Fig. 6.2). To
determine the cooperativity of two-coupled sites, either the ratio of KII/ KI plus two
macroscopic association constants K1 and K2, or three of the four microscopic
binding constants are required to be determined. Tremendous efforts have been
made to estimate the cooperativity of Ca2+ binding to CaM by using peptide
models (362,367), enzymatic fragmentation (363,402,403) and a novel grafting
approach (1,2,57,361). According to calculations on the basis of the grafting
system, we are able to conclude that the energy contribution of cooperativity and
conformational change from the C-terminal domain is 40% greater than that from
the N-terminal domain, which could be one of the mechanisms underlying the
observed high-affinity Ca2+-binding sites at C-terminal domain (1).
Taken together, these studies reveal that the number and type (main chain
or side chain) of ligands, the total ligand charge, the nonchelating residues and
the Ca2+-induced conformational changes are closely related to the Ca2+ binding
affinity (367). No clear-cut and conclusive rules can thus far be derived,
suggesting additional complexity to Ca2+ binding affinity beyond currently
evaluated empirical determinants. Therefore, a comprehensive charge-ligandbalanced model emphasizing the accumulative effects of all these factors is more
scientifically valid to explain the variation in Ca2+ binding affinities.
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Figure 6.2. Schematic diagram of Ca2+ binding to two coupled EF-hand motifs
and binding energetics. G is the free energy change of calcium binding to
two coupled EF-hand motifs. G1 and G2 are the intrinsic energy changes of
each 1:1 metal-ligand binding process, Gcoop and Gconf are the energy
contribution from cooperativity between the two metal binding sites and the
metal-induce conformational changes, respectively. Four site specific binding
constants (microscopic), KI, KII, KI,II and KII,I, are used to describe the
corresponding binding steps.
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Metal binding selectivity
In addition to Ca2+, other metal ions, particularly those sharing similar
coordination chemistry or having similar ionic radii as Ca2+ (0.99 Å), are capable
of binding to CaM with varying binding affinities. Lanthanides (Ln3+), such as Tb3+,
La3+ and Eu3+, have similar ionic radii and coordination geometry as Ca 2+.
However, they first bind to the N-terminal domain with stronger affinities (Kd: 6-12
nM) and then to the C-terminal domain with lower affinities (Kd: 2-3 M),
contradictory to the order of Ca2+ binding dissociation constants. However, this
discrepancy is not observed in the binding constants obtained using the grafting
approach (1). The site-specific binding affinities for both Ca2+ and Ln3+ decrease
in the same order: I>III~II>IV. Since the grafting approach eliminates the energy
contribution from conformational changes and cooperativity, it is highly possible
that the eliminated factors could account for the different stepwise binding modes
between Ca2+ and Ln3+.
To specifically respond to the altered [Ca2+]c, it is crucial for CaM to
discriminate Ca2+ from the overwhelmingly abundant Mg2+ (10-3 M) and
monovalent ions (10-1 M) within the cytoplasm. With excessive concentrations of
monovalent ions, the Ca2+-binding affinities of CaM decrease over 50 fold due to
the screening of electrostatic interactions. To achieve metal selectivity, the Ca2+binding sites in CaM evolved to adopt a pentagonal bipyramidal geometry that is
optimized to favor the size and charge of Ca2+ over other metals, such as Mg2+
(0.66 Å) and K+ (1.33 Å) (367,404). Mg2+, a group IIA metal ion above the Ca2+ in
the periodic table, binds to CaM at the same sites as Ca2+ with the dissociation
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constants ranging from 10-2 to 10-4 M, which is ~1,000-10,000-fold weaker than
the binding constants of Ca2+. Although the intracellular Mg2+ concentration is in
the mM range, previous studies have shown that such weak binding will not
cause significant effects on the cooperative binding of Ca2+ to CaM. However, the
interaction of CaM with some of its target peptides or proteins will be affected.
For example, with the concentration of Mg2+ increased from 0 to 100 mM, the
binding affinity of Ca2+-CaM to its target peptide derived from MLCK is lowered
by almost 40 folds (405). In view of this, the binding affinities of CaM-target
complex obtained under low salt conditions need to be reevaluated with the
presence of physiological amounts of Mg2+ (406). Furthermore, studies on the
Ca2+-binding affinity of the low-affinity N-terminal domain (TR1C) reveals that
Mg2+ can occupy almost half of the binding sites under physiological condition
without triggering a major structural rearrangement (407,408).

6.1.2. Structure of CaM: conformational plasticity and structural malleability
The first structure of CaM was determined in 1985 by Babu et al. Since
then, at least 90 structures of CaM and CaM-target complexes under Ca2+-free or
Ca2+ loaded conditions have been determined by using X-ray crystallography or
NMR, which makes a thorough discussion of these structures beyond our scope.
However, scrutinization of some of the landmark works conducted by Bax’s,
Ikura’s, Brunger’s and Forsen’s groups are sufficient enough to reveal the key
features of CaM and illustrate the striking difference between apo-CaM and Ca2+CaM (363,409-411).
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Attempts to grow crystals of apo-CaM suitable for X-ray crystallography
have proven to be fruitless. The available structures were determined by
multidimensional NMR techniques in 1995. In the absence of Ca 2+, CaM consists
of two sets of compactly packed, twisted, four-helix bundles, one at the Nterminus (helices I-IV) and the other at the C-terminus (helices V-VIII), which are
capped by a short anti-parallel β-sheet. The central helical region connecting the
two domains is interrupted by S81 and is slightly bent. The C-terminal domain
turns out to be less stable than the N-terminal domain as indicated by the much
faster backbone amide hydrogen exchange rate (410). It has been shown that
the helices in apo-CaM are more mobile and less stable, which could explain the
observed reduction in helical content, compared Ca2+-CaM, as revealed by
circular dichroism studies. Upon binding of Ca2+, CaM undergoes drastic
conformational changes and adopts a “dumbbell” shape: two autonomous
globular domains are tethered by a flexible linker (residues 77-80). The most
striking structural change is the rearrangement of helices in each domain and the
increased solvent exposure of hydrophobic surface. The original anti-paralleled
helices in each EF-hand motifs become nearly perpendicular to each other by
undergoing remarkable reorientation (Fig. 6.3). The exposed area of hydrophobic
patches to the solvent is estimated to be 10 X 12.5 Å in both the N- and Cterminal domains (409). Therefore, CaM transits from a compact “closed” state to
a more relaxed “open” state, poising itself to interact with numerous target
proteins (Fig. 6.3A). Comparison of the X-ray crystal structure and NMR structure
of Ca2+-CaM indicates that the N-terminal domain in solution is much less
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opened than in crystalline, where a fifth Ca2+ has been reported to bridge the
electrostatic interaction between Glu47 and Asp58 (411). According to the energy
balance mechanism proposed by Chazin et al, a Ca2+-induced open
conformation is more favored because more energy is required to accommodate
Ca2+ ions in the close conformation (412). A more quantitative expression of
these changes is reflected by the alteration in the interhelical angles and
distances (Table 6.1). The interhelical angles within each EF-hand decrease by
40° and the interhelical distances increases by 4 Å, on average, by addition of
Ca2+ to apo-CaM.
Another unique feature of CaM is the unusual abundance of methionines
(9/148, 6%) in the primary sequence. Methionine has flexible and relatively polar
side chain that results in strong van der Waals interactions. Both domains contain
four methionines (M36, M51, M71, M72 for the N-terminal domain and M109, M124,
M144 and M145 for the C-terminal domain) that are situated at the gate of the
hydrophobic cores and contribute as much as ~50% of the total hydrophobic
surface area (Fig. 6.3B). The binding of Ca2+ to apo-CaM increases the solvent
accessible areas of methionines by 30 fold at the N-terminal domain. The solvent
accessible areas of M109 and M45 at the C-terminal undergo 45-fold and 5-fold
increases, respectively. The importance of the methionine in the broad spectrum
of target recognition has long been realized. Substitution of M by L or Q within
the hydrophobic core significantly impairs CaM’s capability to activate or
deactivate its target proteins, such as phosphodiesterase (413) and the RyR1
(414). Nevertheless, substitution of 8 methionines with unnatural sulfur-free
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homolog of methionine, norleucine, neither significantly changes the structure of
CaM, nor leads to considerable loss of its ability to activate MLCK (415). The role
of methionines in stabilizing the open conformation is further corroborated by
Nelson and Chazin’s less biased, interaction-based studies on the Ca2+-induced
conformational change in CaM by using distance difference matrices and by
analyzing the interresidue contacts (416).

Table 6.1. The interhelical angle and distance in apo-CaM and Ca2+-CaM.
helix pair

Interhelical angle (°)
Apo-CaM

Ca2+-CaM

Interhelical distanceb (Å)
Apo-CaM

Ca2+-CaM

138a/128b

90c/86d

12.3

18.5

III/IV

130/130

86/86

12.3

16.2

II/III

126/130

111/113

11.2

11.3

I/IV

127/121

110/108

10.7

10.7

V/VI

131/137

102/101

11.9

15.1

VII/VIII

133/132

89/94

12.3

14.4

VI/VII

141/144

110/112

11.8

11.0

V/VIII

142/144

119/116

11.2

10.3

I/II

PDB codes: a. 1cfc (410); b. 1dmo (409); c.1cll (417); d: 3cln (418).

6.1.3. Target recognition of CaM: diversity and recurrence
Although it has been known from almost four decades that numerous
proteins can interact with CaM, it was not until 1992 that the first structure of
CaM with a 26-residue target peptide derived from the skeletal myosin light chain
kinase (MLCK) was solved (419,420). This landmark work has unveiled several
key features responsible for the interaction of CaM with its target proteins and
has enabled the prediction of the CaM target sequences. This pioneering work
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A

Ca

Apo-CaM (1cfc)

Ca2+-CaM (3cln)

Ca2+-CaM-sMLCK (1cdl)

B

Figure 6.3. The Ca2+-induced conformational change and binding of a target
peptide from chicken smooth muscle myosin light chain kinase to Ca2+-CaM.
(A), The apo-CaM is comprised of two four-helix bundles linked by an
interrupted central helical region. The binding of Ca 2+ induces considerable
changes in the interhelical angles and results in the exposure of a number of
hydrophobic residues to the solvent. This exposed hydrophobic area is
responsible for the interaction of CaM with its target proteins or peptides, such
as the chicken smooth muscle light chain kinase (smMLCK). (B), Space-filling
representation of distribution of hydrophobic residues (green) and methionine
(orange) residue in Ca2+-free and Ca2+-ligated CaM. The binding of Ca2+
induced a conformational change to expose the hydrophobic residues toward
the solvent, enabling its broad interaction with targets.
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has thus far spurred the determination of more than 30 structures of CaM-target
complexes and new modes of interaction have been discovered in recent years
(see Table 6.2). At least three modes of CaM-target interaction have thus far
been characterized.

The embracing mode
The embracing mode or “wrap-around” mode is well characterized as
exemplified by the Ca2+-CaM-sMLCK complex (419,420). Upon binding to CaM,
the peptide with 1-8-14 spacing pattern of bulky hydrophobic residues and
interspersed basic residues adopts an -helical structure and is engulfed into the
hydrophobic cleft of Ca2+-CaM. The hydrophobic interaction is the main force
driving the interaction of Ca2+-CaM with its targets, whereas the electrostatic
interactions between the positively charged residues of the peptide and the
negatively charged clusters in both N- and C-terminal domains of CaM also
contribute considerably to the interaction. The hydrophobic interaction is
maximized by the unwinding of the central helix, which subsequently bends by
~100 and undergoes a ~120 rotation (Fig. 6.3A). As opposed to the dumbbell
shape of Ca2+-CaM, the CaM-target complex is globular with the N- and Cterminal domains coming close. The originally unstructured peptide binds to CaM
in an antiparallel orientation such that the C-terminal domain of CaM contacts
with the hydrophobic residue at position 1 of the peptide, whereas the N-terminal
domain interacts with residues at positions 14. A similar binding mode has also
been seen in Ca2+-CaM-CaMKII complex with 1-5-10 anchoring spacing and
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Table 6.2. List of CaM-target complexes deposited in protein data bank.
Pdb code
(resolution, Å)
1A29 (2.7)

Target
(length, aa)

Mode

Trifluoperazine

1

Anchor
spacing

CaM:Target
ratio and No. of
bound Ca2+

others

1:2, 4Ca2+

Technique
X-ray

Year

1LIN (2.0)

1:4, 4Ca

2+

1998
1996

1CTR (2.5)

1:2, 4Ca2+

1998

1CDL (2.4)

smMLCK (20)

2+

X-ray

1992

2BBM

skMLCK(26)

1CDM (2.0)

CaMKIIalpha (18)

1

1-8-14

1:1, 4Ca

NMR

1992

1

1-5-10

1:1, 4Ca2+

X-ray

1994

2+

2BDW (1.8)

AID of CaMKII

1

1-5-10

1:1, 4Ca

X-ray

2005

1CFF

Ca2+-pump (20)

2

1-8

1:1, 4Ca2+

NMR

1999

2+

NMR

1999

1CKK

CaMKK (26)

1

1-16

1:1, 4Ca

2:2, 2Ca2+(N)

1IQ5 (1.8)

(24)

1G4Y (1.6)

SK2 channel (81)

3

1-8-14

X-ray

MARCKS (18)

1

1-5-10

1:1, 4Ca2+

X-ray

2003

1-8-14

2+

X-ray

2002

1QX5
1IWQ (2.0)
1K90 (2.8)

X-ray

apo-CaM

1K93 (3.0)

anthrax edema
factor (485)
(485)

1LVC (3.6)

(485)

2

1:1, 2Ca (C)

2001
2004

2002
2002

1XFZ (3.3)

(735)

1L7Z (2.3)

1

others

1:1, 4Ca2+

1MUX

myristolylated
CAP-23/NAP-22
(6)
W7

2005

1

others

1MXE (1.7)

CaMKI (25)

1

1-5-10

X-ray

2003

1:1, 4Ca2+

NMR

1998

1:1, 4Ca2+

X-ray

1998

2+

1NIW (2.1)

NOS (19)

1

1-5-8-14

1:1, 4Ca

X-ray

2003

1NWD

GAD (28)

1

others

1:2, 4Ca2+

NMR

2003

2+

X-ray

2000

X-ray

1QIV (2.6)

DPD

1

others

1:2, 4Ca

rs20 (19)

1

1-8-14

1:1, 4Ca2+

1QIW (2.3)
1QS7 (1.8)

2000

1QTX (1.7)

(21)

1VRK (1.9)

(21)

1SY9
1WRZ (2.0)
1YR5 (1.7)
1XA5
2F2O (2.2)
2F2P (2.6)
2F3Y (1.5)
2F3Z (1.6)
2FOT (2.5)

2003
2003
1999

olfactory CNG
channel (19)
DAP kinase (19)

2+

NMR

2005

X-ray

2006

1

1-8-14

1:1, 4Ca

1

1-8-14

1:1, 4Ca2+

1

others

1:1, 4Ca

2+

X-ray

2004

1

1-5-8-14

2:2, 4Ca2+

X-ray

2006

CaV1.2 channel
(18)
(18)

1

IQ

1:1, 4Ca2+

X-ray

alphaII-spectrin
(23)

1

others

1:1, 4Ca2+

X-ray

(19)
KAR-2 (bis-indol
alkaloid)
calcineurin (25)

2006

(25)

2006
2005
2005
2006

191
Ca2+-CaM-CaMKK complex (421) with 1-16 spacing pattern (Table 6.2). Due to
the spacing variation of anchoring residues, more unwinding of the central linker
region in Ca2+-CaM-CaMKII is observed, further demonstrating the structural
malleability of CaM. From the perspective of function, this mode of interaction
enables CaM to displace the targeted “autoinhibitory domain” from the active site
and activate the enzyme.

The tethering mode
The second mode of interaction has been seen in the CaM-Ca2+ pump
complex (422). Instead of the normal spacing of 1-8-14, certain isoforms of Ca2+pump lack the bulky hydrophobic residue at position 14 (Table 6.2). As a result,
the fragment (C20W) corresponding to the CaM binding site at the N-terminal of
Ca2+ pump binds solely to the C-terminus of CaM and no contact between the
two domains is observed. Here we use the term “tethering” to describe the
binding mode since the peptide physically adheres loosely to one of the two
lobes and is more exposed to the solvent than the MLCK embraced by CaM. In
contrast to the collapsed globular shape of CaM-MLCK complex, CaM-Ca2+
pump complex remains a unique relatively extended form.
A more close-to-reality CaM-target complex structure is determined with
the full sequence of anthrax edema factor (EF) (423). Though the anchoring of
the CaM-binding site of EF follows the 1-8-14 spacing pattern, the extended
structure of this complex does not resemble the collapsed structure typically
observed in the binding mode 1. The N- and C-terminal domains of CaM in the
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complex represent strikingly distinct states. The N-terminal domain remains in a
close conformation without the binding of Ca2+ and interacts with the EF catalytic
domain. In contrast, the C-terminal domain is open and binds two Ca2+. The
constitutive binding of CaM to the “low affinity” N-terminal domain is speculated
to stabilize EF, making it more resistant to enzymatic cleavage. Meanwhile, the
sole binding of two Ca2+ to the C-terminal domain suggests that EF may sense
the changes of cellular [Ca2+] ahead of host CaM-activated enzymes. Overall, the
enzymatic activity of EF has been enhanced by over 100 folds with the binding of
CaM through remodeling of the active site.
Extensive biochemical and biophysical studies have revealed that CaM
under Ca2+-free condition can interact with a number of targets, such as myosin
and neuromodulin that possess characteristic “IQ” motifs (424). Given the wellhidden hydrophobic core in apo-CaM, it is less likely for the interaction of apoCaM with its targets to adopt an embracing mode that requires a large area of
hydrophobic interaction. From the observation of the interaction between apoCaM and the neuromodulin peptide, it has been suggested that the binding of
peptide causes significantly fewer chemical shift changes in the N-terminal
domain than in the C-terminal domain, which could be indicative of binding of the
peptide to the C-lobe of CaM. In view of this, it is highly possible that the apoCaM-target interaction will follow a similar binding mode as that of the CaM-Ca2+
pump complex. High-resolution structures featuring the interaction of apo-CaM
with IQ motifs are needed to elucidate the true binding mode.

193
The oligomerizing mode
CaM-induced oligmerization has been best exemplified by the interaction
of CaM with the small conductance K+ (SK) channel (425) and the glutamate
decarboxylase (GAD) fragment (426). CaM is constitutively associated with SK
channel through its Ca2+-free C-terminal domain. The binding of Ca2+ to its “low
affinity” N-terminus initiates the dimerization of SK channel and ends up forming
a 2:2 complex. Given the fact that the half-maximal activation of SK channel
requires a [Ca2+]i if ~5X10-7, it is intriguing to ask why the sensing of Ca2+ is
carried out by CaM’s low affinity (10-6 M) domain instead of its C-terminal high
affinity Ca2+-binding sites (10-7 M). CaM-induced dimerization is also observed in
its interaction with glutamate decarboxylase with the formation of 1:2 ([CaM]/[GA])
complex. The dimerized peptide, in this structure, is still embraced by Ca2+-CaM.

6.1.4. Prediction and screening of potential CaM target sequences
With the vast amount of genomic information available, new CaM-binding
sequences are reported each year. This raises the question as to whether the
current known CaM-binding motifs are just the “tip of the iceberg”, or if we are
closer to a final appreciation of the CaM-target interaction network. Development
of fast and reliable strategies to predict and validate potential CaM-binding site
would undoubtedly be of great help to visualize the macroscopic picture.
Though low sequence identity has been observed among different target
sequences, all the target peptides (18mer to 26mer) share some key features:
the hydrophobic residues with bulky sidechains that anchor the target sequence
to the hydrophobic cleft of CaM are arranged in particular spacing patterns with
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2-6 positively charged residues interspersed in between. According to the
distribution of anchoring residues in the continuous polypeptide sequence, the
binding motifs can be divided into five classes: 1-5-10 class, 1-8-14 class, 1-16
class, IQ class and others . Among them, the first three classes have been found
to interact with CaM in a Ca2+-dependent way in most cases. The IQ class motifs,
however, are activated or inhibited by CaM in a Ca2+-independent fashion and
CaM seems to be a constitutive part of its functional unit. In addition, there are
several unclassified CaM binding motifs that interact with CaM when the four
Ca2+-binding sites are only half occupied. All of these common features enable
scientists to gain more confidence when confronted by the following two
questions: 1) Are the proteins under investigation capable of interacting with CaM,
and if so, 2) is it Ca2+-dependent or independent? An online server that is
conveniently accessible for scientists to predict calmodulin binding sites has
been generated by Ikura et al (90). Nevertheless, pure in silico work could only
serves as guidance for the research direction and always brings about
researchers’ concerns on its accuracy and accountability. Therefore, several
groups have worked to develop robust methods to screen CaM-binding proteins
(CaMBPs) on the proteome-wide scale.
A CaM binding overlay (CAMBOT) technique that requires labeling of
CaM with

35

S and the use of SDS-PAGE was established by O’Day et al (427). In

this technique, the bacteria-expressed

35

S-CaM was used as the probe to detect

CaMBPs and compare the CaMBPs expression level under different conditions.
Under Ca2+-saturated and Ca2+-free conditions, it is possible, in theory, to detect
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both Ca2+-dependent and Ca2+-independent CaMBPs. This method can be
potentially applied to verify and profile the CaMBPs, to assess the effects of
drugs on CaM-CaMBP networks, and to evaluate the effects of heavy metal ion
present in the environment on the CaM-CaMBP network. However, this method
requires the handling of radioactive products and involves relatively laborintensive and time-consuming procedures. In addition, the amount of proteins
encoded by rare genes is far from sufficient to be detected by SDS-PAGE. An
alternate way to screen CaMBP is explored by Shen et al (428-430). This largescale screening method utilizes the mRNA display technique. mRNA-displayed
enriched proteome library can be selected by biotinylated CaM, which will be
further captured by streptavidin-agarose beads. Another round of selection
involving six steps (PCR, in vitro transcription, crosslinking, cell-free translation
and fusion, reverse transcription and affinity chromatography) can be repeated to
diminish unspecific interactions. Screening of CaMBPs in the human proteome
with this method reveals a large body of previous undetected proteins, such as
ribosomal proteins, proteasome 26S subunits, deubiquitinating enzymes, and
leucine zipper proteins.
The above-mentioned recurring binding modes underlying the interaction
of CaM can surely be applied to some of the newly detected CaMBPs. However,
with such diversity in CaM’s target recognition conferred by its conformational
plasticity and structural malleability, we could highly expect the emergence of
new and surprising modes.
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6.2. Gap junction and calmodulin
Gap junctions comprise the intercellular channels that mediate the cell-tocell transfer of small molecules including metabolites, second messengers and
ions in mammalian cells (431). Gap junctions are composed of two hemichannels
(termed connexons) each comprised of six connexin (Cx) subunits. The
connexon from one cell joins in mirror symmetry with another connexon of the
apposing cell. To date, at least 20 connexin genes have been identified in the
human genome with connexin43 (Cx43) and the most ubiquitous connexin (432).
Gap junctions have been shown to be regulated by intracellular Ca 2+
concentration ([Ca2+]i) (433) that Peracchia and others have shown to be likely
mediated by CaM interacting directly with the connexin proteins (434,435). We
have shown previously that cell-to-cell communication in lens epithelial cell
cultures is inhibited by elevated [Ca2+]i. Specifically, cell-to-cell transfer of the
fluorescent dye AlexaFluor594 was half-maximally inhibited at ~300 nM [Ca2+]i in
lens cell cultures and this inhibition was prevented by preincubation of these
cultures with CaM antagonists (75,436), consistent with earlier reports that
elevated [Ca2+]i increased internal electrical resistance in the lens that was
prevented by preincubation with CaM antagonists (436). Indeed, this action of
Ca2+ in lens cell cultures is due in part to the inhibition of Cx43, the major
connexin in these cell cultures. It has been demonstrated that Cx43-transfected
HeLa cells exhibiting a similar Ca2+ -dependent inhibition appears to be CaMmediated (68). The rapid onset of this Ca2+-dependent inhibition of cell-to-cell
communication (within seconds) suggests that this is mediated by a direct
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interaction of CaM with the connexin protein rather than being mediated via the
action of a CaM-dependent protein kinase. Indeed, the Ca2+-dependent binding
of CaM to rat Cx32 (435), fish Cx35, mouse Cx36 (69) and Cx50 (437) have
been reported. Two cytoplasmic CaM binding domains, with one site (Kd = 27 nM)
in the N-terminus and the other site (Kd = 1.2 µM) in the C-terminal region have
been identified in Cx32 (435), whereas a single CaM binding site (Kd: 11-72 nM )
was identified in the C-terminus of Cx35 and Cx36 (69).
Each Cx43 or Cx44 monomer consists of four highly-conserved
transmembrane

segments,

a

short

N-terminal

cytoplasmic region,

one

intracellular and two extracellular loops, as well as a C-terminal tail. (Fig. 6.4).
Variability in sequence homology across different connexin types is greatest in
the intracellular loop and C-terminus. Efforts to map the potential CaM binding
sites in Cx43 have led to conflicting results. Torok et al reported the binding of the
fluorescent CaM derivative (TA-CaM) to the N-terminal (aa 1-16) region of Cx43
with a dissociation constant of 1.2 µM (435). However, Duffy et al were unable to
detect any interaction of CaM with a peptide spanning the first 21 amino acids of
the N-terminus (438). Both groups, nevertheless, failed to detect the binding of
CaM to the peptides derived from the C-terminal tail (aa 314-325; aa 336-350; aa
346-360) or the intracellular loop (aa 95-114; aa 123-136; aa 119-144). They
suggest that the interaction of CaM with Cx43 might occur via other regions of
the intracellular loop. Interestingly, by using the CaM binding database server
(90), we predicted a potential CaM binding site with high predictive score in the
second half of the intracellular loop of Cx43 (aa 136-158) or Cx44 (aa 129-150)
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that has not been tested before. In the present study, we have applied a variety
of biophysical approaches to examine the binding of CaM to this sequence. Our
findings strongly suggest a Ca2+-dependent interaction between the CaM and the
intracellular loop region of Cx43 or Cx44.

6.2.1. Prediction of calmodulin binding sties in connexins
Using a search program for CaM-binding sites (90), a putative CaM
binding region with high predictive score was identified in the intracellular loop of
Cx43

(Ac-136KYGIEEHGKVKMRGGLLRTYIIS158-NH2)

or

Cx44

(Ac-129 VRDDRGKVRIAGALLRTYVFNI150-NH2) (Fig. 6.4). In addition, two other
stretches of sequences with lower predictive scores, one in the N-terminal part of
the intracellular loop region (Ac-86SVPTLLYLAHVFYVMRKEEKLN107-NH2) and
the other in the C terminus region (Ac-224NIIELFYVFFKGVKDRVKGRSDPY247NH2), were detected in Cx43 but not in Cx44. A common feature of the CaM
binding regions is a number of hydrophobic residues interspersed with positively
charged residues (≥+3), typically forming a 1-5-10, 1-8-14 or 1-16 pattern of
hydrophobic residues (90,439). These regions are normally comprised of 12-30
continuous amino acids with a strong propensity to form an amphipathic helical
structure (90,439). The putative CaM binding region of Cx43 exhibits a 1-5-10
hydrophobic residue motif as reported in other well-characterized CaM targeting
proteins such as CaM Kinase I (440), CaM Kinase II (441), MARCKS (442) and
synapsin

(443).

The

randomized

control

peptide

(Ac-

LGGEYLVTMESKIHIKGKRIGYR-NH2) with the same composition of amino acids
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Figure 6.4. Membrane topology and predicted CaM binding sequences in
Cx43 and Cx44. Primary sequence and transmembrane (TM) topology of
Cx43. The integral membrane protein Cx is composed of four TM regions, two
extracellular loops, one cytoplasmic loop, a short N-terminus, and a longer Cterminal tail. The predicted high-affinity CaM binding site (aa 136-158 in Cx43
and aa 129-150 in Cx44) of highest predicted score is located in the second
half of the intracellular loop between TM2 and TM3. Two other regions (boxes
I and III) with lower predictive scores are also identified. The numeric score
ranges from 1-9, representing the probability of an accurate prediction of a
high affinity CaM binding site. #, hydrophobic residues. :, highly conserved
residues.
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as the Cx43 peptide but arranged in a different order with no predicted CaM
binding capacity is used in the study as control.
The ability of the peptides Cx43136-158 or Cx44129-150 to form an α-helical
structure was evaluated by monitoring its secondary structure using far UV CD in
the presence of varying concentrations of trifluoroethanol (TFE) (Fig.6.5). In
aqueous solution, the free peptides were largely unstructured with a negative
maximum at 197 nm. However, when the TFE concentration was increased to 20%
it started to form α-helical structure (12%), with two major troughs at 208 nm and
222 nm observed in the CD spectra. The helical contents increased up to 50% in
the presence of 40% TFE (Fig. 6.5). TFE, with a dielectric constant one third that
of water, is capable of strengthening intramolecular hydrogen bonding (444), and
is known to induce and stabilize the intrinsic secondary structures in peptides,
possibly by mimicking the hydrophobic environment of the peptide in the intact
proteins (445-447). Several CaM binding peptides have been reported to adopt
similar α-helical structures in TFE solvent as in the CaM-peptide complexes
(448,449). These results support our prediction that this Cx43 136-158 peptide
possesses a strong α-helical-forming propensity.

6.2.2. Secondary and tertiary structure change induced by peptide binding
As described above, the binding of CaM to CaM-binding peptides typically
induces the formation of α-helical structure in these peptides (420). As seen in
Fig. 6.6A and Fig. 6.7A, the addition of a 1:1 molar equivalent of peptides to
Ca2+-CaM results in an approximately 10% more negative signal in the spectrum.
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A

B

Figure 6.5. Far UV CD spectra of the peptides Cx43136-158 (A) and Cx44129-150
(B) with different concentrations of TFE. The inset shows the changes of
molar ellipticity at 222 nm and 208 nm as a function of TFE concentration.
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Since the α-helical content of CaM typically does not increase upon peptide
binding (420), the observed net increase in the CD signal could be reasonably
attributed to CaM-bound Cx peptides. The difference spectrum, obtained by
subtracting the Ca2+-CaM spectrum from the Ca2+-CaM-peptide spectrum,
showed two major troughs at 208 nm and 222 nm, which is strikingly different
from the random coiled structure of the peptide alone (Fig. 6.6B and Fig. 6.7B).
Deconvolution of this difference spectra revealed that the CaM-bound peptides
had ~30-40% helical structure, which is comparable to the helical content of this
peptide in 20%-40% TFE (Fig. 6.5). The Cx43136-158 binding-induced CD signal
change enabled us to measure the peptide binding affinity of CaM. As shown in
the inset of Fig. 6.6A, the signal changes reach the maxima when the Cx43 136-158:CaM ratio was approximately 1:1 and the fitting curves provided an apparent K d
of 100 ± 20 nM (n = 3) in 10 mM KCl and 750 ± 120 (n = 3) nM in 100 mM KCl
(Table 6.3) in the presence of 1 mM Ca2+. The decrease in Kd at the higher salt
concentration suggests that electrostatic interactions might play an important role
in the interaction of Cx43136-158 with CaM. In the presence of 1 mM EGTA, no
significant difference in the far UV CD spectra was detected after the addition of
a 1:1 molar equivalent of Cx43136-158 (Fig. 6.6A) or Cx44129-150 (Fig. 6.7A) to CaM
suggesting that the peptide is unable to interact with CaM or the binding is much
weaker in the absence of Ca2+.
Near UV CD spectroscopy was conducted to examine the tertiary packing
around aromatic residues of CaM, Cx peptides and the CaM-Cx peptide
complexes (Fig. 6.6C and Fig. 6.7C).Both Cx43136-158 and Cx44129-150 exhibited

-1

Molar Ellipticity ( X 10 deg cm dmol res )

-1

A
1 10

0

0 10

3

0

-1 10

4

-2 10

200

210

220

230

240

250

-3
1.0

-6

0.0

0.5

1.0

1.5

2.0

2.5

3.0

3.5

[Peptide]/[CaM]

-1
-1

10
5

D

2

2

-1

-20
-30
-40
-50

0.4

200 208 216 224 232 240 248 256
Wavelength (nm)
Molar ellipticity (deg cm dmol res )

-1

Molar ellipticity (deg cm dmol res )

-10

0.6

0.0

-9

260

C

0.8

0.2

Wavelength (nm)

0

Relative change

4

10

B

2

CaM-EGTA
CaM-Cx43-EGTA
CaM-Ca
CaM-Cx43-Ca

4

3

Molar Ellipticity ( deg cm 2 dmol-1 res-1)

203

260

270

280

290

Wavelength (nm)

300

310

0
-5
-10
-15

260

270

280

290

300

310

Wavelength (nm)

Figure 6.6. Circular Dichroism studies of the interaction between Cx43 136-158
and CaM. (A), Far UV Circular Dichroism spectrum of CaM in the presence of
1 mM EGTA (○) or 1 mM CaCl2 (□), and a 1:1 CaM-synthetic peptide mixture
with 1 mM EGTA (●) or 1mM CaCl2 (■) after subtracting the contribution from
buffer and added peptides. (B), The far UV circular dichroism spectra of
Cx43136-158 (dashed line) and the calculated difference spectrum (solid line) by
subtracting the spectrum of Ca2+-CaM from that of the Ca2+-CaM-Cx43136-158
mixture with 1 mM Ca2+ in a buffer consisting of 100 mM KCl, 10 mM Tris-HCl,
pH 7.4. The inset reports the relative change of the circular dichroism molar
ellipticity at 222 nm as a function of synthetic peptide concentration. (C), Near
UV circular dichroism spectra of CaM in the presence of 1 mM EGTA (○) or 1
mM CaCl2 (□), and 1:1 CaM- Cx43136-158 mixture with 1 mM EGTA (●) or 1mM
CaCl2 (■) after subtracting the contribution from buffer and added peptides.
(D), The near UV circular dichroism spectra of Cx43136-158 (dashed line) and
the calculated difference spectrum by subtracting the Ca2+-CaM spectrum
from the Ca2+-CaM- Cx43136-158 spectrum (solid line) in a buffer consisting of 1
mM Ca2+, 100 mM KCl, 10 mM Tris-HCl, pH 7.4.

204

4

Molar Ellipticity (deg cm 2 dmol-1 res-1)

4

2 10

1 10

A

CaM-EGTA
CaM-Cx44-EGTA
CaM-Ca
CaM-Cx44-Ca

4

1 10

B

5000

Free Cx44

0

0

4

-5000

4

4

-1 10

-2 10

192 200 208 216 224 232 240 248 256

-1 10

Difference spectra in the
presence of Ca2+
200

210

2

-1

-1

Molar ellipticity (deg cm dmol res )

30

C

30

20

20

10

10

0

0

-10

-10

-20

-20

-30

-30
260

270

280

290

Wavelength (nm)

220

230

240

250

260

Wavelength (nm)

Wavelength (nm)

300

310

D

Difference spectra in the
presence of Ca

Free Cx44

260

270

280

290

300

310

Wavelength (nm)

Figure 6.7. Circular Dichroism studies of the interaction between Cx44 129-150
and CaM. (A), Far UV Circular Dichroism spectrum of CaM in the presence of
1 mM EGTA (○) or 1 mM CaCl2 (□), and a 1:1 CaM-synthetic peptide mixture
with 1 mM EGTA (●) or 1mM CaCl2 (■) after subtracting the contribution from
buffer and added peptides. (B), The far UV circular dichroism spectra of
Cx44129-150 (dashed line) and the calculated difference spectrum (solid line) by
subtracting the spectrum of Ca2+-CaM from that of the Ca2+-CaM-Cx44129-150
mixture with 1 mM Ca2+ in a buffer consisting of 100 mM KCl, 10 mM TrisHCl, pH 7.4. (C), Near UV circular dichroism spectra of CaM in the presence
of 1 mM EGTA (○) or 1 mM CaCl2 (□), and 1:1 CaM- Cx44129-150 mixture with
1 mM EGTA (●) or 1mM CaCl2 (■) after subtracting the contribution from
buffer and added peptides. (D), The near UV circular dichroism spectra of
Cx44129-150 (dashed line) and the calculated difference spectrum by
subtracting the Ca2+-CaM spectrum from the Ca2+-CaM- Cx44129-150 spectrum
(solid line) in a buffer consisting of 1 mM Ca2+, 100 mM KCl, 10 mM Tris-HCl,
pH 7.4.
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negligible signal in aqueous solution by itself, but the addition of Ca2+-CaM to Cx
peptides resulted in the appearance of more negative (Cx43136-158) or more
positive (Cx44129-150) ellipticity. Both CaM and the synthetic peptides do not
contain any tryptophan but each contains two tyrosines. The prominent band
above 275 nm is likely due to the tyrosine residues in the C-terminus region of
CaM (Y99 and Y138), while the two peaks at 262 nm and 268 nm are likely due to
the nine phenylalanine residues in CaM (450). The difference spectrum obtained
by subtracting the Ca2+-CaM spectrum from that of Ca2+-CaM-Cx43136-158 (Fig.
6.6D) or Ca2+-CaM-Cx44129-150 (Fig. 6.7D) showed a prominent band between
275 and 279 nm, which is most likely due to the immobilization of tyrosine
residues in the Cx peptides (which contains no tryptophan) following its binding
to CaM. The different near UV difference spectra (Figs. 6.6D and 6.7D) could
arise from the difference in the local environment around the Try residue(s) in
these two peptides. The contribution of signals from the CaM tyrosine residue is
less likely to be dominant although both CaM and Cx peptides contain two
tyrosine residues making it difficult to unambiguously differentiate the contribution
from each macromolecule in the spectra. The Y99 and Y138 in CaM are located in
the C-terminus EF-loops where the local structures of the Ca2+-bound EF-loops
have not been reported to be altered upon peptide binding in the currently known
CaM-peptide complex despite the rearrangement of tertiary structures. Thus, the
local environment of the CaM tyrosine is less likely to be significantly altered
upon Cx peptides binding. No significant differences were observed between the
spectra of apo-CaM and the 1:1 mixture of apo-CaM:Cx peptide (Fig. 6.6C and
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Fig. 6.7C), further supporting the Ca2+-dependent binding of Cx peptide to Ca2+CaM and the resulting conformational changes in Cx peptides revealed by the far
UV CD studies.

6.2.3. Monitoring the CaM-Cx interaction by SPR
The binding of Cx43136-158 to CaM was further confirmed using surface
plasmon resonance spectroscopy with CaM immobilized on the CM5 sensor chip.
Fig. 6.8 shows the sensorgrams of successive peptide binding experiments. The
peptide Cx43136-158 rapidly associated with CaM in the presence of Ca2+. At the
end of peptide injection, dissociation of the complex was observed during
flushing of the chip with peptide-free running buffer. Analysis of the kinetic data
inferred that the apparent Kd for the binding of Cx43136-158 to CaM is
approximately 1 µM with a koff rate of 5 x 10-4 s-1 in the presence of saturating
amount of Ca2+ and 100 mM KCl. In contrast, no significant binding of Cx43136-158
to CaM was detected in the presence of EGTA. Furthermore, the control
randomized Cx43136-158 peptide that contained the same composition of amino
acids as Cx43136-158 did not exhibit specific binding in the presence of either Ca2+
or EGTA; the response units of these injections were not significantly higher than
that of injection of the peptide through the underivatized CM5 chip surface.
These results further confirm the Ca2+-dependent binding and specificity of
Cx43136-158 binding to CaM.

207

A

20

Response Units

15
10 μM Cx43136-158

10

5 μM Cx43136-158

5
1 μM Cx43136-158
0.1 μM Cx43136-158

0
-5

B

0

100

200

300 400
Time (s)

500

600

700

600

700

20

Response Units

15
10
5
10 μM randomized peptide

0
-5

0

100

200

300

400

500

Time (s)

Figure 6.8. Monitoring the interaction of CaM with Cx43136-158 by surface
plasmon resonance spectroscopy. The sensorgrams represent the binding of
0.1, 1, 5 and 10 µM Cx43136-158 (A) or 10 µM of the randomized Cx43 peptide
(B) to the CaM-immobilized chip in the presence of 5 mM Ca2+ (solid line) or
EGTA (dashed line). CaM was immobilized to the sensor chip CM with a
response unit of approximately 3500. The flow rate was set at 5 µl/min. During
recording, running buffer contained 5 mM CaCl2 or 5 mM EGTA in 100 mM
KCl, 50 mM Tris-HCl at pH 7.4 or the same buffer plus the peptides (solid bar).
Subsequently, peptide-free buffer was injected to monitor the dissociation
process.
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6.2.4. Structural changes induced by Cx binding
Next, it was important to demonstrate that there is in fact a direct
interaction between the Cx peptides and CaM. This was confirmed using high
resolution NMR. As shown in Fig. 6.9A-B, in the presence of Ca2+, a number of
dispersed peaks of CaM underwent chemical shifts of greater than 0.05 ppm
following the addition of Cx43136-158 or Cx44129-150. In contrast, only insignificant
changes in several residues were observed upon the addition of Cx43136-158 to
CaM in the presence of 10 mM EGTA (Fig. 6.9C), again supporting the absence
of any of interaction at physiological concentrations of K + in the absence of Ca2+.
In addition, the addition of the control randomized Cx43 136-158 peptide resulted in
only very minor changes in the CaM

15

N-1H HSQC spectra even in the presence

of Ca2+ (Fig. 6.9A, blue). This latter result would appear to exclude the possibility
of non-specific binding between the randomized peptide and CaM arising from
the charge or hydrophobic interactions of certain residues, indicating the
necessity of the specific arrangement of the Cx43 or Cx44 peptide sequences.
The NMR chemical shift resonances of Ca2+-CaM have been assigned by
several groups (420,451,452). By following their movements during titration of
CaM with Cx43136-158 peptide, the dispersed peaks of the peptide-CaM complex
have been unambiguously assigned. CaM has been known to activate
downstream proteins by displacing autoinhibitory domains, remodeling the active
sites, or inducing oligomerization in these proteins (310). The binding of CaM to
target proteins and peptides has been reported to involve the N- and/or Cterminal domains of CaM (14,310,420,422). Analysis of the effects of peptide
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Figure 6.9. Interaction between CaM and Cx peptides revealed by NMR.
(A), Overlaid HSQC spectra of Ca2+-CaM (green) with Ca2+-CaM-Cx43136-158
(red) or Ca2+-CaM:control randomized Cx43136-158 peptide (blue). A subset of
assigned peaks displaying significant movement upon peptide binding were
framed in boxes. (B), Overlaid HSQC spectra of Ca2+-CaM (cyan) with Ca2+CaM-Cx43136-158 (green) or Ca2+-CaM-Cx44129-150 (red). (C), Overlay of
HSQC spectrum of apo-CaM (green) with apo-CaM-Cx43136-158 (red). (D),
Changes in chemical shift of selected well-dispersed resonances as a
function of the Cx136-158:Ca2+-CaM ratio in the presence of saturating Ca2+ at
physiological K+ condition.
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binding on the backbone amide chemical shifts of CaM could shed light on the
underlying mode of interaction of the Cx peptides with CaM. The resonances that
underwent chemical shifts of greater than 0.05 ppm in the peptide titration were
present in both the N- to C-termini of CaM, including residues G25, T29, G33, G40,
A57, G61, D64, K77, K94, G98, G113, T117, G134, N137, A147 and K148 and possibly
others since the assignment of the overlapped regions is still in progress. The
movements of the residues that we were able to assign during the titration
followed a similar chemical shift trend (Fig. 6.9D), suggesting a single binding
process. Furthermore, the chemical shifts saturated when the Cx43 136-158 or
Cx44129-150 to CaM ratio exceeded 1.0. These results demonstrated that the 1:1
Ca2+-dependent

binding

of

Cx43136-158 or

Cx44129-150

to

CaM

induces

conformational changes in both the N- and C-terminal domains of CaM.

6.2.5. Peptide binding affinities and thermodynamics of the CaM-Cx
interaction
The dansyl fluorescence emission maxima, at ~510 nm, are wellseparated from any intrinsic fluorescence arising from aromatic amino acid
residues. Because of this, as well as dansyl’s great sensitivity to environmental
changes, dansylated proteins including dansylated CaM have been widely used
in studying the effect of protein-target interaction of ions, peptides, or drugs (65).

Binding of Cx43136-158 to dansyl-CaM
As shown in Fig. 6.10A-B, Ca2+ binding to dansyl-CaM resulted in an
increase of the fluorescence intensity and an emission blue-shift from 510 to 497
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nm indicating that the dansyl group moved to a more hydrophobic environment.
The addition of Cx43136-158 to Ca2+-dansyl-CaM resulted in a further 80%
increase in dansyl fluorescence intensity and a further emission blue-shift to 477
nm, suggesting that the dansyl groups are located in an even more hydrophobic
environment in the complex. In the absence of Ca 2+, the dansyl fluorescence
remained nearly unaltered when Cx43136-158 was added to dansyl-CaM, indicating
a Ca2+-dependent interaction of Cx43136-158 with dansyl-CaM, Titration data with
Cx43136-158 resulted in apparent dissociation constants of 240 ± 10 nM in 10 mM
KCl and 860 ± 20 nM in 100 mM KCl (Table 6.3) assuming a 1:1 binding mode
(Fig. 6.10A). In addition, the titration of dansyl-CaM with two other Cx43 peptides
(Cx4386-107 corresponding to residues 86-107 in Cx43 in the N-terminal region of
the intracellular loop, and Cx43224-247 corresponding to residues 224-247 in Cx43
in the C-terminus region) that have significantly lower predictive scores for CaM
binding (Fig. 6.4) resulted in no significant fluorescence signal changes (Figs.
6.10C and D) indicating these peptides did not bind CaM.

Binding of Cx44129-150 to dansyl-CaM
As shown in Figs. 6.10E and F, in the presence of EGTA or Ca2+,
dansylated CaM exhibits its fluorescence maxima at 510 nm and 500 nm
respectively. The addition of Cx44129-150 to Ca2+-loaded dansyl-CaM resulted in
~50% increase in the dansyl fluorescence intensity and brought about 17 nm
blue-shift of the fluorescence maximal peak (Inset, Fig. 6.10E), strongly
suggesting that the dansyl groups are located in more hydrophobic environment
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Figure 6.10. Interaction of Cx peptides with dansyl-CaM. (A) Dansyl
fluorescence spectra of apo-dansyl-CaM in the absence (○) and presence (●)
of the Cx43138-158 peptide, and Ca2+-dansyl-CaM in the absence (□) and
presence (■) of the Cx43138-158 peptide (2.5 µM). (B), The dansyl fluorescence
intensity plotted as a function of Cx43138-158 peptide. (C), Dansyl fluorescence
spectra of Ca2+-dansyl-CaM (1.25 µM) in the absence (□) and presence (■) of
the Cx4388-107 peptide (2.5 µM) in 1 mM CaCl2. (D), Dansyl fluorescence
spectra of Ca2+-dansyl-CaM (1.25 µM) in the absence (□) and presence (■) of
the Cx43222-247 peptide (2.5 µM) in 1 mM CaCl2. (E-F),The dansyl
fluorescence intensity plotted as a function of Cx44129-150 peptide in the
presence of Ca2+ or EGTA. The inset showed the dansyl fluorescence spectra
of dansyl-CaM with (solid line) and without (dashed line) the addition of the
Cx44129-150 peptide with 1 mM CaCl2 (E) or EGTA (F). The buffer consists of
50 mM Tris, 100 mM KCl, pH 7.4.
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in the complex. During titration, the fluorescence intensity reached saturation
when the peptide to CaM ratio was around 1:1. In the absence of Ca 2+, the
dansyl fluorescence intensity also increased by ~50%, but the fluorescence
maxima was only blue-shifted by 5 nm after addition of Cx44 129-150 (Inset, Fig.
6.10F), strikingly different from the behavior of Ca2+-loaded dansyl-CaM. Under
salt-free conditions, the Cx44129-150 titration of dansyl-CaM provided a peptide
binding apparent dissociation constants of 43 ± 8 nM with Ca2+ and 414 ± 20 nM
in the presence of EGTA, respectively. However, under physiological salt
condition (100 mM KCl), the peptide binding affinity of EGTA treated dansyl-CaM
(>5 µM) was at least 100-fold weaker than Ca2+-dansyl-CaM (Table 6.3).
Moreover, with even higher concentration of salt (200 mM KCl), the weaker
interaction in the presence of EGTA can be hardly detected by this method.
Given the fact that the intracellular CaM concentration was about 9 µM (453) and
CaM interacted with over 300 target proteins in vivo (3), such weak or unspecific
interaction between the peptide and Ca2+-depleted CaM would be of little
physiological relevance. These results support a model in which the interaction of
Cx peptides with CaM is Ca2+-dependent.

Thermodynamics of the CaM-Cx interaction
The stoichiometry, binding affinity and thermodynamics of the interaction
between CaM and Cx44129-150 were further characterized by ITC. Representative
calorimetric traces of titration are shown in Fig. 6.11. For the peptide Cx44129-150,
the binding event was found to be exothermic (H = -1.15 kcal mol-1) and
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Figure 6.11. ITC microcalorimetric traces and the derived isotherms of CaM
titrated with Cx peptide. Samples are prepared and dialyzed in a buffer
consisting of 20 mM PIPES, 100 mM KCl, 2 mM CaCl2, pH 6.8. All the
solutions were degassed for ate least 15 min prior to experiments. 4-6 µL
aliquots of peptides (400-600 µM) were injected from the syringe into the
reaction cell containing 25 µM CaM in the same buffer at 5 min intervals at
25 °C.
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entropically favorable ((S = 23.97 J mol-1 K-1) with an association constant of Ka
= 1.2  0.2  10 6 M-1 (Kd = 8.3  1.4  10-7 M). Thus, the interaction seems to be
both enthalpically and entropically driven with a G of -8.3 kJ mol-1. Since the
enthalpic terms represent the forces of hydrogen bonds, van der Waals and
electrostatic interaction, whereas entropy mainly reflects the hydrophobic
interaction, it is evident that all these forces are contributing in concert to promote
the interaction between CaM and Cx44129-150. In consistent with our peptide
titration data with dansyl-CaM (Fig. 6.10E), the peptide specifically bound to
Ca2+-CaM with a ratio near 1:1 (n = 1.3  0.1). The binding affinity obtained with
ITC was, nonetheless, notably different from the values derived from titration data
with dansyl-CaM. The discrepancy in the binding affinities using two separate
methods could mainly arise from the modification to CaM by the dansyl moiety
and the difference in buffering and pH conditions (6.8 in ITC vs 7.4 in dansylCaM titration).

6.2.6. Effect of ionic strength and pH on the CaM-Cx interaction
CaM (pI = 4.2) and the synthetic peptide CaM-Cx44129-150 (pI = 10.8) were
oppositely charged with a net charge of about -15 (82) and +3, respectively, at
neutral pH. Such high opposite charges makes it reasonable to anticipate that
electrostatic interaction could be an important determinant in the formation of
CaM and Cx44129-150 complex. To gain an insight into the effects of electrostatic
interaction in the CaM-Cx44129-150 interaction, we further analyzed the effects of
varying salt and pH on the binding affinity. During the complex formation between
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Figure 6.12. Effects of salt and pH on the binding affinity of Cx44 129-150. (A),
Plot of -logKd as a function of varying amount of KCl in 5 mM CaCl2, 50 mM
Tris, pH 7.4. (B), pH dependence of the binding affinity of Cx44 129-150. The
binding affinities were derived from the peptide titration curve of dansyl-CaM.
(n=2-4)
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two oppositely charged macromolecules, an increase in the ionic strength is
expected to decrease the binding affinity mainly due to screening of electrostatic
interactions. As shown in Fig. 6.12A, the CaM-binding affinity of Cx129-150
decreased by almost one magnitude of order as the salt concentration varied
from 0 to 800 mM with a notable plateau stage between 10 to 100 mM. In
addition, the CaM-binding affinity of the peptide exhibited a pH-dependent
increase between pH 5.0 to 9.0 (Fig. 6.12B). As expected, the binding affinity at
pH values near the isoelectric points of CaM (4.2) or the peptide (10.8) was
drastically weakened and the difference in the affinity was ~2 orders of
magnitude. Taken together, both the salt- and pH-dependence of the interaction
between CaM and Cx129-150 indicate that electrostatic interaction is one of the
main forces governing the complex formation, which is in agreement with the
observed negative (favorable) enthalpic change in ITC studies.

6.2.7. Effects of Cx binding on the metal binding properties of CaM
To examine the effect of Cx peptides on the Ca2+ binding properties of
CaM, Ca2+ titrations were performed in the presence of the Ca2+ indicator Oregon
Green 488 BAPTA-5N. Monitored by the intrinsic tyrosine fluorescence, the
fluorescence change in the presence of Cx peptides was significantly left-shifted
when compared to CaM alone (Fig. 6.13).The binding affinity of the peptidebound CaM for Ca2+ was 1.5-3.5 fold stronger than that of CaM alone (Table
6.4). Furthermore, the Ca2+-dependent change in the tyrosine fluorescence of the
CaM:Cx peptide mixtures exhibited stronger positive co-operativity than that of
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Figure 6.13. Ca2+ titration of CaM and CaM-Cx peptides complexes. Ca2+
titration of CaM (○),the 1:1 CaM:Cx43 randomized peptide mixture (▲), the 1:1
CaM:Cx43136-158 mixture (●), and the 1:1 CaM: Cx44129-150 mixture (■) in 100
mM KCl, 50 mM Tris-HCl, pH 7.4. The intrinsic tryrosine fluorescence emission
intensity of CaM or CaM-peptide mixture (8µM) was monitored at 307 nm with
fluorescence excitation at 277 nm. The Ca2+ indicator dye Oregon Green 488
BAPTA-5N was used to calibrate the ionized Ca2+ concentration. Each titration
point is indicated as an open diamond at the bottom of the figure. Data from a
single experiment is representative of at least triplicate experiments.

219

Table 6.3. The binding affinities of Cx peptides to CaM or dansyl-CaM
sample

KCl (mM)

Cx43

10

dissociation constants (Kd, nM)
Ca2+

EGTA

100 ± 20a

NDc

240 ± 10b
100

750 ± 120a

NDc

860 ± 20b
Cx44

10

43 ± 8b

414 ± 20b

100

49 ± 3b

>5,000 b

Data obtained from afar UV CD data or bDansyl-CaM fluorescence (n=3-6). cND: not
detectable.

Table 6.4. Effect of Cx peptides binding on the Ca2+ binding affinity of CaM.
fold
enhancement of

sample

tyrosine

Kd (10-6 M)

nHill

fluorescence
CaM

2.3 ± 0.2

2.9 ± 0.1

2.1 ± 0.1

CaM-randomized control peptide

1.9± 0.1

2.7 ± 0.1

1.9 ± 0.2

CaM-Cx43136-158

1.7± 0.1

1.6 ± 0.1

3.3 ± 0.5

1.8± 0.1

0.8 ± 0.1

5.8 ± 0.4

CaM-Cx44
2+

Data obtained from Ca titration curve (n=3).
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CaM alone (Hill coefficients: 3.3 and 5.8 versus 2.1) for Ca2+ binding. It is well
recognized that the Ca2+ affinity of CaM is significantly enhanced on binding to its
receptor protein as a result of a slower dissociation rate of Ca2+ from CaMreceptor complex than from CaM alone (454-456). The dissociation of Ca2+ from
CaM typically leads to the inactivation or inhibition of its bound protein (14) so
slowing this dissociation would ensure that the CaM:Cx complex remains
associated even during periods of frequent oscillation of [Ca2+]i.
To further confirm that, we measured the rapid kinetics of EGTA-induced
Ca2+ dissociation from CaM-Cx44129-150 complex by monitoring the CD signals
change at 222 nm on a Jasco-810 CD spectropolarimeter with a BioLogic
stopped-flow apparatus. A kobs of 5.3  0.2 s-1 was obtained by fitting the
stopped-flow traces with a single-component exponential decay function (Fig.
6.14A). The observed rate constant for the EGTA-induced dissociation of Ca2+
from CaM could not be measured by this instrument (a minimal sampling interval
of 15 ms) since the release of Ca2+ is too fast to be sampled (Fig. 6.14B).
Bayley’s group had reported an observed rate constant of >800 s -1 for EGTAinduced Ca2+-dissociation from the CaM mutant T26W with fluorescence
stopped-flow techniques (456). Conceivably, the dissociation of Ca2+ from CaM is
drastically slowed when bound with the synthetic peptide Cx44129-150. The
dissociation of Ca2+ from CaM typically leads to the inactivation or inhibition of its
bound protein (14) so slowing this dissociation would ensure that the complex
remains unaltered and that the CaM-Cx44 gap junction intracellular loop
maintains its functional form even during periods of frequent oscillation of [Ca 2+]i.
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Figure 6.14. Stopped-flow trace for the EGTA-induced dissociation of Ca2+
from the CaM-Cx44129-150 complex (A) and CaM (B). Syringe 1 contained 2 μM
CaM-peptide (1:2) mixture with 0.1 mM Ca and syringe 2 consisted of an equal
volume of 10 mM EGTA.
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Furthermore, higher positive cooperativity enables the complex to respond to a
narrower window of [Ca2+]i with higher sensitivity.

6.2.8. Physiological effects of knocking out the putative CaM-binding site in
Cx43. (contribution from Dr. Monica Lurtz)
Physiological experiments were conducted to confirm the results obtained
using various biophysical approaches. Cell-to-cell dye transfer under resting and
elevated intracellular Ca2+ concentration ([Ca2+]i) in communication-deficient
HeLa cells transiently transfected individually with either wtCx43-EYFP or one of
two Cx43-EYFP intracellular loop mutants (CaM binding site knockouts) was
used to demonstrate that CaM mediates the Ca2+-dependent inhibition of Cx43
by directly associating with the aa 136-158 region in Cx43.
HeLa cells transiently transfected with wtCx43-EYFP expressed large gap
junction plaques at the cell-cell interface (Figs. 6.15A & E, left panels) as has
been previously described; there was no significant intracellular expression of
wtCx43-EYFP making it relatively straightforward to identify cells making gap
junctions with adjacent cells (Fig. 6.15A). In contrast both the Cx43K146E, R148EEYFP and Cx43M147Q, L151E, I156E –EYFP CaM binding-deficient mutants expressed
an abundance of protein when transfected in HeLa cells, most of which was in
non-plasma membrane locations (Figs. 6.15B&F, C&G left panels, respectively)
making it harder to identify cells making gap junctions with adjacent HeLa cells.
Under resting [Ca2+]i conditions (1.8 mM extracellular Ca2+ concentration and no
ionomycin), cell-to-cell communication (i.e., AlexaFluor 594 cell-to-cell dye
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transfer) was measured between each pair of cells expressing the wtCx43-EYFP;
every cell that contained EYFP fluorescence exhibited cell-to-cell transfer of
injected dye indicating that Cx43-EYFP formed functional gap junctions (Fig.
6.15I).

In contrast, only 31% of the double mutant Cx43K146E,

R148E-EYFP

transfected HeLa cells and 32% of the triple mutant Cx43 M147Q,L151E,I156E–EYFP
transfected HeLa cells exhibited cell-to-cell dye transfer (Fig. 6.15I). These
results indicated that a significant fraction of the mutant Cx43-EYFP transfected
cells that exhibited EYFP fluorescence did not express functional gap junctions.
This fits with the EYFP fluorescence data (Figs. 6.15B&C) suggesting a
significant fraction of the mutant Cx43-EYFP protein accumulates in non-plasma
membrane locations in the transfected HeLa cells.

Furthermore, mock-

transfected HeLa cells did not exhibit cell-to-cell transfer of injected AlexaFluor
594 dye confirming that the cell-to-cell transfer exhibited by the wt Cx43-EYFP
and mutant Cx43-EYFP transfected HeLa cells is gap junction mediated (Fig.
6.15D). Addition of the membrane permeant polyether antibiotic ionomycin (1 μM)
and subsequent elevation of extracellular Ca2+ from 1.8 mM to 21.8 mM resulted
in a significant (p<0.001) increase of the [Ca2+]i to concentrations known to inhibit
Cx43-mediated cell-to-cell dye transfer in a CaM-dependent manner. As shown
in Fig. 6.15I, elevation of [Ca2+]i in wtCx43-EYFP transiently transfected HeLa
cells results in the inhibition of cell-to-cell dye transfer in all cells tested indicating
that the addition of EYFP on the C-terminus of Cx43 did not affect the ability of
elevated [Ca2+]i to inhibit Cx43 gap junctions. In contrast, elevation of [Ca 2+]i in
HeLa

cells

expressing

the

Cx43K146E,

R148E-EYFP

double
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Figure 6.15. Functional effect of a sustained elevation in intracellular [Ca 2+] on
CaM binding-deficient Cx43-EYFP mutants. Cell-to-cell transfer of injected
AlexaFluor 594 dye between HeLa cells transiently transfected with wtCx43EYFP or the CaM-binding Cx43 mutants (Cx43K146E, R148E-EYFP or Cx43M147Q,
L151E, I156E –EYFP) was measured in confluent monolayers of cells. Panels A-H
show images of transiently transfected wt or mutant Cx43-EYFP or mocktransfected HeLa cells. The left image shows the EYFP fluorescence of the
injected and adjacent cells, the middle image is the fluorescence of EYFP plus
brightfield, and the images on the right are of AlexaFluor 594 dye transfer.
Panels A&E: wtCx43-EYFP transiently transfected HeLa cells; Panels B&F:
Cx43K146E,R148E-EYFP transiently transfected HeLa cells; Panels C&G:
Cx43M147Q,L151E,I156E –EYFP transiently transfected HeLa cells; Panels D&H:
mock-transfected HeLa cells. Panel I: Summary data for cell-to-cell dye
transfer (solid bars) and [Ca2+]i (hatched bars) in the absence or presence of
elevated [Ca2+]i. * indicates cell-to-cell dye transfer was significantly lower
than cell-to-cell dye transfer determined in low [Ca2+]i; ** indicates [Ca2+]i was
significantly higher than the low [Ca2+]i value. (contribution from Dr.Monica Lurtz)
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mutant or the Cx43M147Q,

L151E, I156E

-EYFP triple mutant did not result in the

inhibition of cell-to-cell dye transfer (57% and 67% [respectively] of attempts
resulted in dye transfer). The apparent increase in the percentage of injected
cells inhibiting cell-to-cell dye transfer in elevated [Ca2+]i versus resting [Ca2+]i
was not statistically significant (p>0.1). There was no cell-to-cell transfer of dye
when AlexaFluor 594 dye was injected into mock HeLa transfected cells under
either resting or elevated [Ca2+]i conditions (Fig. 6.15H).

6.2.9. Indication of in vivo interaction
In this study we provide evidence that a peptide derived from the
intracellular loop of the major gap junction protein Cx43 and Cx44, which has the
highest predictive score of any region of Cx to bind CaM (Fig. 6.4), binds CaM
with high affinity in a Ca2+-dependent manner (Table 6.3). Given that intracellular
CaM concentration is approximately 9 µM (453), such an affinity would imply that
this CaM-binding region of Cx43 would be saturated with CaM when intracellular
Ca2+ concentration is elevated and that this association accounts for the well
described ability of Ca2+ to inhibit gap junctions (75). As indicated by our circular
dichroism, fluorescence and NMR data, the stoichiometry of Cx peptides:CaM
binding is close to 1:1 . To our knowledge, this report presents the first
demonstration of a direct CaM-Cx43 or CaM-Cx44 interaction in vitro, which
would explain our previous in vivo observation that preincubation of lens cell
cultures or Cx43-transfected HeLa cells with CaM antagonists counteracts the
intracellular Ca2+-dependent inhibition of Cx43-containing gap junctions (75,436).
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The results clearly demonstrate that the Ca2+-dependent inhibition of Cx43 gap
junctions is mediated via the association of Ca2+-CaM with the intracellular
portion of Cx43. In addition, our results support a mechanism of Cx43 or Cx44
regulation by CaM in which CaM first binds to Ca2+, and then the Ca2+-CaM
complex associates with Cx43 or Cx44 to inhibit the gap junction, rather than a
stable CaM-Cx complex in which Ca2+ binds to the complex which then results in
gap junction inhibition.
A different model for the gating of Cx43 has been proposed by Delmar’s
laboratory (438) in which an intracellular gating element within the C-terminal
domain of Cx43 interacts with a region of the Cx43 cytoplasmic loop. In that
report Duffy et al used surface plasmon resonance, ELISA and NMR approaches
to demonstrate that a portion of the C-terminal of Cx43 comprising amino acids
255-382 associated with a peptide corresponding to the second half of the Cx43
intracellular loop comprising amino acids 119-144, which was significantly
enhanced by low pH. The results reported here for the inhibition of Cx43 by
Ca2+-CaM has an interesting corollary to this pH-dependent inhibition described
by Duffy et al (438) in that binding of a portion of Cx43 C-terminus region or CaM
to the cytoplasmic region of Cx43 inhibits this gap junction protein. However,
while Sorgen et al (457) reported that dimerization of the Cx43 C-terminal region
may be one of the structural changes involved in the pH regulation of Cx43, our
data reported here indicate that Ca2+-CaM and the intracellular loop peptide
associate as a 1:1 complex; i.e. that a single Ca2+-CaM binds to Cx43 (i.e. 6
Ca2+-CaM per connexon hemichannel) to effect gap junction closure. Indeed
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while there is partial overlap of the C-terminal binding domain on the intracellular
loop (residues 119-144) and the CaM binding domain (residues 136-158), it is
clear that CaM will associate with a portion of Cx43 that is very close to the third
transmembrane loop of this connexins so it is well positioned to physically
obstruct the gap junction pore.
As in any molecular study conducted in vitro, direct extrapolation between
the data presented in this report using a peptide, and the mechanisms of Ca 2+CaM gating of Cx43 in intact cells needs to be made with caution. However, it is
worth noting that there are several examples in the literature demonstrating that
two molecular domains that associate in living cells also associate as separate
domains in vitro (60,458).

In the studies of CaM-target interaction, synthetic

peptides have been widely used due to their excellent ability to mimic specific
domains of native proteins (401,419,459-462) . Indeed Peracchia et al (391,434)
have shown that calmodulin is associated with gap junctions and plays a direct
role in the chemical gating of Cx32-containing gap junctions. This was supported
by data for CaM binding to Cx32 in which Török et al (435) identified two distinct
CaM binding amino acid sequences. The sequence of one of these sites in the
N-terminal domain of Cx32 contains a CaM binding motif common to a large
class of CaM-dependent proteins (439); notably this N-terminal CaM binding
sequence is absent in Cx43 and Cx44.

6.2.10. Indication of potential CaM-Cx43136-158 binding mode
Through its reversible binding of Ca2+ and the resultant conformational
changes, CaM is capable of interacting with over 300 target proteins to regulate a
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range of cellular events (3). Although the sequence identity among the CaM
targeted sequences is low, all the consensus peptides for such sequences (18 to
26-mer peptides) possess common features including their ability to form
amphipathic α-helices, containing 2-6 positively charged residues, and their
pattern of bulky hydrophobic residues that anchor the peptides to the
hydrophobic cleft of CaM. Our results demonstrate that the Cx43 136-158 sequence
forms an α-helical structure in TFE as well as in the CaM-peptide complex,
similar to other CaM-bound peptides (442,447,449,463,464). Two lysine and two
arginine residues are contained in the Cx43 136-148 sequence which has a high
predictive score for CaM binding. The basic residues in the N-terminus of CaMbinding sequences have been proposed to ensure an antiparallel orientation of
the peptide with respect to CaM (421), which is believed to optimize the
electrostatic attraction between the basic residues of the peptide with negatively
charged residues in CaM. In addition, the hydrophobic residues M147-L151-I156 of
the Cx43 peptide (I139-L143-V148) in the Cx44 peptide) reflect the 1-5-10 type of
CaM-binding pattern (Fig. 6.4), which is similar to the CaM-binding regions of
CaMKI and CaMKII (90,439,463).
In addition to the formation of α-helical structure by the Cx peptides, the
hydrophobicity of the peptide environment as well as the tertiary arrangement of
CaM are also changed following the formation of CaM:Cx complexes. As
indicated by the near UV CD studies, the chemical environment around the
tyrosine residues is significantly perturbed following the binding of Cx43 136-158 to
CaM. Furthermore, the significant blue shift and concomitant enhancement of
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fluorescence intensity induced by Cx peptides binding to dansyl-CaM (Fig. 6.10)
suggests that the dansyl group in dansyl-CaM is shielded from the solvent and
moves into a highly hydrophobic environment on binding to Cx peptides; similar
changes have been observed for the binding of dansyl-CaM to other receptors
(465-467). A number of the currently-assigned CaM resonances in the NMR 1H15

N HSQC spectra exhibited chemical shift movements ≥0.05 ppm. These

residues were spread in both the N- and C-terminal domains of CaM as well as in
the linker region, indicating that a global conformational change occurred upon
binding of the Cx43136-158 peptide to CaM. Such global changes of amide
chemical shifts have also been reported in other CaM complexes such as Ca 2+CaM-skeletal muscle myosin light chain kinase and Ca2+-CaM-CaMKI (420,468).
Together these observations suggest that the Ca2+-CaM-Cx interaction might
adopt the commonly seen wrapping-around mode of action (469).

6.2.11. In vivo functional analysis of the putative Cx43 CaM-binding site
Transient expression of a Cx43-EYFP construct without and with
mutations in communication-deficient HeLa cells provided a system by which to
test our biophysical data in a physiological manner. Because CaM interaction
with a protein requires both an electrostatic interaction and a hydrophobic
interaction, we generated two Cx43 mutants - Cx43K146E, R148E-EYFP that knocks
out the Cx43 electrostatic interaction with CaM, and Cx43 M147Q, L151E, I156E –EYFP
that knocks out the hydrophobic interaction of Cx43 with CaM.

Transient

expression of these EYFP-tagged Cx43 constructs was consistent with the
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anticipated results. The wtCx43-EYFP formed very large gap junction plaques
and dye transfer was restricted to those cells expressing EYFP fluorescence (see
Fig. 6.15A&E). With elevated [Ca2+]i, these junctions were no longer dye coupled
as reported by us previously with wt Cx43 that lacked the EYFP label.
As CaM has been implicated in Cx32 assembly at two stages of
oligomerization, it was anticipated that the Cx43 K146E, R148E-EYFP and Cx43M147Q,
L151E, I156E

–EYFP mutants would probably encounter problems reaching the

plasma membrane, and perhaps fail to form functional gap junctions. Indeed,
although both of the mutant Cx43 proteins did express, the majority of the
expressed protein was trapped inside the cell, very little of this protein appeared
to reside in the plasma membrane, and no obvious gap junction plaques were
observed. Thus it was not anticipated that either of the mutants would exhibit
cell-to-cell transfer of injected dye as reproducibly as we observed with the Cx43EYFP. This proved to be the case because while in low (~1 μM) [Ca 2+]i 100% of
the wt Cx43-EYFP transfected HeLa cells exhibited cell-to-cell transfer of injected
dye, only approximately 30% of each of the mutant-transfected HeLa cells
appeared to be functional and exhibited cell-to-cell transfer of injected dye (Fig.
6.15I). However, while elevated [Ca2+]i

completely prevented cell-to-cell dye

transfer between wt Cx43-EYFP transfected HeLa cells, elevated [Ca2+]i was now
unable to inhibit cell-to-cell dye transfer between HeLa cells transfected with
these Cx43 mutants. Thus, knocking out the CaM binding capability of the
residue 136-158 region of Cx43 abolished the Ca2+-dependent inhibition of Cx43
gap junctions supporting our biophysical data that demonstrates that CaM
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mediates the Ca2+-dependent inhibition of Cx43 via its interaction with residues
136-158 in this connexin.

6.3. Summary
In summary, we have identified a CaM binding sequence in the ubiquitous
gap junction protein Cx43 and Cx44. This sequence resides in a juxtamembrane
region of the only intracellular loop of Cx43 and Cx44. Our results demonstrate a
1:1 Ca2+-dependent CaM-Cx peptides interaction with an affinity in the
submicromolar range. The binding of this peptide to CaM enhances the Ca 2+
affinity of CaM 2-4 fold. These results explain the molecular basis of our
previously reported Ca2+-CaM-dependent regulation of both lens and Cx43containing gap junctions via a direct interaction of CaM with this connexin protein
(75,436). The data reported here confirms that this regulation is effected via the
Ca2+-dependent association of CaM with residues 136-158 of Cx43 (129-150 of
Cx44) that in turn affects a change in the structural organization of Cx43 or Cx44
such that gap junction permeability is significantly inhibited. Further elucidation of
the structural changes within both CaM and Cx43 is the subject of ongoing
investigations in this laboratory.
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7. Conclusions and major discoveries

We have developed a computational tool for the accurate prediction of EFhand or EF-hand-like Ca2+-binding proteins from primary sequences that will
benefit the whole metalloprotein field. To our knowledge, our server
(http://www.chemistry.gsu.edu/faculty/Yang/Calciomics.htm) is the first of its kind
to provide such service for scientists. More importantly, the comprehensive
prediction and detailed analysis on putative prokaryotic and viral EF-hand and
EF-hand like Ca2+-binding proteins will contribute to improved understanding of
versatile roles Ca2+ ions play in various biological systems, and should
encourage more intensive studies toward this direction.
The studies on the rubella virus (RUB) nonstructural (NS) protease have
established a model in which both Ca2+ and Zn2+ are required for the optimal
protease activity and efficient virus replication.
The studies on the interaction between CaM and connexins 43 and 44
have confirmed a Ca2+-dependent CaM-Cx interaction model and advanced the
understanding of the structural basis underlying Ca2+-dependent gating of gap
junction.
All of the completed work discussed in this dissertation combined
computational prediction methods, followed by extensive experimentation to
validate predictions through protein engineering and peptide approaches. More
importantly, as demonstrated by results from cell-based assays, the predicted
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motifs have been tightly linked to biological functions. Such three-pronged
“prediction to protein engineering to function” approaches could be extended to
the study of many other subjects.
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Appendices

This section includes: 1) analyzing key factors governing the metal binding
events by inserting well-characterized Ca2+-binding sequences from cellular
proteins into CD2.D1 with the grafting approach; 2) predicting and identifying a
putative CaM binding site in rubella virus nonstructural protease; 3) list of CD2
variants I made and their primary sequences and physiochemical properties.

A1. Analysis of factors affecting the metal-binding affinities of isolated
Ca2+-binding motifs
The established grafting approach enables us to study factors governing
the metal binding properties of isolated EF-hand motifs without the complexity
encountered in multiple cooperative Ca2+-binding processes. Specifically, we
have generated a series of engineered CD2 proteins grafted with i) the 12residue EF-loop and modified loops from the Ca2+-binding site III of calmodulin to
study the effects of charge distribution on metal binding affinities. ii) the pseudo
(denoted as CD2.Cal1) and canonical EF-hand loops (denoted as CD2.Cal2)
from calbindin D9k to examine the effects of coordinating residues on metal
binding affinities. At present, these constructs have been made and some
preliminary studies have been carried out. However, this project is still in its early
stage and will be further explored.
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A

B

Figure A1. The charge-ligand-balanced model. Both the number of negatively
charged ligand residues and the balanced electrostatic dentate-dentate
repulsion by the adjacent charged residues (positions 2 and 11) are two
determinants for the relative affinities of the EF-loops (1,2). Experimental
design to test the “charge-ligand-balanced model”. Substitutions of position 2
(residue Ile) and 11 (residue Glu) with Lys residues in the EF-loop IV of
calmodulin is expected to mimic the EF-loop I of calmodulin and has similar
affinity.
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Effects of charge distribution
Previous studies carried out by Dr. Yiming Ye and Dr. Hsiau-Wei Lee have
characterized the metal binding affinities of 4 EF-loops from calmodulin (1,2). It
has been found that the Tb3+binding constants follow the order of: I > II ~ III > IV,
which is correlated to the overall charge of the isolated EF-loops (-2, -2, -4, -5,
respectively) (Fig. A1A). Based on this observation, a “Charge-ligand-balanced
model” has been hypothesized, in which both the number of negatively charged
ligand residues and the balanced electrostatic dentate-dentate repulsion by the
adjacent charged residues are two determinants for the relative affinities of the
EF-loops (1,2). To further test this hypothesis, we further engineered the “lowestaffinity” site IV of EF-loop (denoted as CD2.IV5G) by mutating residues at
position 2 and 11 individually or in combination to positively-charged residue K
(denoted as I2K, E11K and KK, respectively) (Fig. A1B). These proteins have
been expressed and purified to homogeneity (Fig. A2A). The grafting of these
sequences will not disrupt the host protein structure (Fig. A2B & C). We will carry
out metal titration experiments to obtain metal binding affinities for each variant in
the future.

Effects of coordinating residues
EF-hand motifs are divided into two major types: the canonical EF-hands
and the pseudo EF-hands. The S100 protein Calbindin D9k contains a pseudo
EF-hand Ca2+-binding sites at its N terminus and a canonical EF-hand Ca2+binding sites at its C terminus (Fig. A3A). The major difference between these
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Figure A2. The grafting of EF-loop does not disrupt the host protein structure.
(A) SDS-PAGE of proteins under study. Far UV CD (B) and Trp fluorescence
(C) spectra of engineered proteins are also shown.
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Figure A3. The pseudo and canonical EF-hands in calbindin D9k. (A) 3D
cartoon representation of Ca2+-binding sites (highlighted as yellow) in
Calbindin D9k (PDB code: 1b1g). (left) Pseudo EF-hand loop coordinates
Ca2+ by mainchain carbonyls (position 1,4,6,9) and sidechain carboxylates at
position 14. (right) Canonical EF-hand loop chelates Ca2+ by sidechain
carboxylates (position1,3,5,12) and one mainchain carbonyl (position 7). The
water ligand is not shown here. (B) Grafting the EF-loops to CD2.D1. After the
insertion of 12- or 14-residue EF-loops, the host protein retains it native
structure, providing the foundation to study the effects of coordinating
residues on metal binding properties. (left) SDS-PAGE of engineered proteins
CD2.Cal1 and CD2.Cal2. (middle) Far UV CD spectrum of engineered
proteins. The observed difference below 210 nm arises from the insertion of
12 residues that increases the random coil structure by ~10%. (right)
Tryptophan fluorescence spectra of engineered proteins.
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two groups lies in the Ca2+-binding loop: the 12-residue canonical EF-hand loop
binds Ca2+ mainly via sidechain carboxylates (loop sequence positions 1, 3, 5,
12), whereas the 14-residue pseudo EF-hand loop chelates Ca2+ primarily via
backbone carbonyls (positions 1, 4, 6, 9). The residue at the position 9 (11 in
pseudo EF-hand) coordinates the Ca2+ ion through a bridged water molecule.
The pseudo and canonical EF-hand loops have a bidentate ligand (Glu) at
position 14 and 12, respectively. It is worth asking how the coordination of metal
ion by main chain carbonyls or side chain carboxylates will affect metal binding
properties. The grafting approach, which obviates the metal binding cooperativity
encountered in natural proteins containing multiple EF-hand Ca2+-binding sites,
would provide a solution to this question. Given that, we inserted the 14-residue
pseudo EF-loop (denoted as CD2.Cal1) and the 12-residue canonical EF-loop
(denoted as CD2.Cal2) into CD2.D1 between Ser52 and Gly53 with –GGG- linkers.
Now we have successfully designed and purified the proteins (Fig. A3B-D) and
will soon address this interesting question.

A2. Prediction of a putative CaM binding site in the RUB NS protease
Using the search program for CaM-binding sites (90) as described in
Section 6.2.1, a putative “IQ-like” CaM binding region with high predictive score
was identified in the rubella virus nonstructural protease. The location of the CaM
binding site is immediately prior to the entering helix of the helix-loop-helix EFhand Ca2+-binding motif (Fig A4). To test whether the predicted sequence is
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Figure A4. Prediction of a CaM binding site in RUB NS protease. (A) The
location of the predicted CaM binding site (CaMB). The CaMB is situated
prior to the entering helix of the EF-hand motif (black box). (B) Titration of
CaM into a synthetic peptide (red box) encompassing the putative CaMB in
the presence of Ca2+ (left upper) or EGTA (left lower). Right panel showed
the Trp intensity as a function of the [CaM]/[Peptide] ratio.
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capable of interacting with CaM in vitro, we synthesized a 32-mer peptide
encompassing

the

CaM

binding

(1152CWLRAAANVAQAARACGAYTSAGCPKCAYGRA1183).

region

Since the peptide

contains a Trp residue and CaM contains zero Trp and two Tyr residues, the Trp
fluorescence signal from the peptide can be used to monitor the interaction
between the peptide and CaM. As shown in Fig. A4B, the Trp fluorescence
emission spectrum of the free peptide exhibited a major peak at 354 nm,
indicating that the peptide is largely unstructured and the only Trp residue is fully
exposed to the solvent. Following the addition of CaM in the presence of 1 mM
Ca2+, the fluorescence intensity increased by nearly 2 fold and the emission peak
underwent a 16-nm blueshift, strongly suggesting that the Trp residue is now
buried within a highly hydrophobic environment due to the peptide-CaM
interaction. An apparent dissociation constant of 260 ± 6 nM is obtained by fitting
the curve with a 1:1 binding process. In the absence of Ca 2+, however, neither
fluorescence intensity enhancement nor emission peak shift is observed. Thus,
the interaction between the CaM binding site in RUB NS protease and CaM
seems to be a Ca2+-dependent event, which is commonly seen in many other
CaM-target interactions (90). Since the putative CaM binding site is within the NS
protease, it is expected that its effect would be on protease activity, either
through its interaction with the neighboring EF-hand Ca2+-binding motif or by a
mechanism independent of the EF-hand motif. It is also possible that the CaM
binding event has an effect on other unknown aspects of P150 function. The
physiological relevance of this CaM binding domain will be further characterized.
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A3. Primary sequences and physiochemical properties of engineered CD2
variants
Primary sequences of engineered CD2 variants:
>CD2
GSRDSGTVWGALGHGINLNIPNFQMTDDIDEVRWERGSTLVAEFKRKMKPFLKSGAFEI
LANGDLKIKNLTRDDSGTYNVTVYSTNGTRILNKALDLRILE
>CD2.RUBCA
GSRDSGTVWGALGHGINLNIPNFQMTDDIDEVRWERGSTLVAEFKRKMKPFLKSGGGDA
SPDGTGDPLDGGGAFEILANGDLKIKNLTRDDSGTYNVTVYSTNGTRILNKALDLRILE
>CD2.RUBCA.AA
GSRDSGTVWGALGHGINLNIPNFQMTDDIDEVRWERGSTLVAEFKRKMKPFLKSGGGDA
SPAGTGDPLAGGGAFEILANGDLKIKNLTRDDSGTYNVTVYSTNGTRILNKALDLRILE
>CD2.RUBCA.EF
GSRDSGTVWGALGHGINLNIPNFQMTDDIDEVRWERGSTLVAEFKRKMKPFLKSGGGSQ
RWSASHADASPDGTGDPLDPLMETVGAGGGAFEILANGDLKIKNLTRDDSGTYNVTVYS
TNGTRILNKALDLRILE
>CD2.SIN
GSRDSGTVWGALGHGINLNIPNFQMTDDIDEVRWERGSTLVAEFKRKMKPFLKSGGGDL
DNEKMLGTREGGGAFEILANGDLKIKNLTRDDSGTYNVTVYSTNGTRILNKALDLRILE
>CD2.POX
GSRDSGTVWGALGHGINLNIPNFQMTDDIDEVRWERGSTLVAEFKRKMKPFLKSGGGDY
DGNGTETRGEGGGAFEILANGDLKIKNLTRDDSGTYNVTVYSTNGTRILNKALDLRILE
>CD2.SHR
GSRDSGTVWGALGHGINLNIPNFQMTDDIDEVRWERGSTLXAEFKRKMKPFLKSGGGDL
DGDGKLSKTEGGGAFEILANGDLKIKNLTRDDSGTYNVTVYSTNGTRILNKALDLRILE
>CD2.CAL1
GSRDSGTVWGALGHGINLNIPNFQMTDDIDEVRWERGSTLVAEFKRKMKPFLKSGGGAA
KEGDPNQLSKEEGGGAFEILANGDLKIKNLTRDDSGTYNVTVYSTNGTRILNKALDLRI
LE
>CD2.CAL2
GSRDSGTVWGALGHGINLNIPNFQMTDDIDEVRWERGSTLVAEFKRKMKPFLKSGGGDK
NGDGEVSFEEGGGAFEILANGDLKIKNLTRDDSGTYNVTVYSTNGTRILNKALDLRILE
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>CD2.III5G.F
GSRDSGTVWGALGHGINLNIPNFQMTDDIDEVRWERGSTLVAEFKRKMKPFLKSGGGDK
DGNGYISAAELRHVMTNLGGGAFEILANGDLKIKNLTRDDSGTYNVTVYSTNGTRILNK
ALDLRILE
>CD2.III5G.EF
GSRDSGTVWGALGHGINLNIPNFQMTDDIDEVRWERGSTLVAEFKRKMKPFLKSGGGEE
EIREAFRVFDKDGNGYISAAELRHVMTNLGGGAFEILANGDLKIKNLTRDDSGTYNVTV
YSTNGTRILNKALDLRILE
>CD2.III5G.SKEAA
GSRDSGTVWGALGHGINLNIPNFQMTDDIDEVRWERGSTLVAEFKRKMKPFLKSGGGSE
EEKREAERVFDKDGNGYISAAELRHAATNLGGGAFEILANGDLKIKNLTRDDSGTYNVT
VYSTNGTRILNKALDLRILE
>CD2.IV5G
GSRDSGTVWGALGHGINLNIPNFQMTDDIDEVRWERGSTLVAEFKRKMKPFLKSGGGDI
DGDGQVNYEEGGGAFEILANGDLKIKNLTRDDSGTYNVTVYSTNGTRILNKALDLRILE
>CD2.IV5G.I2K
GSRDSGTVWGALGHGINLNIPNFQMTDDIDEVRWERGSTLVAEFKRKMKPFLKSGGGDK
DGDGQVNYEEGGGAFEILANGDLKIKNLTRDDSGTYNVTVYSTNGTRILNKALDLRILE
>CD2.IV5G.E11K
GSRDSGTVWGALGHGINLNIPNFQMTDDIDEVRWERGSTLVAEFKRKMKPFLKSGGGDI
DGDGQVNYKEGGGAFEILANGDLKIKNLTRDDSGTYNVTVYSTNGTRILNKALDLRILE
>CD2.IV5G.KK
GSRDSGTVWGALGHGINLNIPNFQMTDDIDEVRWERGSTLVAEFKRKMKPFLKSGGGDK
DGDGQVNYKEGGGAFEILANGDLKIKNLTRDDSGTYNVTVYSTNGTRILNKALDLRILE
>CD2.STIM1
GSRDSGTVWGALGHGINLNIPNFQMTDDIDEVRWERGSTLVAEFKRKMKPFLKSGGGSF
EAVRNIHKLMDDDANGDVDVEESDEFLREDLGGGAFEILANGDLKIKNLTRDDSGTYNV
TVYSTNGTRILNKALDLRILE
>CD2.PMR1
GSRDSGTVWGALGHGINLNIPNFQMTDDIDEVRWERGSTLVAEFKRKMKPFLKSGGGSV
DEALEKLDTDKNGGLRSSNEANNRRSLYGGGAFEILANGDLKIKNLTRDDSGTYNVTVY
STNGTRILNKALDLRILE
>CD2.CX43
GSRDSGTVWGALGHGINLNIPNFQMTDDIDEVRWERGSTLVAEFKRKMKPFLKSGGGKY
GIEEHGKVKMRGGLLRTYIISGGGAFEILANGDLKIKNLTRDDSGTYNVTVYSTNGTRI
LNKALDLRILE

246

Table A1. The physiochemical properties of engineered CD2 variants.
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